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Abstracts 
 
Proteins and enzymes are large and complex biological molecules, characterized by unique 
three-dimensional structure are highly flexible and dynamic nature. Thorough understanding 
of protein and enzyme function requires studying of their conformational flexibility, because 
important physiological processes, such as ligand binding and catalysis rely on an enzyme’s 
dynamic nature and their ability to adopt a variety of conformational states. Computational 
methods are widely applied in studying enzymes and proteins structure and function 
providing a detailed atomistic-level of resolution data about the dynamics and catalytic 
processes, mechanisms in biomolecules, therefore even more nowadays a term 
‘computational enzymology’ has emerged. Experimental methods often have difficulty in 
predicting dynamic motions of proteins. Computational simulations techniques, such as 
Molecular Dynamics simulations, have proven successful in simulating the conformational 
flexibility of proteins in studying structure-function relationships.  
Additionally, the binding events between two molecules, e.g. an enzyme and its substrate, 
can be computationally predicted with molecular docking methods. Enzymes are proteins 
that catalyse almost all biochemical reactions and metabolic processes in all organisms. In 
order to study the conformational flexibility of proteins we apply molecular dynamics 
simulations, and in order to simulate their reaction mechanisms we apply quantum 
mechanical simulations. Quantum mechanical simulations can also be used to predict the 
electronic structure of organic compounds, by calculating their electronic structures we 
perform orbital analyses and predict their optical properties. The results gained from our 
computational simulations can give new insights into explanation of experimental findings 
and data and can inspire and guide further experiments.  
Focus of this thesis is computational investigation of the following systems: 
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Comparative Molecular Dynamics (MD) investigation of Tryptophan 7-halogenase 
and Tryptophan 5-halogenase – These two enzymes are responsible for the halogenation 
of tryptophan, they do this in a highly regioselective manner. Halogen substituted natural 
products, such as antibiotics, are a particular area of interest to the pharmaceutical industry, 
however efficiently producing these compounds in a regioselective manner poses a 
significant challenge. In contrast, halogenating enzymes can perform direct halogenation of 
aromatic organic compounds, using only halide salts and mild conditions they can produce 
greater yields than present synthetic methods. Therefore a detailed understanding of the 
enzymatic mechanism of regioselective halogenation of natural organic compounds and 
knowledge of the origin of their regioselectivity is important for inspiring new paths for the 
organic chemical synthesis of new halogenated compounds.  
Our study focuses on structural analysis through extensive Molecular Dynamics (MD) 
simulations of two flavin-dependent tryptophan halogenases; tryptophan 7-halogenase 
(PrnA) and tryptophan 5-halogenase (PyrH). Long range atomistic MD simulations of the 
two enzymes were performed, for 1 microsecond, in order to elucidate structure-function 
relationships and mechanistic implications related to the origin of regioselectivity in both 
enzymes. The performed MD simulations show that the binding sites of the cofactor-flavin 
adenine dinucleotide (FAD) and the substrate tryptophan do not come into close proximity 
during the timescale of the simulations. MD simulations confirmed that the FAD “strap” 
region observed previously in the PyrH crystal structure also exists in PrnA and likely fulfils 
a similar role, and acts as a line of communication between the two distant binding sites. The 
two catalytically important active site residues glutamate and lysine proposed 
experimentally to be involved in binding and the reaction mechanism of chlorination of 
tryptophan are vital to the orientation and positioning of the proposed chlorinating agent 
hypochlorous acid. It is likely that the positioning of the hypochlorous acid supported by 
glutamate and lysine and the environment they create in close proximity to the to-be 
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halogenated carbon drives the reaction. In addition, the differences in the regioselectivity 
between PrnA and PyrH probably arises due to differences in the tryptophan binding site, 
positioning different sides of the tryptophan indole ring towards the active glutamate and 
lysine sidechains. 
 
Quantum mechanical (QM) investigation of the electronic structure of the Fat mass 
and obesity associated protein (FTO) – FTO is a protein associated with the regulation of 
metabolism, certain mutant forms of the enzyme are found to cause an increased risk of 
obesity, cancer, diabetes, and Alzheimer’s disease. FTO is part of a family of enzymes 
known as non-heme iron 2-oxoglutarate dependent oxygenases, it catalyses the removal of 
methyl groups from DNA and RNA nucleotides. It repairs DNA/RNA bases that have 
become damaged by external alkylating agents, and restores them to their natural states, it 
also has an as of yet unknown regulatory role in demethylating adenine in messenger RNA. 
Understanding the reaction mechanism of FTO can aid in the design of novel inhibitor 
molecules that may be used to treat a range of conditions related to FTO malfunction. The 
reaction mechanisms of 2OG dependent oxygenases are well conserved across the family of 
enzymes, and other enzymes of this family have been extensively studied with quantum 
mechanical simulation techniques. Our study focuses on the formation of the reactive 
Fe(IV)-oxo species, this species is responsible for substrate hydroxylation which leads to the 
formation of the demethylated substrate. To study the electronic structural changes of the 
reaction mechanism quantum mechanical calculations were performed on cluster models of 
the enzymes active site, as well as combined quantum mechanics/molecular mechanics 
methods. These calculations have given us insight into the electronic structure of the 
enzyme’s active site and the effect that individual residues have on the proposed reaction 
mechanism.  
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MD simulations and docking of the mammalian fructose transporter protein GLUT5 
– GLUT proteins are facilitator transporter proteins responsible for the movement of 
carbohydrate molecules into cells, they do this in a substrate specific manner. GLUT5 is an 
unusual GLUT transporter as it is responsible solely for the transport of fructose, and is 
found to be aberrantly over expressed in certain types of cancer. Cancer cells use altered 
metabolic pathways to fuel their rapid proliferation into tumours, understanding the 
mechanism of fructose transport by GLUT5 may assist in the development of new diagnostic 
and therapeutic techniques against cancer. To aid in this, we have collaborated with an 
experimental group focussed on the development of fluorescent probes that are selectively 
transported by GLUT5. These Mannose-Coumarin (ManCou) probes can be used as 
fluorescent markers against cells that have over expressed GLUT5 allowing for the non-
invasive identification of these cancer cells. Molecular docking techniques have been used 
to predict the binding pose of the natural substrate fructose to the GLUT5 receptor due to 
the lack of experimental structures of this receptor-ligand complex. Based on this we were 
able to predict the binding mode of the experimentally developed ManCou probes and 
provide structural insight into how they interact with the GLUT5 receptor. Based on the 
predicted ligand bound structures we have created a membrane bound GLUT5 system and 
performed molecular dynamics simulations in order to understand its conformational 
flexibility and the interactions between the ligand and the receptor over time.  
 
Docking analysis of Odorranalectin- This peptide is the smallest known protein found to 
exhibit lectin-like carbohydrate binding properties, this selective recognition and binding of 
specific carbohydrate residues make it a particularly interesting compound. Cancer specific 
glycans are aberrant glycosylated structures that are only produced by cancerous cells, these 
structures can be recognised on the surface of cancer cells. Lectin proteins can specifically 
recognise these cancer specific glycans, allowing for the creation of new diagnostic tests for 
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cancer that allow for early detection, and lead to better treatment outcomes. Lectins can also 
bind to cancer specific cell surface glycans and interfere with cell adhesion to prevent tumour 
cells from metastasising. Our computational simulations were used to compliment 
experiments performed by our experimental collaborators to predict the binding of various 
sugar molecules to Odorranalectin and predict their binding energies. The resultant energies 
were found to correlate with the experimental binding affinities of the sugars and provided 
insights into key experimental findings.  
 
QM calculations of Fluorescent Probes – Fluorescent probes are important chemical 
compounds used to track the movement of tagged molecules through biological systems in 
non-invasive manner. The pH sensitive fluorescent probes show observable differences in 
their fluorescent properties in response to pH change, and thus can allow the visualisation of 
pH in incredibly small intracellular spaces. Cancer cells are known to have particularly 
acidic intracellular pH levels in comparison to those of healthy cells, being able to detect the 
pH changes associated with tumour formation could lead to new methods of cancer 
diagnosis. Our experimental collaborators have developed novel pH sensitive fluorescent 
probes for the purpose of imaging intracellular pH. Our computational studies have aided in 
explaining the difference in the electronic structures and properties of the developed probes. 
Using quantum mechanical simulation methods, we have provided atomistic details that will 
assist in the design and development of new fluorescent probes.   
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1 – INTRODUCTION 
 
Enzymes are complex biological molecules which catalyse biochemical reactions in the 
cellular environment, they are able to greatly accelerate the rate of a reaction and show high 
specificity towards a substrate. Enzymology is a mature field with a wealth of experimental 
research; however, this experimental methodology has limits regarding the study of  
structure function relationships at the atomistic level. When the first three-dimensional 
atomic structure of an enzyme was elucidated in 1965 [1] it was realised that the static 
structure provided by the atomic coordinates could not fully explain how the enzyme 
catalyses the reaction [2]. To understand an enzyme’s reaction mechanism several factors 
must be accounted for; the steric and electronic environment created by the proteins active 
site as well as the way the enzymes internal dynamics can affect the structure of the active 
site. Quantum Mechanics (QM) simulations are an ab-initio method which allow us to 
investigate the electronic environment of a reaction by simulating electrons using the 
Schrödinger wave equation to better understand reaction mechanisms [3]. Molecular 
Dynamics (MD) simulations are an empirical method which allow us to sample the 
conformational dynamics of a protein over time, with the aim of identifying important 
motions that may influence the reaction mechanism and lead to a greater understanding of 
the proteins structure [4-6].  
Empirical methods often referred to as Molecular Mechanics (MM), use parameters derived 
from experiments or high level ab-initio QM calculations and are computationally “cheap” 
allowing for large system sizes of thousands of atoms and long simulation timescales of 
microseconds (µs). This allows them to study phenomena such as protein dynamics and 
protein folding as well as the sampling of thermodynamic properties such as the free energy 
of binding. However, MM does not simulate electrons so cannot be used to study reactivity, 
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for this, QM simulation methods are necessary. By simulating electrons and nuclei with the 
Schrödinger wave equation QM methods can accurately model chemical reactions and study 
the factors that influence them. This high level of theory comes at the cost of large 
multifactorial calculations which take a long time to solve, this limits the size of systems to 
tens or hundreds of atoms depending on the exact computational cost of the method used. A 
technique which combines QM and MM exists [7]. Combined Quantum 
Mechanics/Molecular Mechanics (QM/MM) are a multi-scale method often used for the 
modelling of enzymes which treats the reactive subset of atoms in the system with a QM 
level of theory, without incurring the computational cost of applying this calculation method 
to the whole system by treating the remainder of the atoms with an MM level of theory [6]. 
The QM subset is influenced by the electronic and steric effects of the surrounding 
environment allowing for a more accurate representation of an enzymes active site. 
Molecular docking is another empirical technique used to predict the binding between two 
molecules, these are usually peptides or small drug like molecules being docked to receptor 
proteins [8]. Docking can be used to assist the design of novel compounds that target a 
desired receptor to produce an inhibitory or activating effect [9]. 
These computational techniques are often used in conjunction with and to compliment 
conventional lab based experiments, they can help explain experimental data and provide 
new insights to chemical phenomena that can drive more directed experimentation [10].  
1.1 MOLECULAR MECHANICS 
 
Molecular mechanics (MM) uses classical mechanical physics to model atoms and 
molecules, the models don’t rely on electronic structure simulation as is the case with QM 
but instead use empirical data gathered from known molecules or high level ab-intio QM 
calculations. Although they cannot explain the electronic structural changes of chemical 
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reaction processes, the MM method lends itself incredibly well to defining the structural 
properties of molecules such as shape, volume, flexibility and the change in these properties 
over time [11]. The measurement and observation of these properties is particularly 
important in the study of proteins and enzymes, when the first structures of proteins were 
resolved by experimental techniques it became apparent that these static models weren’t 
adequate representations of the actual structure [2]. The dynamic movements of these 
biological molecules had to be accounted for to explain their biological functions [12]. MM 
methods are relatively computationally “cheap” compared to QM methods, they can 
incorporate systems sizes of hundreds of thousands of atoms as opposed to the hundreds of 
atoms offered by even the lower level QM theories. This allows them to simulate solvated 
protein systems, allowing the study of their dynamic nature in a physiological environment.  
 
MM theory is based on force fields with most being specialised to a specific class of 
molecules e.g. protein and biological, hydrocarbons, polymers, etc. The forcefields are 
composed of parameters; each element can have several atom types each corresponding to 
how it is bonded to other atoms. For instance, a detailed MM force field for hydrocarbons 
will reflect all the different carbon-carbon bond types as well as the most common groups it 
may be bonded to. The atom types have defined parameters obtained through experimental 
observation with techniques such as X-ray crystallography, NMR, IR spectroscopy as well 
as high level QM calculation [13]. The parameters cover all the different atomic motions and 
interactions, these can be divided into the two categories bonding and non-bonding 
interactions. The bonding interactions can then be split into bond stretching, bond angle 
bending and dihedral torsion. Non-bonded interactions are split into van der Waals and 
electrostatic interactions. A typical force field to describe the energy of a system in its 
functional form is shown in Equation 1. 
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𝑉(𝑟𝑁) = ∑
𝑘𝑖
2
(𝑙𝑖 − 𝑙𝑖,0)
2 +
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𝑘𝑖
2
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2 +
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(1 + cos (𝑛𝜔 − 𝛾))
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+ ∑ ∑ (4𝜀𝑖𝑗 [(
𝜎𝑖𝑗
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)
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− (
𝜎𝑖𝑗
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)
6
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𝑞𝑖𝑞𝑗
4𝜋𝜀0𝑟𝑖𝑗
)
𝑁
𝑗=𝑖+1
𝑁
𝑖=1
 
Equation 1: A term for calculating the potential energy (𝑽) of a number (𝑵) of particles of 
positions (𝒓) and includes all the bonding and non-bonding interactions between these. 
 
1.1.1 Bonded Interactions 
The bond stretching and compression term calculates the potential energy associated with 
this action using Hooke’s law, the bond is represented as a spring of length (𝑙𝑖) and deviation 
from the ideal length (𝑙𝑖,0) results in an increase in potential energy. Bond angles are 
calculated in the same fashion, instead of an ideal bond length there is a reference bond angle 
(𝜃𝑖,𝑜) parametrised for the angle between three atom types and any deviation from (𝜃𝑖,𝑜) to 
another angle (𝜃) coincides with an increase in the potential energy. Bond torsion or dihedral 
angle rotation occurs between four atoms and refers to the out of plane twisting of these. It 
is a more complex interaction than angle bending or bond stretching as there are several 
fluctuations in the potential energy when the bond is rotated 360° based on the steric 
hindrance and symmetry of the attached groups, hence it can’t be expressed in a similar way 
to bond stretching and bending [14]. The angle 𝜔 is the dihedral angle between the 1st and 
4th atom, 𝑉𝑛  is the barrier height of the energy, 𝑛 is the symmetry number i.e. the number of 
times the wave repeats in a 360° rotation and 𝛾 is used to determine whether the energy is at 
a minima of maxima when 𝜔 is 0°; if it is a maxima then 𝛾=0 and if it is a minima then 
𝛾=180. Improper dihedrals are another type of torsion force that is used in some forcefields 
to ensure planarity is maintained for certain atoms such as aromatic rings. 
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1.1.2 Non-bonded Interactions 
Non-bonded interactions all rely on charge relationships so the permittivity of the medium 
(𝜖) plays a role in modulating their strength. The Lennard-Jones 12-6 potential is one 
common way of approximating the Van der Waals (VDW) interactions between two 
particles [15]. The strength of the interaction is dependent on two parameters that can be 
most easily illustrated by a graph (Figure 1). 
 
 
Figure 1: A graphical representation of Lennard-Jones potential. 
 
The value of 𝜎 represents the distance at which the potential energy between the two particles 
is 0 being neither attractive nor repulsive, it is different for each pair of particles and is 
obtained through experimental observation. The Lennard-Jones 12-6 potential is widely used 
due to its computational simplicity even though more accurate models of van der Waals 
interactions exist [11]. 
 
Electrons and protons aren’t modelled explicitly in the MM model so atoms have to be 
assigned partial charges based on their atom type parameters. The forces between two 
charged particles are then calculated using Coulomb’s law, where 𝑞 is the magnitude of the 
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charge expressed in coulombs for each point charge and 𝑟 is the distance between the 
particles. Giving partial charges to atoms is an approximation, real charges rely on electron 
movement which is dynamic and polarizable. Although polarizable forcefields exist they 
present their own unique challenges and are mainly used for specialized systems where they 
are absolutely necessary [16].  
 
Because non-bonded interactions don’t decay to zero in theory every particle in a system has 
an effect on every other particle, this would be incredibly computationally expensive to 
implement. To simplify non-bonded interactions cut-off ranges are used, atoms outside of a 
predetermined distance range aren’t considered when calculating the non-bonded energy of 
two particles [14]. The cut-off distance for long range interactions can have a significant 
effect on the results of an MD simulation, choosing the cut-off distance for the van de Waal’s 
and electrostatic interactions is an important compromise between being large enough for 
accuracy and small enough for computational efficiency [17]. 
 
1.1.3 Solvent Modelling  
Solvent effects play a key role in enzyme catalysis as well as overall protein structure, 
dehydrated enzymes are generally not active [18], therefore simulations done in vacuum 
aren’t representative of the true nature of the protein. The majority of modern enzyme 
simulations use explicit solvation and depending on their size will usually contain thousands 
of water molecules which will be treated at the MM level of theory. A variety of forcefields 
exist to simulate water, commonly used ones include SPC[19], SPC/E[20], TIP3P and 
TIP4P[21]. These different water models vary in how they treat the distribution of point 
charge in the water molecule as well as minor changes in geometry and Lennard-Jones 
potential parameters, these are adjusted to better correlate with experimental results [22]. 
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1.1.4 The Common MM forcefields 
The AMBER forcefield was originally developed by the Weiner group [23] for the modelling 
of proteins and nucleic acids [24]. It used bonded parameters obtained from crystallographic 
structures of peptide fragments, VDW interaction parameters from earlier liquid state 
simulations and partial charges were obtained through QM calculations. The AMBER 
forcefield is updated often with each new package of AMBER. Related AMBER forcefields 
also exist for the simulation of lipids, DNA, zinc coordination and non-biological systems 
[25, 26]. 
The GROMOS forcefield was created alongside the GROMACS program for molecular 
dynamics simulations at the University of Groningen [27]. Containing parameters for a range 
of biological molecules the program is free and open source. The GROMOS forcefield 
exclusively uses a united atom system where aliphatic non-polar hydrogen atoms are 
subsumed into their constituent carbon atoms. 
CHARMM was created as both a forcefield and software package by the Karplus group[28] 
for use in molecular dynamics simulations. It features parameters for DNA, RNA, proteins, 
lipids, sugars and other biological molecules of importance. 
OPLS was originally created by Jorgensen et al[29] for the simulation of water and other 
liquids but grew to include proteins and other biological molecules. Like AMBER 
CHARMM and GROMOS the first versions of OPLS were united atom forcefields but now 
all atom versions are also available.  
 
1.1.5 Parametrisation 
To simulate new molecules containing atom types not available in a forcefield, 
parametrisation of the new molecule must be undertaken. Some examples of molecules 
generally not found in biological forcefields but that are important to include are: small 
molecule ligands, non-standard or modified amino acids, and coordinated metal ions. The 
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new parameters for the bonded and non-bonded interactions as well as atomic charges and 
assigned atom types are collected in a topology file, this topology can then be integrated into 
the simulation setup process and allows the parametrised molecule to be simulated along 
with other atoms in a simulation. 
 
Parametrisation is generally achieved using a combination of identifying atom types in the 
new molecule for which parameters already exist and using these, as well as QM calculations 
to create new parameters for those which no usable analogous parameters exist. This can be 
done in an automated way using webservers like PRODRG[30] or SwissParam[31], or 
packages like Antechamber[32] or MCPB[33] for AMBER[34]. 
 
1.2 MOLECULAR DYNAMICS SIMULATIONS        
 
Molecular Dynamics (MD) uses the MM forcefield to calculate the forces acting on a 
particle, this is a rearrangement of Newton’s second law (Equation 2). In this equation, the 
subject is changed to calculate the acceleration (𝑎) acting on the particles, where the forces 
(𝐹 calculated by the forcefield) and mass (𝑚) are known. For more than one particle we can 
write the equation of motion with acceleration as a derivative of velocity 𝑣, and velocity as 
a derivative of position 𝑥, where 𝑥 represents the coordinates of all atoms (Equation 3). The 
resulting differential equations can then be solved numerically, but in reality Verlet methods 
are employed along with discrete timesteps to improve their implementation into MD 
software. 
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𝑎 = 𝐹/𝑚 
Equation 2: The rearrangement of Newton’s second law equation. 
 
𝑑𝑥
𝑑𝑡
= 𝑣       
𝑑𝑣
𝑑𝑡
=
𝐹(𝑥)
𝑚
 
Equation 3: The derivative equation of motion. 
 
The simulation proceeds in timesteps (usually 1-2 femtoseconds), for each timestep the 
forces are calculated and the atomic coordinates are moved and velocities are updated, this 
process is repeated with each new calculation updating the velocity and coordinates to 
produce a trajectory. Simulations are started from coordinates with each atom having an 
initial velocity that is randomly assigned according to a Boltzmann distribution for the 
temperature of the simulation.  
 
MD simulations of proteins typically use coordinates derived from X-ray crystallography or 
NMR experiments, although homology modelling techniques can be used predict the 3D 
structures of proteins based on their amino acid sequences[35]. X-ray crystallography cannot 
accurately resolve the position of hydrogen atoms due to their small size, these are added to 
the structure at the start of the simulation setup process. The initial structure needs to be 
energy minimised to remove slight inaccuracies or artefacts in the initial coordinates that can 
lead to unnatural structures and ultimately simulation crashes. Energy minimisation is 
performed using the MM forcefield usually using different algorithms designed to move the 
atomic coordinates towards local energy minima. When using MD methods to study proteins 
it is usually desirable to study them under physiological conditions, this means solvated in 
water at ~300K and 1atm of pressure. Solvation effects can be simulated with either implicit 
or explicit methodologies, implicit solvation attempts to mimic the effects of solvent 
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molecules using an artificial polarizable homogenous medium to reduce the number of 
particles in the system, however they cannot model important atomistic protein-solvent 
interactions. Explicit solvation uses large numbers of solvent molecules, usually with fixed 
atomic charges, to model the effect of solvation on the protein structure. The inclusion of 
solvation brings about the problem of periodicity, that is, how are particles at the edges of 
the system treated? In a simulation box with a fixed size, particles near the edge will collide 
with the boundaries and experience different forces than those at the centre of the box, this 
would create irregularities in the density of the system. A solution to this problem is the 
inclusion of Periodic Boundary Conditions (PBC), under these conditions the box is 
surrounded by identical copies of itself in every plane, a particle moving out of the box on 
one side will re-enter the box on the opposite side. 
 
1.3 MOLECULAR DOCKING 
 
Molecular docking was primarily designed to predict the binding of small drug like 
molecules to receptor proteins, many diseases are caused by the malfunction of proteins and 
therapies are focused on the inhibition or activation of these specific target proteins. 
Traditional lead generation methods for drug discovery normally entail assaying a large 
variety of interesting compounds against a specific protein known to be a disease target and 
hoping to observe a binding interaction [36]. Modern high throughput screening uses robots 
to automate the both the handling of the experiment and observation of the results to greatly 
increase throughput. However, these experimental techniques are still limited by the need to 
have a constant supply of new compounds, proteins/enzymes and laboratory resources [36]. 
Docking can be used to virtually screen new compounds in a similar way to physical high 
throughput screening as well as offering atomistic level insight to aid in structure based drug 
design [37].  
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The aim of docking is to find stable binding conformations between two molecules, this is 
achieved by assessing all the possible conformations in a defined space [38]. Usually the 
spatial search is limited to a known binding site which is predicted by experimental 
observations, however specialised software can also be used to identify protein binding sites 
[39]. This reduction of spatial search area reduces the number of possible conformations to 
a more manageable search. Blind docking refers to the practice of not restricting the search 
area of the docking to a confined active site and instead considering the entire protein surface 
for possible docking conformations, this technique is much more computationally intensive 
but can be useful for finding previously unknown secondary binding sites [40, 41].  
 
Aside from considering all possible conformations a docking process must also be able to 
rank these conformations to determine which pose produces the most chemically realistic 
and stable binding conformation. Evaluation of the different potential poses is also called 
scoring, most docking programs use an MM type forcefield to estimate the difference in free 
energy of binding (ΔGbinding) between the free ligand and receptor and the ligand and 
receptor complex, a typical way of estimating this is shown in Equation 4 [42]. In this 
equation L is the ligand, R is the receptor, the potential energy difference terms are 
represented with V and 𝛥𝑆𝑐𝑜𝑛𝑓 represents an estimation of the change in entropy upon ligand 
binding. Calculating the potential energy V has several constituent factors such as: van der 
Waals, electrostatic and hydrogen bonding interactions, any internal strain energy incurred 
by the docking pose as well as the desolvation energy needed to displace water molecules in 
the receptor site. One way of combining these factors for energy calculation is shown in 
Equation 5 where W is a weighting constant which is a parameter based on observed 
experimental binding constants. The energy contribution of the different types of interaction: 
VDW, H-bond, desolvation, Electrostatic and torsional are calculated via classical 
mechanics methods similar to that used for the typical MM forcefield in Equation 1. 
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ΔG𝑏𝑖𝑛𝑑𝑖𝑛𝑔 = (𝑉𝑏𝑜𝑢𝑛𝑑
𝐿−𝐿 −  𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝐿−𝐿 )+(𝑉𝑏𝑜𝑢𝑛𝑑
𝑅−𝑅 −  𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝑅−𝑅 ) + (𝑉𝑏𝑜𝑢𝑛𝑑
𝑅−𝐿 −  𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝑅−𝐿 +  𝛥𝑆𝑐𝑜𝑛𝑓) 
 
Equation 4: A typical way of calculating the free energy of binding for a receptor ligand 
complex. 
 
 
Another large factor to consider in the docking search is the flexibility of the ligand and 
receptor molecules, in reality molecules are never static so the consideration of flexibility 
and torsion of bonds is incredibly important in ensuring the accuracy of the docking process.  
Rarely is completely static docking appropriate, both ligand and receptor will change shape 
to accommodate one another [43]. Allowing bonds to rotate and flex increases the degrees 
of freedom and therefore the complexity of the conformational search. Allowing a small 
number of bonds to rotate in the ligand doesn’t incur much of a penalty with modern 
computational power. However, simulating the flexibility of a protein receptor can be a more 
complex task due to the much larger number of rotatable bonds. Most docking software 
places limitations on this by only allowing a set number of user specified sidechains to be 
flexible, this in order to keep the possible number of conformations to a manageable number 
[42].  
 
Different algorithms have been designed to more optimally search the conformational space 
thus reducing the computational time needed allowing for a more exhaustive search. One of 
the simplest algorithms for docking is the shape-complimentary method, the ligand and 
V = WVDW + WH-bond + Wdesolvation + WElectrostatic + Wtorsional 
Equation 5: An example of an empirical potential for calculating the potential energy 
between a ligand and recpetor 
27 
 
receptor binding site are represented as two complimentary surfaces and the algorithm seeks 
to create poses with the best fit between them as well as considering those with the most 
complimentary interactions [44, 45]. Complimentary docking methods are relatively 
computationally inexpensive but cannot consider flexibility so must be used with caution. 
Other docking algorithms are based on MD, by sampling the conformational flexibility of 
the ligand and receptor in multiple short MD runs followed by MM minimisations some of 
the flexibility of both the ligand and receptor can be simulated [46]. MD based docking 
algorithms tend to be relatively computationally expensive, however they have the 
advantage of being able to model flexibility. Another common method for docking involves 
the use of genetic theory to aid the conformational search, genetic algorithms represent each 
potential pose as a “gene” [47]. Pairs of genes are combined to produce new genes which 
are a random combination of their parents, in practice this means potential poses are 
combined to create a pose which include elements of the two parent poses [48]. In addition 
to the combination genes the algorithm implements a fitness function which discards poses 
which score poorly. In addition to regular combination, some random mutation of the pose 
geometry is introduced to improve variety in the gene pool. Genetic algorithms are very 
effective at finding low energy binding poses in docking situations with large conformational 
search areas, however, they may require a large number of evaluations to find the pose with 
the best binding affinity [46]. 
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1.4 QUANTUM MECHANICS 
 
Quantum mechanical methods for studying chemistry are primarily concerned with the 
Schrödinger wave equation (Equation 6), this equation seeks to calculate the wavefunction 
(ψ) for a particle [49]. The wavefunction of a particle is a property which is difficult to 
represent using classical physics and is a unique concept in quantum mechanics, however it 
can provide us with the means to calculate physical properties such as the velocity, position 
and spin of a particle. In the Born interpretation the square of the wavefunction is the electron 
density, calculating this gives us the probability of finding an electron in a given volume 
[50], and thus we can derive all the physical properties and measurements in the system [49]. 
The Hamiltonian operator (?̂?) is the sum of the kinetic and potential energy of all the 
particles present, it acts on the wavefunction to produce the total energy (E) as an eigenvalue 
[51].  
?̂?ψ = Eψ 
 
Equation 6: The time independent Schrodinger wave equation. 
 
−
(ℎ/2𝜋)2
2𝑚
∇2 ψ −
𝑍𝑒2
4𝜋𝜀0𝑟
ψ = Eψ 
Equation 7: The Schrodinger equation for the hydrogen atom. 
 
In Equation 7, ℎ is Planck’s constant, 𝑚 is the resting mass of an electron and the portion 
of the equation referring to the change in Cartesian coordinates is substituted by the 
Laplacian operator (∇2). The coulomb interaction term describes the attractive energy 
between the orbiting electron and the nucleus; it is always a negative value to reflect this 
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being a potential energy quantity. In this term 𝑍𝑒 represents the charge of the nucleus where 
𝑍 is the atomic number of the atom and 𝑒 is the unit of elementary charge (1.6022x10-19 
Coulombs), 𝜀0 is the permittivity of a vacuum (a constant 8.8542x10
-12 J-1C2m-1) and 𝑟 is the 
distance between the electron and the nucleus [52].  
 
Somewhat simplifying the equation for atoms larger than hydrogen is the Born-Oppenheimer 
approximation, this states that since the electrons weigh around 1800 times less than the 
lightest nucleus (the proton at the centre of the hydrogen atom) the movements of the 
electrons will instantaneously adjust with any changes in position of the nuclei [53]. 
 
[−
(ℎ/2𝜋)2
2𝑚𝑒
(∇𝐴
2 + ∇𝐵
2 ) + (−
𝑍𝑒
2
4𝜋𝜀0𝑟
(
𝑍
𝑟𝐴
+
𝑍
𝑟𝐵
−
1
𝑟𝐴𝐵
))] ψ = Eψ 
 
Equation 8: The Schrodinger equation for a helium atom. 
 
The Schrödinger wave equation for the helium atom is shown in Equation 8, in this equation 
there are two electrons A and B, each ∇𝐴 
2  or ∇𝐵 
2  represents the change in position of the 
Cartesian coordinates of one of the electrons. 𝑟𝐴 and 𝑟𝐵 represent the distance of the two 
electrons A and B from the nucleus and 𝑟𝐴𝐵 is the distance of the two electrons from one 
another. Since there are two electrons in the helium atom there are three particles all 
interacting with one another, two electrons and one nucleus, this is a three bodied problem 
for which no exact solution can be calculated [54]. Another problem arising with the 
Hamiltonian for the helium atom relates to it not including a term to take into account the 
electron spin. Electrons like most other sub atomic particles have an innate quantum 
mechanical property known as spin; electrons can either have a spin quantum number of 
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+1/2 (spin up) or -1/2 (spin down). The importance of spin becomes apparent when 
considering the Pauli Exclusion Principle; it states that no two electrons may occupy the 
same orbital unless they are of opposite spin. This lays down the foundations of atomic 
orbital structure, and helps defines the s, p, d and f orbitals chemists are familiar with [55].  
 
Another facet of the Pauli Exclusion Principle proposes that since all electrons are equivalent 
so any two electrons regardless of their spin orientation must be able to be swap positions 
without changing the electron density of the system, this is the referred to as the 
antisymmetry principle [51]. In a system like Helium with two electrons the wavefunction 
must not change value if the coordinates of electron 1 and 2 are swapped as this would 
change the electron density of the system. The wavefunction is however allowed to change 
sign, since the electron density of the system can be described as the square of the 
wavefunction a change in the sign doesn’t affect the probability of locating an electron in 
the given volume. An alternative way to express this so that the wavefunction does not 
change value is shown in Equation 9. 
 
ψ(1,2) = −ψ(1,2) 
ψ(1,2) =
1
√2
[ψ1(1)ψ2(2) − ψ1(2)ψ2(1)] 
Equation 9: A way to express the antisymmetry criteria of a two electron system e.g. 
helium 
 
In Equation 9, 
1
√2
 is a normalisation factor that ensures the wavefunction stays as a 
continuous probability value, ψ1 and ψ2 are the spin states of the electrons and (1) and (2) 
are the orbital positions of the two electrons in the helium atom. However, this method of 
writing out all the possible combinations of orbitals and positions becomes unwieldy with 
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systems with more than two electrons. A more general form is needed, one that can be 
extended to any number of electrons, this is a Slater determinant and is shown in Equation 
10. 
 
ψ(1,2, … N) = −ψ(1,2, … N)  
ψ(1,2, … N) =
1
√𝑁!
|
ψ1(1) ψ2(1) ⋯ ψ𝑁(1)
ψ1(2) ψ2(2) ⋯ ψ𝑁(2)
⋮ ⋮ ⋱ ⋮
ψ1(𝑁) ψ2(𝑁) ⋯ ψ𝑁(𝑁)
| 
Equation 10: A Slater determinant for N number of electrons in a system. 
 
Atomic systems containing more than one electron cannot be exactly solved by the 
Schrödinger wave equation, this is in part due to the larger number of variables involved, 
and also due to it being an n-bodied problem which are not possible to solve exactly with 
analytical methods [52]. Diverse approximation methods have been developed over the years 
to estimate the Schrodinger wave equation for systems with more than one electron, by 
utilising iterative calculation methods they can arrive at solutions that provide insight into 
chemical phenomena that can’t be observed with experimental methods [56]. Originally QM 
calculations were performed by people, however computer algorithms can more rapidly 
perform iterative calculations so produce results more rapidly calculations than those done 
by hand. A brief survey of the most used calculation methods is given below. 
 
1.4.1 Hartree-Fock (HF) 
Originally published in 1928 [57] this approach was formulated by Douglas Hartree and 
further developed by Vladimir Fock leading to it being named the Hartree-Fock method 
(HF). It was found to offer a good ab-initio approximation of the Schrödinger wave equation 
that allowed for the calculation of a relatively large number of electrons in a system. Also 
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called the self-consistent field approach, this name gives a good description of the 
calculation process. To begin, all the atomic orbitals are approximated for each electron, and 
then a single electron is selected and its wavefunction is calculated while the influence of 
the other electrons is modelled as a single source of potential. The position of the electron is 
adjusted according to this potential whilst keeping all the other electrons frozen in place. The 
process is repeated for each electron in the system, the calculated single electron 
wavefunctions are combined to produce the multi-electron wavefunction. The calculated 
wavefunction is consequently inputted into the next cycle of calculations. The calculation 
process is repeated until the wavefunction is no longer improved, in this way the calculations 
are said to be self-consistent [58]. The way in which the other electrons are frozen in place 
whilst only one is calculated leads to problems, electrons in the HF method are repelled by 
an average field of electron repulsion rather than by individual electrons. In reality electrons 
interact and repel each other instantaneously and neglecting to calculate these correlation 
effects can mean the energies differ between model and experiment significantly[59]. Post 
Hartree-Fock methods attempt to fix this problem with the HF method; this is mainly 
addressed by creating a way in which electron correlation effects can be integrated into the 
HF method. Coupled Cluster (CC) methods promise to be the one of the most accurate QM 
methods to date, they are however restricted to very small systems due to their high 
computational cost [60]. 
 
1.4.2 Semi-empirical 
In the early days of Quantum chemical modelling the HF method was restricted to only small 
molecules due to the large number of integrals involved in their calculation. Researchers 
began to calibrate their results against experimental findings and replace some portion of the 
ab-initio calculation with parameters from experimental results, these methods offered the 
ability to study larger molecules and polyatomic systems with the computational power 
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available at the time [61]. The combination of ab-initio methodology with parameters 
calibrated with experimental results is referred to as a semi-empirical method. Semi-
empirical methods attempt to simplify larger systems by splitting the electrons into two 
groups, valence and non-valence electrons. The majority of the electrons in most larger 
systems aren’t situated in the valence shell, hence aren’t directly involved in bonding[62]. 
The core electrons, or non-valence shells, contribution can be approximated by combining 
their charge into the nuclear core to give a reduced nuclear charge. The core potential of a 
given atom has its properties estimated based on its similarity to other atoms in an empirical 
force field which is derived from experimental observations or high level QM calculations. 
The valence electrons are then treated with ab initio methods and combined with the core 
potentials; this process hopes to produce an answer comparable to that of a higher level of 
calculation theory at only a fraction of the computational cost [63]. The use of parameters to 
simplify calculations means the method is inherently inaccurate, if the electronic 
environment surrounding the atom in the simulation differs significantly from the one in 
which parameter is based on then the results will be negatively impacted[64]. Semi-empirical 
methods are most used where total accuracy isn’t the prime concern and instead the 
calculation needs to be very quick, this makes it ideal for the optimisation and 
parametrisation of organic molecules for the purposes of docking and MD simulation [32].  
 
1.4.3  Density Functional Theory (DFT) 
In HF methods the wavefunction is constructed of a combination of single electron 
wavefunctions, Density Functional Theory (DFT) methods do also calculate single electron 
wavefunctions, however they do not use these to calculate a multi-electron wavefunction. 
Instead of calculating a multi-electron wavefunction DFT methods use the single electron 
wavefunctions to calculate the total electronic energy, as well as the density and distribution 
of electrons in the system, from these all the other properties of the system can be derived 
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[65]. DFT has the advantage of accounting for electron correlation effects and this means in 
some select systems it can produce results closer to experimental values. By not calculating 
the multi-electron wavefunction it can also do this at a fraction of the computational cost of 
wavefunction based ab initio methods [66]. The excellent accuracy/effort ratio of this 
technique has made it one of the most popular methods in computational chemistry studies, 
particularly QM/MM studies, owing to its efficient treatment of a relatively large number of 
atoms such as those composing an enzymatic active site region. Like every method, DFT 
has its short-comings and has trouble in describing weak non-bonded interactions (Van der 
Waals, dipoles and hydrogen bonding), it can also have trouble describing excited states 
although solutions are becoming increasingly available to these problems and its 
performance continues to improve [67, 68].  
 
1.4.4 Hybrid Functionals 
By relying on the strengths and advantages of both, DFT and wavefunction methods can be 
combined to produce a method that is more accurate whilst also being more computationally 
efficient than its constituent methods. The popular Becke, 3-parameter, Lee-Yang-Parr 
(B3LYP) method named after its creators was developed in 1993 [69] as an attempt to offer 
an alternative to the very computationally expensive Post Hartree Fock Møller-Plesset 
perturbation theory methods. To achieve this, elements of HF methodology (known as HF 
exact exchange) parameters are added to DFT methodology to improve the description of 
electron correlation effects. Hybrid functionals such B3LYP are very popular as they give 
structural and chemical properties that agree well with experimental results, however they 
can perform poorly at describing weak interactions like van der Waals forces [70]. More 
recently double hybrid functionals (such as B2-PLYP) have been developed to resolve this, 
these methods intergrate two additional parameters into the DFT method [71]. In addition to 
HF exact exchange, double hybrid functionals incorporate elements from post-HF 
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methodologies (such as MP2) to achieve greater chemical accuracy [72]. This methodology 
hopes to bridge the gap between the chemically accurate but difficult to implement “gold 
standard” that is coupled cluster calculation methods, and the widely used DFT methodology 
[71, 73]. 
 
 
 
1.5 QUANTUM MECHANICS / MOLECULAR MECHANICS 
 
QM/MM  simulations of enzymatic reactions have developed significantly as a technique 
since their first implementation nearly 40 years ago, the overall concept however has 
remained the same [7]. A detailed electronic structure simulation of a relatively small 
number of atoms that make up the reacting portion of the system, this QM region often 
encompasses the substrate, cofactor as well as surrounding reacting amino acid residues. 
This QM region is embedded in a larger region that is simulated using an MM forcefield, 
the MM region consists of the remainder of the protein structure and the solvent 
environment. The purpose of this approach is to treat the important reactive group of atoms 
in the QM system with the scrutiny of a high level of calculation theory such as ab initio or 
density functional theory, without incurring the computational cost of applying this 
calculation method to the large number of atoms that represent the rest of the system. In this 
way the bond formation/breaking that occurs at the active site can be accurately described 
whilst also accounting for the bonding and non-bonding interactions contributed by the rest 
of the protein and solvent system which is simulated at the MM level [74]. The combined 
QM/MM simulation of enzymes in this way can provide insights into the mechanistic details 
of the enzymatic reaction. The simulation can be used to model the reaction path [75], define 
the structure of transition states [76], and calculate energetic transitions of the reaction [77, 
78].  
1.5.1 Calculating the QM/MM Energy of the System 
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The total energy for the system cannot be summed up as a simple addition of the energies of 
the QM region and MM region, another term needs to be introduced to account for the 
interaction between the two regions. In the additive method for QM/MM calculations 
(Equation 11) the total energy of the QM region (EQM) and the MM region (EMM) are 
calculated separately and then added together. This addition alone does not fully define the 
total energy of the whole system so a coupling term (EQM/MM) is needed, this represents the 
bonding, electrostatic and Van der Waals interactions between the two regions [79]. The 
additive method is the most popular from the point of view of  biomolecular simulations 
because it considers the influence of the MM region on the QM region, this is often vital 
when understanding how the protein environment contributes to enzyme reactivity [80]. A 
distinct disadvantage with the additive method is the need for a coupling term and the 
calculation of this term can create difficulties of its own. 
 
𝐸𝑎𝑙𝑙 = 𝐸𝑄𝑀 + 𝐸𝑀𝑀 +  𝐸𝑄𝑀/𝑀𝑀  
Equation 11: The additive method for calculating the energy of a QM/MM simulation 
system. 
 
The subtractive method (Equation 12) starts with the energy of the whole system 
(𝐸𝑀𝑀 𝑤ℎ𝑜𝑙𝑒 𝑠𝑦𝑠𝑡𝑒𝑚) being first calculated at the MM level, the energy contribution of the QM 
region calculated at the MM level (𝐸𝑀𝑀 𝑄𝑀 𝑠𝑦𝑠𝑡𝑒𝑚) is then subtracted from this. To this 
subtracted amount the energy contribution of the QM region as calculated using QM 
methods (𝐸𝑄𝑀 𝑄𝑀 𝑟𝑒𝑔𝑖𝑜𝑛) is added, this gives the total energy of the whole system as 
calculated with two distinct levels of theory [81]. 
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𝐸𝑡𝑜𝑡𝑎𝑙 = (𝐸𝑀𝑀 𝑤ℎ𝑜𝑙𝑒 𝑠𝑦𝑠𝑡𝑒𝑚 −  𝐸𝑀𝑀 𝑄𝑀 𝑠𝑦𝑠𝑡𝑒𝑚) + 𝐸𝑄𝑀 𝑄𝑀 𝑟𝑒𝑔𝑖𝑜𝑛  
Equation 12: The subtractive method for calculating energy of a QM/MM simulation system. 
 
The subtractive energy calculation method has some advantages over the additive method in 
that it can process more than two levels of calculation, and can in fact be extended to “n” 
number of layers each represented by a different level of theory [82]. Unlike the additive 
method, the QM region of the subtractive method must also be calculated at the MM level. 
Problems can arise as to the treatment of non-parametrised atom types such as metals or 
transition states, without a successful calculation of this region with an MM force field the 
total energy of system cannot be calculated using the subtractive method.  
 
1.5.2 The Treatment of Bonds Spanning Across the QM/MM Partition  
In systems where the QM region is covalently bound to the MM region, for example this can 
occur with attempts to include a smaller reactive portion of a larger molecule such as a 
protein into the QM region. Such partitions are particularly necessary when active site 
residues directly react with the substrate, therefore need to have their electronic structure 
accurately modelled [66]. Creating a QM/MM partition along a covalent bond to include one 
portion of a molecule in the QM and other in the MM region requires the bond to be broken; 
this leaves the two boundary atoms with unsatisfied valencies. Not all bonds can be broken 
to form partitions in this way, conjugated polar or aromatic bonds should not be cut across 
as the uneven distribution of electrons in these will lead to strange behaviours in the 
simulation [83].  
A simple solution originally suggested in a paper by Singh and Kollman[84] proposed 
saturating the unoccupied valencies with link atoms, this method is relatively easily 
implemented. The link atom method can be a hydrogen atom, a methyl group or even 
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pseudo-halogen atoms to the partitioned atoms. However, the addition of these extra atoms 
into the QM region can cause problems, it changes the thermodynamics of the system by 
adding to the number of total atoms. In studies seeking to simulate the thermodynamics of a 
reaction this can cause complications in defining the energy of the QM region[85]. These 
extra atoms can also negatively affect geometry optimisation processes[86]. 
Another alternative method for treating boundary atoms is the use of pseudoatoms, instead 
of a link atom being used a new atom with only a single valence is added to cap the system 
[87]. This atom is added to the boundary the QM region and through parametrisation of 
model systems be adjusted to have the same bond length, strength and electronic properties 
as the bond that it is replacing. It is “visible” to both the QM and MM region, in the QM 
region it replicates the bond which has been severed and in the MM region it functions as a 
normal MM atom [66]. The pseduoatom method suffers from some of the same problems as 
the link atom method in that it introduces artificial atoms into the simulation. Another 
problem is the parametrisation process for the creation of the pseudoatom, if done incorrectly 
it could result in a QM system that isn’t representative of the real system. 
The frozen local orbital approach is another method for treating the partition of bonds, an 
orbital is introduced to the unoccupied valence of the boundary atom to close the QM system 
[88]. The orbital is excluded from calculations and acts as lone pair pointing towards the 
severed MM atom. In this way it does not affect the other orbitals in the QM region and can 
be specifically designed and adjusted in such a way as to not affect the charge distribution, 
position or interactions of the boundary atoms [89]. Although the frozen orbital method is 
more difficult to implement it does provide a truer description of the QM/MM boundary as 
it doesn’t introduce artificial atoms. The generalized hybrid orbital approach is a 
modification of other methods; the QM atom remains attached to the MM atom. The MM 
atom then has multiple orbitals added to it, the bonds between the MM atom and other MM 
atoms are frozen orbitals and the orbital between QM and MM atom remains open. Because 
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of this the electron density across the partition can readjust over the course QM/MM 
calculation rather than remaining fixed as in other methods [90]. 
The choice of the treatment of boundary regions is a crucial part of the QM/MM simulation 
process and is often a balance between simplicity and accuracy.  
 
1.5.3 Embedding Techniques 
How the electrostatic interactions are treated across the QM and MM region defines the 
embedding technique that is used. Originally the charges from the MM region were 
evaluated and their influence added to the atoms of the QM region as point charges, this is 
known as mechanical embedding because the interaction is described without the need for 
quantum terms [91]. However this can create problems as both regions must be 
parameterised in an MM force field so that the partial charges can be combined, transition 
state atom types and metals are not normally included in MM force fields and therefore 
create problems with this method of embedding [86].  
The newer and more complex alternative to this is electrostatic embedding, instead of MM 
electrostatic interactions being added to the QM system as partial charges, the charge 
distribution of the MM region is directly allowed to influence the wavefunction in the 
calculation of the QM region [66]. Although requiring a more accurate sampling of the 
electrostatic environment of the MM region electrostatic embedding has distinct advantages 
in that it does not require the parametrisation of the QM system in an MM forcefield, 
additionally it allows the QM systems charge distribution to constantly adjust with any 
changes in the MM system [92]. 
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1.6 AIM OF THE PROJECT  
Aims:  
1A Study the similarities and differences in the conformational dynamics of the two FAD-
dependent tryptophan halogenase enzymes tryptophan 7-halogenase (PrnA, Pseudomonas 
fluorescens) and tryptophan 5-halogenase (PyrH, Streptomyces rugosporus) that lead to their 
differences in regioselectivity. 1B Investigate the effect of point mutations on the structure 
of PrnA and compare the results with those obtained experimentally in order to offer 
atomistic insight to these effects. 1C Study the interactions between the substrate tryptophan, 
hypochlorous acid FAD and the protein at the atomistic level to provide insights into the 
enzyme’s proposed reaction mechanism. 
2A Create a model of the Fat mass and obesity associated enzyme’s (FTO) active site in 
order to study the electronic environment surround the catalytic iron centre. 2B Using the 
active site cluster model, simulate key points in the FTO reaction mechanism using a range 
of conditions to examine the effects that cluster size and calculation method have on the 
geometry and electronic environment of the model system. 2C Create a QM/MM model of 
the FTO enzyme substrate complex and compare the electronic structure and geometry with 
that of the various cluster models. 2D Compute the energy barrier of key reaction steps with 
varying cluster sizes and computational methods to compare against previous experimental 
and computational models from other publications. 
3A Elucidate reasonable bound structures for a range of ligands to the sugar facilitator 
transporter protein (GLUT5 protein encoded by the SLC2A5 gene) and attempt to correlate 
these results with those structures obtained via experimental methods. 3B Study the 
conformational dynamics of the GLUT5 structure in a model lipid membrane to assess the 
contribution of the lipid membrane to the protein structure. 3C Study the interaction between 
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the ligands and receptor over time to assess the influence of the ligands on the dynamic 
motions of the protein. 3D Estimate the free energy of binding between the GLUT5 receptor 
and a range of ligands to compare the computationally calculated values with those obtained 
with experimental methods. 
4A Predict the bound structures of a range of sugar ligands to the experimentally obtained 
odorranalectin (no currently identified gene) structure as well as two lactam bridged 
modified derivative lectin structures. 4B Estimate the free energy of binding between the 
sugar ligands and the three lectin structures and compare these results with those obtained 
experimentally. 4C Use the predicted bound structures to explain the preferred binding of 
some sugars as opposed to other at an atomistic level. 
5A Predict the atomic structure and molecular orbital structures and energies of the various 
fluorescent probes in both the protonated and deprotonated. 5B Computationally predict the 
fluorescence spectra of the probes and compare the results with those obtained by 
experiment. 5C Use the predicted structures of the probes along with the computed orbital 
structure to explain the differences in the fluorescence between the different probes. 
Methodology: To simulate and study the conformational dynamics and structural flexibility 
of the studied enzymes, molecular dynamics simulations were performed using the Gromacs 
[93] and Amber [25] packages. To predict the binding poses of ligands to proteins and 
peptides docking techniques were utilised with the Autodock4 [42] software. To study the 
geometry and electronic structure of enzymatic active sites, cluster models were created and 
calculations were performed using the Gaussian09 [94]. The influence of the protein 
environment on the geometry and electronic structure of the active site was studied using a 
QM/MM model, calculations on the model were performed using the ONIOM method [82] 
in Gaussian09 [94].  
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2  STRUCTURAL INSIGHTS FROM MOLECULAR 
DYNAMICS SIMULATIONS OF TRYPTOPHAN 7-
HALOGENASE AND TRYPTOPHAN 5-HALOGENASE  
 
 
2.1 PREFACE 
This chapter concerns MD studies of two tryptophan halogenase enzymes namely 
tryptophan-7-halogenase (PrnA) and tryptophan-5-halogenase (PyrH), in order to study their 
conformational flexibility and remarkable regioselectivity. All the computational 
simulations and analysis are completed and a manuscript is in the final editing stages before 
submission for publication. Additional figures, graphs and tables can be found attached in 
the appendix section as “Supporting Information for Structural Insights from Molecular 
Dynamics Simulations of Tryptophan 7-Halogenase and Tryptophan 5-halogenase”. 
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2.2 INTRODUCTION  
Many pharmaceutically important natural organic compounds (including antibiotics, such as 
chlortetracycline [95] and vancomycin [96], the antifungal compound pyrrolnitrin [97] and 
chemotherapeutics - salinosporamide A [98] and rebeccamycin [99, 100]) are chlorinated.  
Halogenating enzymes perform regioselective halogenation of aromatic compounds 
efficiently in solution using only chloride ions at pyshiological temperatures and 
atmospheric pressure. Selective non-enzymatic chlorination of C-H bonds remains a 
chemical synthesis challenge, for example the halogenation of tryptophan in solution lacks 
regioselectivity and produces a mixture of products with chlorine added at 1st, 5th and 7th 
carbon of the indole ring [101]. From and industrial point of view this is unacceptable as the 
desired isomer is produced with a lower yield and expensive to separate from the others. At 
the same time many natural products with pharmaceutical relevance contain halogen atoms 
at a range of different positions, which would be difficult to synthesise and rely on the use 
of protecting groups and metal based catalysts, these strategies introduce extra reaction steps 
to the synthesis; increasing financial costs and lowering yields [102, 103]. Hence a detailed 
understanding of the enzymatic mechanism of regioselective chlorination/halogenation of 
natural organic compounds and knowledge of the origin of the regioselectivity is of 
importance to organic chemical synthesis. Halogenating enzymes are attractive as 
biocatalysts because they can be engineered to suit different synthetic purposes [104], not 
only adjusting their regioselectivity but their ability to accept a range of different substrates 
[105]. The indole ring of tryptophan is chlorinated at different positions -  respectively at the 
5th, 6th  or  7th carbon atom by distinct flavin-dependent halogenases, these include: PyrH-
Streptomyces rugosporus [106] (trypthophan 5-halogenase), Thal-Streptomyces 
albogriseolus [107] and SttH-Streptomyces toxytricini [108] (tryptophan 6-halogenases) and 
RebH-Lechevalieria aerocolonigenes [109] ,and PrnA-Pseudomonas fluorescens [110] 
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(tryptophan 7-halogenase). All of these enzymes exhibit high level of regio- and stereo- 
selectivity.  
Our study focuses on the simulation of two flavin-dependent halogenases - tryptophan 7-
halogenase PrnA and tryptophan 5-halogenase PyrH  to study their conformational flexibility 
and possible structure function relationships. In particular PrnA catalyzes chlorination of 
free tryptophan to 7-chlorotryptophan, the first step in the biosynthesis of the antibiotic and 
antifungal compound pyrrolnitrin [97]. PyrH catalyzes chlorination of free tryptophan to 5-
chlorotryptophan, part of the biosynthesis of the antibiotic compound pyrroindomycin B 
[106]. It is important to analyze the reason for the regioselectivity, with focus towards the 
differences at the active sites of these structurally similar enzymes. X-ray crystallographic 
structures, of the two halogenases exist and provide the basis for our MD simulations [110, 
111]. The catalytic turnovers of tryptophan 7-halogenase and tryptophan 5-halogenase 
differ, in one experiment PyrH was found to convert 100% of  tryptophan, whereas PrnA 
converted only 59%, the origin of this difference has not yet been elucidated [105]. 
 
 
Figure 2: Two proposed mechanisms for the halogenation of tryptophan by 
hypochlorous acid. 
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 Several reaction mechanisms were proposed for the enzymatic chlorination of tryptophan 
[112], all the presented alternate mechanisms agree that FAD reacts with dioxygen to 
produce to produce a reactive 4α-hydroperoxyflavin intermediate. In Figure 2, mechanism 
A and B 4α-hydroperoxyflavin reacts with a chloride ion to produce hypochlorous acid, the 
free hypochlorous acid travels through a “tunnel” in the protein to the bound tryptophan 
substrate. In Mechanism A electrophilic aromatic substitution of tryptophan occurs at C7 
facilitated by the interaction of hypochlorous acid with the active lysine sidechain [110]. In 
Mechanism B, hypochlorous acid reacts with a deprotonated form of the active lysine residue 
to produce a Chloro-Lysine intermediate, this then reacts with the C7 of tryptophan in an 
electrophilic aromatic substitution reaction [113]. Mechanism A and B both agree that 
hypochlorous acid is produced but differ in the way hypochlorous acid reacts with 
tryptophan, both mechanisms also specify that deprotonation of the chlorotryptophan 
intermediate by the active glutamate to produce 7-chlorotryptophan. Other mechanisms were 
hypothesised before the X-ray crystal structure of PrnA was solved, they are based on similar 
monooxygenase enzymes like PHBH [114, 115]. These mechanisms are based on direct 
contact between FAD and the substrate tryptophan. Presently this type of mechanism seems 
unlikely, inspection of the crystal structures of the known FAD dependent halogenase 
enzymes shows a >10Å distance between the FAD and tryptophan binding sites [106-110]. 
The separation between the ligands would be too far for direct interaction. However, close 
contact between the cofactor and the substrate, whilst not observable in the crystal structure, 
is a possibility that cannot be entirely excluded. A large conformational change could take 
place in the protein structure, bringing the two binding sites into close proximity and allow 
direct reaction between the two ligands. 
Because the FAD and tryptophan binding sites are distant, the chlorinating agent 
hypochlorous acid is thought to travel through a channel in the protein[110]. Two amino 
acids - K79 and E346 in PrnA (analogous to K75 and E354 in PyrH) are positioned in close 
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proximity to the reactive carbon of tryptophan’s indole ring, they are thought to be involved 
in the activation of the hypochlorous acid for the halogenation step of the reaction [116].  
The role of K79 and E346 in PrnA is supported by an experimental mutagenesis showing 
that the K79A mutant had no detectable activity, and in the E346Q mutant the Kcat values 
for the halogenation are decreased by two orders of magnitude [110].  
PyrH and PrnA have a 40% sequence identity and 58% sequence similarity making their 
amino acid sequencing quite similar[117, 118]. In the crystal structure of the PyrH FAD binding 
domain a “strap” region was identified. The FAD binding strap is hypothesized to be a 
structural feature that allows for “communication” between the two binding sites, in addition 
it is also hypothesized to be involved in the regulation of FAD binding [111]. The crystal 
structures of PyrH and PrnA reveal that the FAD binding sites are basically identical, the 
FAD binding site of the RebH crystal structure [109] was also found to overlay almost 
identically to PrnA and PyrH (Figure 3). PyrH possesses a structurally different tryptophan 
binding site to PrnA, the substrate tryptophan in the PyrH crystal structure is bound in a way 
that is upside down in respect to tryptophan in the PrnA crystal structure (Figure 4). 
However, the active to-be halogenated carbon of tryptophan in PrnA and PyrH superimpose 
when the two protein structures are aligned. The positioning of the active carbon is located 
between the active lysine and glutamate residues (Figure 4), these two residues show similar 
orientation between the two enzymes, this suggests that the reason for the two enzymes 
producing different halogenated products lies in the way that tryptophan is bound in the 
active site. The tryptophan and FAD binding domains are highlighted in Figure 5. 
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Figure 3: The ribbon structure of PrnA (dark green) and PyrH (gold) structurally aligned 
with one another. Stick representations of the bound ligands FAD and tryptophan as 
well as the active glutamate and lysine residues. Hypochlorous acid and the to-be 
halogenated carbon of tryptophan are respresented as spheres. Light blue carbons 
represent PrnA and green carbons represent PyrH. Additonally element colours are as 
follows; nitrogen is dark blue, oxygen is red and hydrogen is white. 
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Trp-S 
Hypochlorous Acid 
FAD 
E346/E354 
K79/K75 
Figure 4: A view of the aligned crystal structures of PrnA and PyrH rendered 
with transparent protein ribbons, with PrnA with yellow ribbons and PyrH with 
green ribbons. The substrate tryptophan, hypochlorous acid and the active lysine 
and glutamate residues are rendered as tubes with carbon atoms coloured 
according to the protein, PrnA in bright green and PyrH in light blue. The to-be 
halogenated carbon (C7/C5) of the substrate tryptophan is rendered as a sphere. 
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Figure 5: The structure of PrnA highlighting the FAD and tryptophan binding domains, 
the FAD binding domain ribbons are coloured oink while the tryptophan binding 
domain ribbons are coloured light blue. The FAD and substrate tryptophan ligands are 
rendered as tubes with carbon atoms coloured bright green and heteroatoms coloured 
according to: nitrogen is dark blue, oxygen is red, phosphorus is orange and hydrogen is 
white. 
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Enzymes are large, flexible and dynamic molecules that naturally undergo a wide range of 
conformational changes and molecular motions, these range in timescale from 
femtoseconds to hours[5, 119]. Many of these motions are functionally important and 
relate enzyme structure to function [2, 120]. Experimentally determined protein structures 
(e.g. by X-ray crystallography) provide valuable structural information however, limited to 
only a snapshot or static structure, averaged over the number of molecules in the crystal 
lattice, and the duration of the experiment [121]. In addition, steric effects can arise due to 
the compactness of the crystal environment [122]. Enzyme conformational flexibility can 
play a substantial role in stabilizing the protein interactions vital in facilitating ligand 
binding and unbinding events [123]. In addition enzymatic molecular plasticity is involved 
in assisting the migration of ligands to the binding site, the diffusion of gases and small 
molecules through the protein [124]. Mutations of key residues, involved in catalysis, and 
binding, can influence not only locally the structure, but can also exercise a long range 
structural effect on the protein conformation as a whole. Exploration of dynamic events in 
proteins, using experimental methods, can be a challenge; thus computer-based 
experiments, for example Molecular Dynamics (MD) simulations can be applied to study 
this [119-121, 125]. Long range atomistic molecular dynamics (MD) simulations of the 
two enzymes were performed in order to elucidate the structure-function relationships and 
mechanistic implications related to the origin of regioselectivity in both enzymes.  
 
2.3 METHODS 
An initial structure for the MD simulations of the wild type full complex PrnA was created 
from the pdb structure of the enzyme (PDBID: 2AR8) [110]. The product 7-
chlorotryptophan was separated to create the substrate tryptophan and hypochlorous acid, in 
addition the chloride ion bound at the FAD binding site was removed and FAD modified to 
create hydroxyl-FAD (from this point forward FAD will be refer to hydroxy-FAD) . These 
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changes were made with the aim of replicating the active full complex of mechanism A and 
B prior to the halogenation of the substrate tryptophan. Modification of the atomic 
coordinates was performed using Maestro 9.9.013 [126].  The site-mutants K79A and E346Q 
were prepared by mutating the respective residues in the wild-type full complex structure 
using Maestro [126]. The initial structure of PyrH for MD simulations was prepared by 
superimposing the PyrH crystal structure (PDBID: 2WET) with that of the wild-type full 
complex PrnA, the coordinates of hypochlorous acid from this were then added to the PyrH 
crystal structure and the sulphate and chloride ions from the crystal structure were removed. 
The parameters for FAD-OH and hypochlorous acid were generated by the PRODRG web 
server [127] for the GROMOS96 43a1 forcefield [128] with atomic partial charges for 
hypochlorous acid supplemented from QM calculations performed by the Automated 
Topology Builder web server [129]. The missing coordinates of the two loop regions in the 
PyrH crystal structure (PDBID: 2WET) structure were modelled using the Modeller [130] 
plug-in for Chimera 1.10.2 [131], the setup for PyrH then followed the same protocol as the 
one for PrnA. 
The hydrogen atoms missing from the X-ray crystal structure were added using Gromacs 
4.5.5 [93]. To remove unfavourable steric clashes in the starting structure in vacuo energy 
minimization was performed using the steepest descent algorithm until the maximum force 
was less than 100 KJ/mol-1/nm-1, the protein was then placed in a box with periodic boundary 
conditions. The energy minimized protein structure was then solvated using the Single Point 
Charge [19] (SPC) model for water. The total charge of the system was neutralized by adding 
the correct number of Na+ or Cl- ions, to make the overall charge of the system zero. Another 
energy minimisation (using the same conditions as described for in vacuo energy 
minimisation) was then performed, to reduce close contacts between solvent molecules or 
ions that may be unfavourably close to the protein structure. The energy minimized structure 
was then subject to position restrain MD for 50ps at 300K, during that, the protein structure 
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was restrained and the water was allowed to equilibrate. The position restrained dynamics 
simulations are performed in NVT ensemble, a constant Number of particles, Volume, and 
Temperature with a time step of 2fs. The productive MD was then carried out with the output 
structure from position restrained dynamics providing the initial structure for 1µs as in NPT 
ensemble at a temperature of 300K.  The MD trajectories, were analysed over the time period 
of 100ns-1000ns, after equilibration phase was reached, using tools provided in Gromacs 
and visualisation and inspection of the trajectories was made with Visual Molecular 
Dynamics (VMD) [132]. Dynamic Cross Correlation Analysis (DCCA) and Principle 
Component Analysis (PCA) were performed using the Bio3D package [133] for Rstudio 
[134]. DCCA is used to visualise which residues play a role in the correlated motions that 
occur between different components of the protein structure [135]. The level of correlation 
between each c-α atom can be quantified and visualised on a plot, with correlations ranging 
from +1 to -1 indicating strong positive to negative correlation. This allows the identification 
of regions in the protein showing correlated motion in the simulation that could be 
overlooked by visual inspection. All images of molecular models for this chapter were 
created using UCSF Chimera 1.11.2 [131]. 
2.4 RESULTS AND DISCUSSION 
2.4.1 Conformational Dynamics of Full Complex Wild-Type PrnA 
In total five 1µs MD simulations were performed: the full complex of wild-type PrnA, 
apoenzyme PrnA, two single point mutant forms K79A and E346Q of PrnA as well as the 
full complex wild-type PyrH.  
The RMSD profile for all Cα atoms for the 1 µs MD simulation of the wild-type full complex 
PrnA is 3.5Å. The RMSD profiles of all five of the 1µs simulations (Figure 6) indicated that 
the initial equilibration phase was completed after 100ns. As well as the 1µs simulations 
three additional independent 200ns MD simulations of the wild-type full complex of PrnA 
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were performed, these used the same initial structure but different initial velocities (SI Figure 
1). These repeat simulations were created to evaluate the effect of statistical error on the 
quality of the simulations. The RMSDs for the each of these trajectories was consistent with 
the 1µs wild-type full complex PrnA simulation indicating the good quality of the 
simulations. The average RMSD from the 200ns runs (calculated between 100ns-200ns) was 
3.3Å[136] and their radius of gyration (SI Figure 2) was 22.9Å, showing  that the protein 
remains compact and stable during the simulation timescale.  
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Figure 6: The RMSD plot of all five 1µs MD simulations; the PrnA full complex, Apo-
enzyme PrnA, PyrH full complex as well as the K79A and E346Q mutant forms of 
PrnA. 
 
The average RMSD of the full complex wild-type PrnA was 3.5Å and of the apoenzyme 
PrnA was 3.6Å, this shows that the ligand bound structures have similar levels of structural 
flexibility. The solvent accessible area (SAS) of the apoenzyme PrnA is slightly lower than 
the SAS of the full complex wild-type PrnA (SI Figure 3). This is likely due to structural 
change associated with ligand binding, in which the protein structure of PrnA becomes less 
compact to accommodate the bound ligands.  
The RMSF profiles of the full complex PrnA and apoenzyme PrnA are presented in Figure 
7. For the full complex PrnA, The peak region at residue P93 exhibits a high RMSF reflecting 
its position at a particularly flexible point of the loop that precedes the key tryptophan 
interacting residues: H101, F103, G104 and N105, these residues are involved in the binding 
of the tryptophan substrate. It is therefore possible that the flexibility of this loop is functional 
in the binding and orientation of the tryptophan substrate.  
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Figure 7: The RMSF plot of the PrnA full complex and PrnA Apo-enzyme simulations. 
 
A flexible loop consisting of residues from 147-159 has a maximum RMSF value of 6.73Å 
centred on residue G152 in the full complex PrnA (Figure 7), the same region has an 
RMSF value of only 1.81Å in the apoenzyme form of PrnA. The loop in questions is found 
on the exterior of the protein and is solvent, intra-loop hydrogen bonds are found between 
the residues 147-159 of the loop. The loop immediately precedes S157, a hydrogen 
bonding residue of the tryptophan substrate. The RMSD plot of the loop region 147-159 
(Figure 8) shows the loop adopting a stable orientation after 300ns, it is upon adopting this 
conformation that S157 forms a hydrogen bond with the carboxylate of the substrate 
tryptophan. The dynamics of the loop differ greatly between the full complex wild-type 
PrnA and the apoenzyme PrnA, suggesting that a conformational change occurs in the loop 
upon binding of the substrate tryptophan. In the apoenzyme the S157 sidechain forms 
hydrogen bonds with the neighbouring residues A80, M156 and Y443 instead. These 
protein-protein hydrogen bonds stabilize the 149-159 loop of the apoenzyme and it 
maintains a more compact conformation which is reflected in the lower RMSD of the loop 
in the apoenzyme.  
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The DCCA of the full complex wild-type PrnA (SI Figure 5), indicates about strong positive 
correlation (the red region) between the strap region (residues 39-54) and the flexible loop 
region 149-157 in the tryptophan binding domain (roughly residues 154-170 in the DCCA 
plot). In the DCCA plot of apoenzyme PrnA (SI Figure 6) this region of positive correlation 
is much smaller suggesting that the correlated motion may be associated with the binding of 
the tryptophan substrate. A correlated motion between the portion of the FAD strap region 
closest to the substrate tryptophan (residues 50-54) and the important catalytic residue E346 
was also found and supports the idea of the strap region being an important link between the 
two binding sites.   
 
Figure 8: A plot showing the relationship between the RMSD of the flexible loop region 
in both the full complex PrnA and the apo-enzyme PrnA spanning residues 154-170 
(left y axis), and the hydrogen bonding interaction distance between S157 side chain 
oxygen and the substrate tryptophan (right y axis). 
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The regions of residues 250-262 correspond to a flexible loop positioned between the FAD 
and tryptophan binding sites, this region shows correlation with the catalytic residue K79 in 
the DCCA plot of the full complex wild-type PrnA (SI Figure 5). Upon inspection of the 
trajectory this correlated motion is likely due to the close proximity of the two protein strands 
forming hydrogen bonds along their respective backbones.  
The region of residues from 355 to 380 that show fluctuation in both the RMSF plot of the 
full (Figure 7) complex wild-type PrnA and apoenzyme PrnA correspond to a long α-helix 
that intersects the FAD and tryptophan binding sites, it contains the tryptophan hydrogen 
bonding residue Tyr351. In the DCCA plot of the full complex wild-type PrnA (SI Figure 
5) this region 355-380 shows correlation with the important tryptophan binding residue 
W455. The same region in the DCCA of the PrnA apoenzyme -enzyme (SI Figure 6) shows 
a less intense correlation, this likely indicates that the motion is related to tryptophan 
binding. A relatively large span of residues from 396-456, shows relatively more fluctuation 
in the full complex than the apoenzyme (Figure 7), possibly due to its proximity to many 
important tryptophan binding residues. This area 396-456 is composed of several helices 
joined by loops, intermolecular interactions create a compact hydrophobic cluster stabilising 
the structure of the area, and the region directly precedes the important tryptophan binding 
residues: Y443, Y444, W455 E450 and F454 and N459.  
2.4.2 Tryptophan binding site interactions of Wild Type PrnA 
The high level of regioselectivity of FAD-dependent halogenating enzymes is thought to 
depend on the proper orientation of the substrate tryptophan [113]. Tryptophan position and 
orientation allows only for the respective carbon from the indole ring (C7 in PrnA or C5 in 
PyrH) to be most favourably oriented for reaction. In order to accomplish stable binding of 
tryptophan, an extensive network of hydrogen bonds, electrostatic interactions, and Van der 
Waals interactions are found around it. The measured distances of the significant interactions 
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of the tryptophan substrate observed in the X-ray crystal structure and our wild type full 
complex PrnA MD simulation are recorded in Table 1, Table 2 and Table 3. K79 and E346, 
thought to be important for hypochlorous acid activation are also involved in a network of 
hydrogen bonding and electrostatic interactions that maintain their orientation in the active 
site relative to the substrate tryptophan and the chlorinating agent hypochlorous acid. 
 
Residue 1 Atom 1 Residue 2 Atom 2 
% of the 
simulation 
time <3.5Å 
Average 
distance 
(Å) 
Distance in 
Crystal 
Structure 
(Å)  
H395 NE2 E346 OE2 53 3.5 2.5 
E346 OE1 HYP  O1 91 3.0 3.5 
E346 OE2 HYP  O1 90 3.1 5.2 
G104 N Trp O 82 3.0 6.0 
G104 N Trp OXT 81 3.1 8.0 
Y443 OH Trp N 95 3.1 3.1 
F454 O Trp N 69 3.4 2.8 
 
Table 1: Hydrogen bonding interactions for the tryptophan-binding site in the wild-type 
full complex PrnA. Measurements are made between the donor and acceptor atoms. 
 
The substrate tryptophan (Table 1) can act as both a hydrogen bond donor and acceptor 
with its amino, carboxylate and indole ring nitrogen. For example, the backbone 
nitrogen of G104 participates in a hydrogen bond to tryptophan’s carboxylate moiety.  
The amino group of tryptophan is hydrogen bonded to the sidechain phenolic oxygen of 
Y443 and the backbone carbonyl oxygen of F454. The amino group of tryptophan can 
also makes electrostatic interactions (Table 2) with the carboxylate of E450 with an 
average distance of 4.2Å. E450 in turn interacts with the sidechain amino group of K57 
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distance 5.8Å, this kind of electrostatic interaction network ensures strong binding of 
the substrate tryptophan. The proposed electrostatic interactions of the substrate 
tryptophan are shown in Figure 9. 
Residue 1 Atom/Group 1 Residue 2 Atom/Group 2 
Average 
distance 
during 
MD (Å) 
Crystal 
Structure 
Distance 
(Å) 
H395 NE2 E346 Carboxylate 3.7 4.5 
E346 Carboxylate Hypochlorous acid  H 2.5 4.6 
K79 NZ Hypochlorous acid O1 6.7 3.2 
E450 Carboxylate  Trp N 4.2 3.8 
K57 NZ E450 CD 5.8 10.3 
 
Table 2: Electrostatic interactions for the tryptophan binding site of the PrnA full 
complex. Measurements are made from the centre of the charged group. 
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Hypochlorous acid can participate in hydrogen bonds as well as interacting with charged 
residues in the enzyme active site. For example the hydrogen atom of hypochlorous acid has 
a partial positive charge (0.455e) and forms a strong hydrogen bond with the sidechain of 
E346, at a distance of 2.5Å (Table 2). In our initial structure of PrnA K79 is in close 
proximity to hypochlorous acid and seems a likely candidate for hydrogen bonding, however 
in the MD simulation hypochlorous acid moves away from K79, reflected in the average 
distance of 6.7Å in the MD (Table 2). The carboxylate sidechain of E346 has two oxygen 
atoms: OE1 and OE2 with which it is possible to form potential hydrogen bonds (Table 1). 
The E346 carboxylate forms an electrostatic interaction with the NE2 nitrogen atom of the 
protonated H395 sidechain. Hypochlorous acid makes a strong hydrogen bonding 
interactions with the carboxylate sidechain of E346, the average distance between the 
hydrogen and two carboxylate oxygen atoms was measured and found to be 3.1Å. The E346 
carboxylate side chain also interacts with the positively charged doubly protonated H395 
Trp-S 
FAD 
Hypochlorous 
Acid 
Figure 9: The potential electrostatic interactions around the substrate tryptophan binding 
site in PrnA. The distances between the interacting atoms are found in Table 1. 
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3.7Å (Table 2). In the crystal structure the indole nitrogen atom of tryptophan forms a 
hydrogen bond with the backbone carbonyl oxygen of E346 [105], however in the MD 
simulation the backbone carbonyl of E346 moves away from tryptophan to make other 
hydrogen bonding interactions with Thr348 and the hydroxyl oxygen of hydroperoxyflavin 
moiety of FAD. The hydrogen bonding interactions of the substrate tryptophan are shown in 
Figure 10. 
 
  
Trp-S 
FAD 
Figure 10: The hydrogen bonding interactions surrounding the substrate 
tryptophan in PrnA, the distances between the donors and acceptors are shown in 
Table 1. 
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Residue name 
and number 
Average distance 
(Å) 
Distance in Crystal 
Structure (Å) 
Ile52 6.2 5.0 
His101 6.3 5.4 
Phe103 4.7 5.6 
W455 5.1 5.9 
 
Table 3: Distances between the Centres of Mass between the hydrophobic sidechains 
and the indole ring of the substrate tryptophan. 
F103, W455 and H101 form π-π stacking interactions with tryptophan (average distances 
between the centres of mass respectively 4.71Å, 5.07Å and 6.27Å). Strong positive 
correlation between residues 100-130 and residues 475-505 is found in the DCCA plot of 
the full complex wild-type PrnA (SI Figure 5) The region of Residues 475-505 form a long 
alpha helix running perpendicular to His101/Phe103 region. The correlation is likely caused 
by hydrophobic interactions between the two features as the loop portions of the 
His101/Phe103 region are seen in SI Figure 7, from the structure it is clear to see that the 
two regions are interwoven and any movement in one will affect the other region as well. 
The intensity of the correlation is much less pronounced in the DCCA plot of the apoenzyme 
(SI Figure 6), suggesting that this correlation only arises in when tryptophan is bound. 
Throughout the MD simulation W455 remains close to the substrate tryptophan participating 
in a stable π-π stacking interaction with the substrate (Table 3). E346 and hypochlorous acid 
are also located in close proximity to the sidechain of W455, why then doesn’t W455 become 
halogenated? K79 is not found in proximity to W455, this reinforces the idea that suitable 
proximity to both K79 and E346 are needed for the halogenation reaction to occur as 
otherwise W455 would become halogenated. The potential hydrophobic interactions in the 
tryptophan binding site are shown in Figure 11. 
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Trp-S 
Figure 11: The hydrophobic contacts surrounding the substrate tryptophan in 
PrnA, the distances between the centers of mass of the  substrate tryptophan’s 
indole ring and the hydrophobic amino acid sidechains are shown in 3. 
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2.4.3 FAD binding site in PrnA 
A structural feature previously observed in the crystal structure of PyrH, is the FAD binding 
“strap”. This strap region is thought to control the binding of FAD, and is also hypothesised 
to act as a line of communication between the FAD-binding and tryptophan-binding sites in 
PyrH [111]. In the crystallographic study of PyrH the authors remarked that the electron 
density of the strap region is relatively low, implying that it is a particularly flexible region 
of PyrH [111] Through inspection of the crystal structure, we found that a similar strap 
region superimposes with that of the Pyrh crstal structure so likely exists in PrnA. The high 
flexibility of the strap region, along with its probable influence on both FAD and tryptophan 
as shown in SI Figure 8 and SI Figure 9 points towards the strap region fulfilling a similar 
role to one it is hypothesised to in PyrH. In both enzymes, the strap region consists of a long 
straight section of residues running parallel to FAD with no secondary structure elements 
(SI Figure 9). The region of the strap that is in close contact to FAD forms several hydrogen 
bonds, electrostatic interactions, Van der Waals and cation-π interactions with FAD, these 
are evident in the crystal structure as well as the MD simulations of the PrnA wild type full 
complex (SI Table 1) [112]. The interactions of FAD in the binding site can be seen in Figure 
12 and Figure 13.  
 
Trp-S 
FAD 
Figure 12: The potential hydrogen bonding interactions of FAD within the PrnA enzyme. 
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Figure 13: The potential hydrophobic and cation-π interactions of FAD within the PrnA enzyme. 
 
FAD 
Trp-S 
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FAD is a flexible molecule, in the crystal structure it adopts a linear extended conformation, 
in the MD we see it undergoing a structural transition around 200ns to adopt a more bent 
and compact conformation (SI Figure 19 and SI Figure 21). We see this structural transition 
of FAD in all MD simulations of PrnA and PyrH. In the PrnA full complex simulation the 
change in the conformation of FAD happens concurrently with a structural transition seen in 
the FAD strap region (SI Figure 8), the strap adopts a conformation after around 200ns that 
shows reduced structural flexibility. In comparison, the RMSD of the strap region in the 
apoenzyme form of PrnA shows higher flexibility as well as larger fluctuations (SI Figure 
8). The increased flexibility of the strap region in the apoenzyme PrnA MD in contrast to 
the full complex PrnA MD suggests that the strap region is heavily involved with the binding 
of FAD and becomes more stable in the presence of FAD. This is most obvious when 
comparing hydrogen bonds of the X-ray crystal structure to those from the MD (SI Table 1). 
The RMSF profile of the strap region (SI Figure 10) shows that although the apoenzyme 
form possesses higher flexibility this is mainly due to residues 45-49 located in close 
proximity to the flavin moiety of FAD and forms stable hydrogen bonding interactions with 
FAD (SI Table 2). The region of residues from 50 to 53 connects the FAD binding residues 
to those of the tryptophan binding site. S54 hydrogen bonds E450, is a key salt bridge 
interaction for the binding of the amino group of tryptophan. The equilibration of the strap 
region and FAD causes a conformational change that brings the sidechain of S54 into the 
proximity of E450 to form a hydrogen bond. This movement brings E450 into the proximity 
of the tryptophan amino group (). This movement shows a structural basis for the predicted 
communication between the FAD and tryptophan-binding sites, the binding of FAD can 
directly influence the binding of tryptophan through the strap region that connects both 
domains. 
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Most of the hydrophobic interactions of FAD in the MD simulations and X-ray crystal 
structure (SI Table 1) are made with the flavin moiety. The adenine moiety of FAD has the 
potential of forming a cation-π interaction with the sidechain of R221. Most FAD binding 
hydrogen bonds are formed with the backbone carbonyl oxygen and nitrogen atoms of the 
surrounding residues (SI Table 2). Residues, A50, S347, T348, and I350 are key residues 
found to form stable hydrogen bonding interactions with the flavin ring moiety of FAD. The 
residues E346 and P344 interact with the hydroxyl group of FAD; this was added to more 
accurately depict the reactant complex after formation of hypochlorous acid so its 
interactions in our MD cannot be compared with the crystal structure. The interaction 
between hydroxy-FAD and E346 could have interesting implications for the mechanism of 
the reaction.  
In the DCCA plot of the full complex wild-type PrnA (SI Figure 5), one the largest regions 
of positive correlation corresponds to two areas of protein from residues 205 to 255 and 305 
to 350 (Figure 14). The area makes up a large part of the FAD binding site and contains 
many important FAD binding residues (SI Table 1 and SI Table 2). It also contains important 
residues from the tryptophan binding site such as E346 and S347. The intensity of the 
correlation is reduced in the DCCA plot of the apoenzyme PrnA (SI Figure 6) suggesting 
that the correlated motion relies on the protein’s interactions with FAD.  
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Figure 14: The two DCCA correlated regions described as spanning residues 205 to 255 
coloured in red and the region spanning from residues 305 to 350 coloured in blue. The 
important residues E346 and S347 are displayed with blue tubes and the FAD and the 
substrate tryptophan are rendered with green coloured carbon tubes. 
 
  
Trp-S 
FAD 
β17  
α9  
β15 
β9 
β8 
β7 
β16 
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2.4.4 The possibility of direct contact between FAD and tryptophan binding 
site/module 
The 1µs MD simulations show that close contact between FAD and tryptophan does not 
occur at this timescale, the distance between the FAD binding site and the substrate 
binding site remains relatively high during MD. The average distance between the 
Flavin and tryptophan binding sites was found to be 12.08Å, 13.45Å and 14.23Å 
respectively for PrnA full complex, apoenzyme PrnA and PyrH full complex MD 
simulations (SI Figure 11). The distance between the proposed site that chloride reacts 
with FAD, the FAD C4A atom, and the to-be halogenated carbon of tryptophan 
(CZ2/CZ3) remains prohibitively high throughout the MD simulations of PrnA and 
PyrH (Table 4). The sidechains of residues K79 and E346 remain distant from flavin at 
the 1µs timescale of the MD simulations (Table 4). Some hydrogen bonding is found 
between hydroxyl group of flavin and the backbone carbonyl oxygen of E346, this 
would not however allow for direct halogenation of the E346 or K79 sidechains (SI 
Table 1). These observations support the main catalytic mechanism in which the 
intermediary halogenating hypochlorous acid is created at the FAD binding sire and 
travels through a channel between the FAD and tryptophan binding sites [110].  
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 Average distance  PrnA 
full complex (Å) 
Average distance PyrH 
full complex 
Flavin C4A – 
Substrate tryptophan  
CZ2/CZ3 
11.6 11.0 
Flavin C4X – Active 
Lysine NZ 
7.0 6.9 
Flavin C4X – Active 
Glutamate CD 
8.3 10.8 
 
Table 4: Average distances between the proposed reactive atoms of the tryptophan 
binding site: Lys-NZ, Glu-CD and Tryptophan CZ2/CZ3 and the proposed reactive 
atom of FAD-C4X in the MD simulations. 
 
2.4.5 Effects of Mutations on Binding 
Mutational studies show that both K79 and E346 in PrnA, and K75 and E354 in PyrH, play 
a vital role in the reaction of chlorination of tryptophan. The residues are conserved across 
the known FAD-dependent halogenases: PyrH [106] (trypthophan 5-halogenase), Thal [107] 
and SttH [108] (tryptophan 6-halogenases) and RebH [109] ,and PrnA [110] (trypthophan 
7-halogenases), indicating their key roles in catalysis [137]. In PrnA the mutation of K79 
leads to a complete loss of activity, and when E346 is mutated it is found that activity drops 
by orders of magnitude to a level where it is barely detectable[110]. Although possessing no 
formal charge hypochlorous acid has a strong dipole moment (oxygen -0.456 and hydrogen 
0.445 calculated by the ATB [129]) so dipole interactions with K79 and E346 will have an 
influence on its position and orientation. In order to test the stabilising effect of the two 
charged residues and explain experimental effects of mutations we performed MD 
simulations on the in silico mutated forms of PrnA K79A and E346Q. In the absence of the 
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electronic environment created by both K79 and E346, hypochlorous acid moves away from 
tryptophan and back along the proposed channel towards FAD. In this position, 
hypochlorous acid is too distant from tryptophan and would be unable to carry out 
halogenation (SI Figure 12). In the MD simulation of K79A mutant the hypochlorous acid 
remains closer to the flavin ring and forms hydrogen bonds with the O4 atom of FAD. In the 
E346Q mutant form MD simulation, the hypochlorous acid moves away from the tryptophan 
binding site along the channel towards FAD where it forms a hydrogen bond with T263, 
which although technically close to K79 is separated by internal protein structure and not 
accessible for interaction. The simulations of the two mutant forms show hypochlorous acid 
Cl to Trp-CZ2 distances which indicate that both residues are in key importance for the 
positioning hypochlorous acid in proximity to tryptophan and ensuring that the movement 
of hypochlorous acid only occurs from FAD to tryptophan. 
2.4.6 Comparison of PyrH to PrnA 
With PyrH and PrnA being structurally similar enzyme carrying out similar reactions it is 
surprising that the enzymes have different kinetics, PyrH is the more efficient enzyme at 
chlorinating tryptophan, it converts 100% conversion to 5-chlorotryptophan, whereas under 
the same conditions PrnA converts only 59% of tryptophan to 7-chlorotryptophan [105]. The 
binding mode of FAD in both enzymes is almost identical (Figure 3 and SI Figure 9) so the 
differences in their regioselectivities and kinetics probably has a structural basis found in the 
tryptophan binding domain. The way the two enzymes bind the substrate tryptophan in the 
active site is quite different, the substrate tryptophan in PyrH is oriented in an upside down 
position relative to its binding orientation in PrnA. The benzene moieties of the indole rings 
for both PrnA and PyrH are near superimposable in the crystal structure (Figure 3), the slight 
rotational difference means that the C5 atom in PyrH is in an almost identical place to that 
of the C7 atom in PrnA. During the MD simulation of PyrH we observe a rotation of the 
tryptophan substrate to a slightly different orientation, after equilibration this orientation 
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remains relatively stable (SI Figure 13). Despite this movement the orientation of the C5 
atom of the indole ring of tryptophan in relation to K75 and E354 is preserved. The position 
of hypochlorous acid in the PyrH MD simulation also remains more stable relative to the 
PrnA MD, this is evidenced by the lower levels of fluctuation in the RMSD plot of 
hypochlorous acid in SI Figure 14. 
We believe that the higher efficiency of PyrH may correlate with the reduced flexibility of 
the PyrH tryptophan binding site, with the more rigid binding site making it an overall more 
efficient enzyme for halogenating tryptophan [105]. The averaged distances from the MD 
trajectories between K79/K75-NZ, hypochlorous acid Cl and Trp (CZ2 in PrnA and CZ3 in 
PyrH), clustered and shown in SI Figure 15 and SI Figure 16. K79/K75-NZ to hypochlorous 
acid-Cl and tryptophan CZ2/CZ3 to hypochlorous acid distances in PyrH are shorter 
indicating a more compact binding site. We propose that our MD simulations of PyrH 
showing hypochlorous acid making more stable interactions with relatively lower levels of 
fluctuation between the active lysine and glutamate residues. The stability of these 
interactions could mean that a more energetically favourable version of the reaction 
mechanism is taking place in PyrH as opposed to PrnA, this could be one of the contributing 
factors to the experimentally observed greater catalytic turnover of PyrH compared to PrnA. 
The average RMSD of PyrH was 2.8Å, this is significantly lower than the PrnA full 
complex and PrnA apoenzyme simulations and means that PyrH is less flexible than PrnA 
(Figure 6). In the RMSF plot comparing the PyrH full complex and PrnA full complex MD 
simulations (SI Figure 17) the region around G37, which immediately precedes the FAD 
binding strap that runs from residues 37-50, we see a similar feature seen in the RMSF plot 
of PrnA. However, in PyrH this region shows lower levels of flexibility. However, In PyrH 
both the FAD strap region (SI Figure 18) and FAD show more conformational fluctuations 
than that of PrnA (SI Figure 19). Due to the differences in tryptophan binding between PyrH 
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and PrnA we find no analogous interaction between S50 and E450 that is found in PrnA. 
Instead a direct hydrogen bonding interaction between the sidechain of S50 and the 
carboxylate moiety of tryptophan is found (SI Table 3). This implies that despite the 
differences in tryptophan binding between PyrH and PrnA, the role of the “strap” region 
between the two enzymes remains the same. The function of providing a direct means of 
communication between FAD and the tryptophan binding site is conserved even though the 
mechanism in which it does this is not identical to that of PrnA.  
Another important structural difference hypothesised by us to be of key importance to 
tryptophan binding, in PrnA is the flexible loop region which spans residues 147-159. In this 
region there is a hydrogen bond between the sidechain of S157 and the carboxylate moiety 
of tryptophan seen to be affected by the dynamics of the 147-159 loop which we propose is 
important for tryptophan binding (SI Figure 4). In PyrH there is a similarly positioned 
flexible loop which had to be modelled due to its lack of coordinates in the crystal structure. 
This loop in PyrH is similar to the loop in PrnA in that G153 acts as a hinge residue with 
several internal hydrogen bonding interactions forming within the loop during the MD 
simulation such as between: T156 and D149, S151 and D149, and R154 and E150. This loop 
could play a similar role in PyrH as the equivalent loop 157-59 does in PrnA, acting as a 
structural link between the FAD binding strap and the substrate tryptophan. However, the 
residue S157 from PrnA is not found in PyrH, instead F164 is found in a similar spatial 
position, probably fulfilling a similar role in hydrogen bonding the substrate tryptophan. 
After equilibration, Phe164 forms a stable hydrogen bonding interactions with the substrate 
tryptophan amino and carboxylate moieties (Figure 15).  
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Figure 15: A plot showing the relationship between the RMSD of the flexible loop 
region spanning residues 148-165 in the PyrH simulation and the hydrogen bonding 
interaction between F164 and the substrate tryptophan. 
 
 
When comparing the DCCA plot of the PyrH full complex (SI Figure 20) with of the PrnA 
Full complex (SI Figure 5) we see a lot of similar correlations in similar regions indicating 
that the two enzymes share a lot of correlated motions. 
In general, most of the binding interactions of the substrate tryptophan and the cofactor FAD 
in the PrnA have analogous interactions in PyrH. For example tryptophan is bound in a 
similar way between hydrophobic sidechains making π-π stacking interactions with their 
indole rings (SI Table 4). In PrnA the residue W455 is replaced by the similarly positioned 
residue F451 in PyrH, although the distance is greater (average distance 6.95Å) making the 
interaction weaker and less significant to tryptophan binding. F49 in PyrH occupies a similar 
position to F454 in PrnA, with an average distance of 5.34Å to the substrate tryptophan (SI 
Table 4). H101 and F103 from PrnA are conserved in PyrH as H92 and F94 and fulfil a 
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similar role as hydrophobic residues in proximity to the substrate tryptophan (SI Table 4). A 
comparison of the tryptophan binding sites of PrnA and PyrH is shown in Figure 16. 
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Figure 16:A - The overlaid tryptophan binding sites of PrnA and PyrH. B - The tryptophan 
binding site of PrnA. C - The tryptophan binding site of PyrH. In all parts of the figure the 
substrate tryptophan is rendered with balls and sticks whereas the interacting residues are 
rendered as tubes. 
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In PyrH the amino group of the substrate tryptophan interacts electrostatically with the 
sidechain of E452 (distance of 3.92Å) (SI Table 5). In the crystal structure of PyrH a similar 
electrostatic interaction supports E452 and appears to be created by R96, however the 
average distance of this interaction during the MD simulation is much greater and therefore 
weaker than the analogous interaction between K57 and E450 observed in the MD 
simulation of PrnA. In PyrH the important catalytic residue E354 interacts with the 
protonated H40 with a similar distance to that of H395 to E346 seen in PrnA (SI Table 5). 
Hypochlorous acid forms strong interactions with both the active site K75 and E354, low 
average distances indicate that these interactions are stronger and more stable than in PrnA 
(SI Figure 15 and SI Figure 16). This may be another contributing factor to the increased 
efficiency of PyrH as an enzyme.  
The greatest differences in tryptophan binding between PyrH and PrnA are found in the 
hydrogen bonding of the substrate tryptophan. The different orientations of the substrate 
between PrnA and PyrH lead to very different hydrogen bonding. In PyrH the relative upside 
down positioning of tryptophan means that the tryptophan NE1 atom no longer points 
towards hypochlorous acid channel, this means it is more able make hydrogen bonds with 
the surface residues of the tryptophan binding pocket (Figure 3). In PyrH S345 forms a 
hydrogen bond with the substrate tryptophan NE1 atom, S50 is the main residue responsible 
for the hydrogen bonding of the substrate tryptophan carboxylate moiety, and Phe164 forms 
hydrogen bonds with both the amino and carboxylate moiety of tryptophan (SI Table 3). 
Similarly, to the PrnA MD simulation we find that FAD undergoes a structural transition 
from a linear to a bent form (SI Figure 21). The transition occurs much more rapidly in PyrH 
than PrnA, this is seen in the loss of several hydrogen bonds in the crystal structure compared 
to the MD (SI Table 5).  The binding mode of FAD in PyrH shows a high level of similarity 
to that of PrnA, in that it is mainly bound by backbone hydrogen bonds. Some of the Van 
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der Waals interactions between hydrophobic sidechain residues and the adenine and flavin 
moieties are conserved by similar residues to those in PrnA in both the crystal structure and 
MD simulations (SI Table 6). 
 
2.5 CONCLUSIONS 
Through the creation and analysis of several MD simulations we have gained insight into 
the structure function relationships of the two halogenases PrnA and PyrH and the origin of 
their selectivity. The study of the tryptophan binding site in our MD simulations have 
identified the key residues for the positioning of tryptophan in the active site, the specific 
positioning of tryptophan is likely the key factor in the regioselectivity of the enzymatic 
reaction. By comparing the crystal structure to that gained from the MD simulation, we can 
see that important structural differences created during the crystallisation process. The MD 
simulations have identified several dynamic regions that have implications for substrate 
binding and the proposed function of the “strap” in the mechanics of the enzyme. We have 
provided suggestions for the structural basis of the previously proposed line of 
communication that links the tryptophan and FAD binding sites. The study of the two mutant 
forms of PrnA has reaffirmed the results experimental mutagenesis studies and helped to 
understand the likely structural basis for reduced activities observed for these two mutant 
forms of the enzyme. Comparison of the PyrH and PrnA has led to the suggestions of why 
PyrH is the more efficient halogenating enzyme.  The atomistic insights gained from the 
simulations provide important structural information that can be related to enzyme function. 
 
  
81 
 
3 COMPUTATIONAL INSIGHTS IN THE REACTION 
MECHANISM OF THE 2-OXOGLUTARATE 
DEPENDENT OXYGENASE - THE FAT MASS AND 
OBESITY-ASSOCIATED PROTEIN (FTO) 
 
3.1 PREFACE 
This chapter represents an ongoing computational investigation into the reaction mechanism 
of the fat mass and obesity associated protein (FTO), utilising QM and QM/MM 
methodology, to specifically investigate the electronic and geometric changes that occur 
during the formation of the Fe(IV)-oxo intermediate. The continued direction of the research 
is highly dependent on planned calculations and the scope of the project will be expanded as 
more results become available for analysis. The results and discussion sections of this 
chapter represent the interpretation of preliminary findings. Suggestions for how the project 
will be developed are described in the future work section and when completed the research 
detailed in this chapter will lead to one or more publications.   
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3.2 INTRODUCTION 
 
The fat mass and obesity-associated protein (FTO) is an Fe (II) 2-oxoglutarate (2OG) 
dependent oxygenase found in humans that has several variants that are strongly correlated 
with obesity susceptibility in humans [138]. The FTO gene variants that are linked to obesity 
are thought to exert their body mass increasing effects by increasing overall appetite, 
increasing the intake of high fat and protein foods and reducing satiety [139]. As well as the 
increased risk of obesity in both children and adults [140], FTO malfunction has been 
implicated  as a risk factor for certain forms of cancer [141-144]. However, the problem is 
twofold because the risk of cancer is greatly increased in overweight individuals, it has been 
shown that there is a link between the state of altered energy metabolism regulation through 
FTO activity and the formation of cancerous cells in humans [145]. The effects of FTO 
function are long reaching with certain variants of FTO also being implicated as risk factors 
for Alzheimer’s disease [146] and type 2 diabetes [147]. In healthy individuals, FTO 
functions as a demethylase enzyme, catalysing the removal of methyl groups from 
methylated DNA (3Me-T) and RNA (6Me-Ad) bases (a simplified mechanism of this 
reaction is shown in Figure 17) to fulfil roles in DNA/RNA repair and epigenetic control. In 
the case of DNA/RNA repair, bases that have become damaged through external toxins can 
be demethylated by FTO to return the base to its natural demethylated state [148]. In the case 
of epigenetic control, bases are modified by the addition and removal of methyl groups to 
control whether a gene is expressed or not, FTO is expressed to remove these methyl groups 
to allow the gene to be expressed [149]. FTO is also part of a family of human AlkB analogue 
enzymes, including ALKBH1-ALKBH8. AlkB was first identified in E. coli, where it is 
expressed as a response to alkylating damage of DNA for the purpose of DNA repair. 
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Figure 17: A simplified mechanism for the demethylation of the methylated base 3-MeT 
by FTO. A more detailed mechanism is shown in Figure 18. 
 
Belonging to the family of non-heme iron 2OG dependent oxygenases, these enzymes all 
utilise a conserved non-heme iron centre. In the resting state iron (II) is coordinated by a 
conserved 2 Histidine and 1 Aspartate/Glutamate motif (aka the HXD/E...H triad) and 3 
water molecules. 2OG binds in a bidentate fashion at the equatorial position and 2 water 
molecules are displaced. Upon substrate binding the remaining bound water molecule 
dissociates from iron, this creates the 5-coordinate complex with the free axial position for 
oxygen binding. Iron binds the dioxygen molecule and donates an electron to form the iron 
(III) super-oxo intermediate. The distal atom of the bound dioxygen attacks the C2 atom of 
2OG to produce a peroxo bridged bicyclic intermediate. The intermediate complex collapses 
and the O-O bond breaks, the C1 atom of 2OG leaves as carbon dioxide and the remaining 
4-carbon molecule (succinate) is monodentately bound by its newly formed terminal 
carboxylate group. In this state iron (IV) is a 5-coordinate complex with a single oxygen 
atom bound in the axial position. It has been shown by QM/MM study of AlkB that at this 
stage oxo-rotation occurs to bring the axial oxygen to an equatorial position, this is necessary 
to bring the oxo group into proximity of the methylated base [150]. The highly reactive iron 
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(IV) oxo then abstracts a hydrogen atom from the methyl group of the methylated base 
substrate. The methyl group radical of the substrate reacts with the iron (III) bound hydroxyl 
group to produce a hydroxylated substrate. The hydroxylated substrate collapses with the 
target methyl group leaving as formaldehyde, in this way the base is left demethylated, 3 
water molecules displace succinate and the catalytic iron (II) centre is ready for further 
reaction [151]. The proposed generic catalytic cycle for this reaction is shown in Figure 18. 
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Figure 18: The conserved mechanism for non-heme iron 2OG dependent oxygenases. 
 
FTO is composed of two distinct domains, the N-Terminal Domain (NTD) shares a lot of 
structural similarity with other Fe (II) 2OG-oxygenase enzymes, particularly AlkB and 
ALKBH1-ALKBH8, through a conserved “jelly-roll” motif. This arrangement of eight beta 
strands split into two anti-parallel sheets forms a distorted barrel shape which is open at one 
end [152]. The NTD contains the catalytic site; iron, 2OG as well as room to accommodate 
the methylated base and oxygen. Despite sharing this conserved structural feature, Fe (II) 
2OG-oxygenase enzymes are found throughout nature where their oxidating abilities are 
employed in a diverse range of roles such as; the synthesis of secondary metabolites, lipid 
metabolism and collagen biosynthesis [153, 154]. With such diverse substrates and 
conserved active sites, the enzymes mostly differ in how they recognise and bind their 
substrates, in FTO the CTD is thought to play a key role in this process and does not show 
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significant homology with any other protein. Even though the CTD has no clear catalytic 
role, the isolated NTD was found to be inactive, this supports the idea that the CTD has a 
necessary but indirect role in catalysis [152]. Initial In-vitro experiments of FTO showed 
that it had a preference towards 3-methylthymidine (3-MeT) in single stranded DNA or 3-
methyluradine in single stranded RNA with no reaction to double stranded DNA or RNA 
[140, 155]. However, more recently in-vivo experiments have shown that FTO more 
efficiently demethylates 6-methyladenosine, a methylated base that is mostly found in 
transfer and messenger RNA [156]. When preparing FTO for crystallisation the protein is 
incubated with the free base form of the methylated base, allowing the observation of the 
active site interactions of the methylated base substrates without the complications of 
crystallising the DNA/RNA bound complex [152]. However currently no crystal structure 
of FTO in complex with 6-methyladenosine exists, the publication of such a structure would 
aid in the explanation of the substrate preferences and specificity of FTO [151]. The 2OG 
cosubstrate analogue, N-oxylglycine (NOG), is also commonly used as it acts as an inhibitor 
allowing the enzyme-substrate complex to be more easily crystallised and studied [157]. 
 
FTO is a desirable drug target for the treatment and prevention of obesity, diabetes and 
cancer. Inhibitors that emulate 2-oxoglutarate are not effective due to the large number or 
other Fe (II) 2-oxoglutarate dependent enzymes in human body, with over 80 currently 
identified examples specific inhibition of FTO would be difficult [158]. Molecules that 
instead emulate the binding mode of the substrate should be the preferred inhibition strategy, 
each substrate is highly specific to only a small number of enzymes, therefore its 
corresponding inhibitor would have reduced off-target effects [159]. A proven method for 
discovering inhibitor molecules involves emulating the structure of transition states [160]. 
Transition states by their very nature cannot be directly observed by experimental means due 
to their instability leading to incredibly short half-lives [161]. The structures of transition 
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states can be determined by QM and QM/MM methodology, by modelling the enzymes 
reaction mechanism we can characterise the structure of transition states [160, 162]. These 
could be used in the design of novel inhibitor molecules for the treatment of diseases 
associated with the malfunction of FTO. 
 
Although a QM/MM study of FTO was published in 2015 [163], this study primarily focused 
on the reaction path of the hydroxylation of the 3Me-T and 6Me-Ad substrates and their 
subsequent hydrolysis to their demethylated forms. Our study will focus on the part of the 
reaction mechanism concerned with the formation of the Fe(IV)-oxo species from the 
Fe(III)-superoxo complex, this reaction step has been the focus of  other studies of other 
non-heme iron 2OG dependent oxygenases but not of FTO [148, 150, 164, 165]. In addition 
to modelling the reaction path we will attempt to investigate what effects the choice of 
methodology and cluster size has on the calculated structures. The results of these 
calculations on the different QM cluster structures will be used to assess the individual 
contributions that each key residues has on the important molecular orbitals, geometric 
features, spin densities and charges of the enzyme substrate complex of FTO. In addition the 
reaction path for the formation of the Fe(IV)-oxo species will be modelled with different 
cluster sizes, functionals, and basis sets to assess the effect these have on the resultant 
transition state and intermediate structure geometries, the effects on the reaction barrier and 
reaction energy will be investigated. The QM cluster results will be compared to those of the 
QM/MM model, as well as existing published results of other computational studies of FTO 
and similar non-heme iron containing 2OG dependent enzymes [163, 164]. 
 
3.3 METHODS 
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In order to study the reaction mechanism of FTO, several different cluster models in varying 
size as well as a QM/MM model were created. To create the desired reactant complex the 
crystal structures of 3LFM [152] and 4IDZ [157] were combined using chimera [131] to 
overlay the two protein structures. The 3LFM structure contains the methylated base 3MeT 
but has an unusual distorted active site, 4IDZ has the correct active site geometry but doesn’t 
contain 3MeT so its coordinates are copied from the 3LFM structure. NOG was also 
modified to produce 2OG to represent the natural enzyme substrate complex. For the QM 
and QM/MM iron oxygen bound model the axial bound water molecule was replaced with 
dioxygen bound in the end on bent conformation with geometry that is consistent with 
experimental spectroscopic studies of model compounds [165]. Hydrogen atoms were added 
to the structure and the titratable amino acid protonation states were determined with the 
PROPKA web server [166], solvent molecules were added using the leap module for 
Amber14 [25]. The reactant complex was modelled with high spin iron (S=2), oxygen is 
antiferromagnetically coupled so has no net influence of  on the quintet spin state of the 
overall system, this is based on past experimental and computational studies [163-165]. 
 
The QM cluster models were created by modifying the full enzyme structure in GaussView 
[167] and the calculations were performed using Gaussian09 [94]. In the X-ray crystallised 
structures of FTO 2OG/NOG is found to adopt an extended conformation, this is supported 
by other structural studies of Fe (II) 2OG dependent oxygenases [168, 169]. In the full 
enzyme structure the C5 carboxylate of 2OG interacts electrostatically with R316. To 
preserve this extended linear conformation of 2OG in the QM cluster models, we first 
employed a distance restraint to the C5 atom of 2OG, however this posed problems when 
scanning for the formation of succinate as the newly formed succinate was not able to move 
to re-bind to iron. To overcome this a dihedral restraint was used to freeze the dihedral angle 
between the C2 and C3 bond, this maintained the linear extended conformation whilst giving 
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more realistic results for the binding of succinate following the scan to form Fe (IV)-oxo. 
The iron coordinating histidine and aspartate residues were truncated at their β-carbon atoms 
and a hydrogen atom was added to fill the open valency, distance restraints between these 
β-carbon atoms were added to preserve the structure of the facial triad. Different cluster sizes 
incorporated additional amino acids to study the effect of cluster size on the calculations, 
these were treated in the same method as the iron coordinating amino acids. Different 
optimisations of the clusters were performed with the BP86 functional [170, 171] with 10% 
HF exchange. To simulate the hydrophobicity of the enzyme active site the implicit solvent 
model conductor-like polarisable continuum model was used, with a dielectric constant of 
ε=4.3 and diethyl ether solvent molecule was used[172], this method was applied to all the 
clusters. Frequency calculations of the optimised structures were performed to check for 
negative frequencies which might indicate an unnatural structure. The systems were treated 
with two different basis sets 6-311G* for iron and its immediate coordinating atoms and 6-
31G* for the other atoms in the system. Potential energy scans were performed to simulate 
the reaction mechanism step for the formation of the Fe (IV)-oxo intermediate from the Fe 
(III)-superoxo complex. Multiple scans with varying conditions were made to assess the 
effect of cluster size and functional on the potential energy landscape.  
The QM/MM model of FTO was created from the aforementioned FTO model, the Amber 
parameters for 2OG and 3MeT were created using the General Amber Force Field 
(GAFF)[26] in AntechAmber for Amber 14 [25]. Their atomic charges were amended using 
the Restrained Electrostatic Potential (RESP) method for charge fitting following a single 
point calculation with the HF method and a 6-31G* basis set using Gaussian09 [94]. The 
parameters for iron and its coordinating residues were created using the Metal Centre 
Parameter Builder (MCPB) tool, by designating the metal coordinate bonds as being 
covalent. The force constants for bond stretching and bending were derived using the 
Seminario method and charges were assigned using the charge model B method in MCPB. 
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The system setup in GaussView [167] and was truncated at 20Å with all atoms outside the 
20Å limit being frozen, atoms within 20Å were allowed to move freely during optimisation. 
The whole system was initially optimised at the MM level using Amber14 for 10,000 steps 
using a combination of the steepest descent and conjugate gradient algorithms, during this 
process the active site residues were restrained with a potential of 100 kcal mol−1 Å2 to 
preserve active site geometry. The system was split into two layers according to the ONIOM 
method [173], the QM region was defined as being iron and its bonded histidine and 
glutamate residues (cut-off at the β-carbon and link atoms used to saturate the open valency) 
as well as 2OG, 3Me-T and oxygen, the remainder of the system was treated with an MM 
level of theory. The optimisation was performed with ONIOM[173] in Gaussian09[94], with 
BP86 10%HF exchange/Amber method [25, 170, 171] and two basis sets, 6-311G* for iron 
and its coordinating atoms and 6-31G* for the rest of the QM layer. All images of molecular 
models for this chapter were created using GaussView [167]. 
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3.4 RESULTS 
 
  
Figure 19: The optimised QM cluster structure of FTO rendered in ball and sticks 
rendering with the iron binding ligands labelled. Atom colours are as follows: carbon-
grey, hydrogen-white, oxygen-red, nitrogen-blue and iron-purple. S=2, Charge=-1 
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The optimised geometry of the standard sized Fe(III)-superoxo complex QM cluster model 
is shown in Figure 19. Reduced versions of this standard cluster size are shown in: Figure 
20, where 2OG is cut at the C3 atom to create the “cut 2OG” model; Figure 21, full 2OG 
without 3Me-T. The QM/MM optimised oxygen bound Fe(III)-superoxo complex is shown 
in Figure 32 and Figure 33, the measured distances from the QM/MM optimisation are 
compared against those from the initial pdb structure as well as the optimised structures of 
the different QM models in Table 5.  
In addition to these reduced versions of the standard sized QM cluster model, several larger 
clusters were created. These are shown in Figure 22, the standard cluster with the sidechain 
of R316 added; Figure 23, the standard cluster with the sidechain of R322 added; Figure 24, 
the standard cluster with the sidechains of R322 and R316 added; Figure 25, the standard 
cluster with the sidechains of R96, R316 and R322 added. These complexes were all 
optimised from the pdb model created by combining the crystal structures of 3LFM and 
4IDZ (exact procedure described above in the methods section). The measured distances for 
the extended cluster structures can be found in Table 6. All the above described structures 
were optimised with the BP86 functional with 10% HF exchange, the 6-311G* basis set was 
used for iron, O2 and the iron coordinating atoms, the rest of the atoms in the system used 
the 6-31G* basis set. 
Potential Energy Surface (PES) scans using different reaction coordinates were created from 
the optimised oxygen bound clusters, the PES scans used the reaction coordinate the C1-C2 
bond of 2OG. The PES scans were performed by increasing the C1-C2 bond of 2OG by 
0.05Å for ten steps, for the standard QM cluster (O2 bound, full 2OG, with 3Me-T), the full 
2OG without 3Me-T cluster, and the cut 2OG with 3Me-T cluster.  All scans were performed 
using the same BP86/10% HF exchange functional with the basis sets applied to the atoms 
being the same as for the geometry optimisation calculations.  
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The PES scan plots for the three clusters are shown in Figure 26, the measured distances for 
the global maximum (potential TS) and global minimum structures can be found in Table 7. 
Additionally the final structures from the PES scans were optimised with CO2 removed and 
the measured distances can also be found in Table 6.   
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Figure 20: The optimised structure of the cut 2OG with 3Me-T QM cluster model. S=2, 
Charge=0 
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Figure 21: The optimised structure of the cut 2OG without 3Me-T QM cluster model. 
S=2, Charge=-1 
  H307 H231 D233 2OG 
(C1-
O) 
2OG 
(C2-
O) 
Fe-O 
(prox.) 
O(prox.)-
O(dist.) 
2OG 
C2-
O(dist.) 
3Me-
T(CH3)-
Fe 
PDB structure 
(4IDZ/3LFM) 
2.02 2.04 2.07 2.08 2.07 n/a n/a n/a 4.28 
Standard QM 
cluster 
2.20 2.10 1.96 1.96 2.22 1.93 1.28 3.12 4.23 
Full 2OG no 
3DT optimised 
structure 
2.15 2.13 1.96 1.99 2.20 1.92 1.28 2.93 n/a 
Cut 2OG with 
3DT optimised 
structure 
2.04 1.99 1.95 1.93 2.32 1.88 1.29 2.43 4.20 
QM/MM 
optimised 
structure 
2.13 2.13 2.09 2.03 2.43 2.21 1.22 2.56 4.30 
His231 
His307 
Asp233 
2OG
O2
Fe 
96 
 
Table 5: Measured distances comparing the geometry of the initial pdb structure, 
optimised QM/MM structure and optimised QM cluster model structures. 
 
 
Figure 22: The extended QM cluster including the sidechain of R316. S=2, Charge=0 
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Figure 23: The extended QM cluster including the sidechain of R322. S=2, Charge=0 
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Figure 24: The extended QM cluster including the sidechains of R316 and R322. S=2, 
Charge=+1 
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Figure 25: The extended QM cluster including the sidechains of R96, R316 and R322. 
S=2, Charge=+2 
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Table 6: The measured distances for the extended QM cluster models compared to the 
standard QM cluster, all distances are displayed in Å. 
  
  H307 H231 D233 2OG 
(C1-
O) 
2OG 
(C2-
O) 
2OG 
C1-C2 
Fe-O 
(prox.) 
O(prox.)
-O(dist.) 
2OG C2-
O(dist.) 
3Me-
T(CH3)-
Fe 
Standard 
QM cluster 
2.20 2.10 1.96 1.96 2.22 1.48 1.93 1.28 3.12 4.23 
R316 
extended 
region 
2.14 2.09 1.93 2.02 2.27 1.56 1.91 1.28 2.86 4.43 
R322 
extended 
region 
2.13 2.10 2.00 2.06 2.19 1.55 1.92 1.27 4.10 5.48 
R322, 
R316 
extended 
region 
2.02 1.97 2.10 1.98 2.18 1.53 1.89 1.30 2.57 4.34 
R96, R316, 
R322 
extended 
region 
2.11 2.09 1.92 2.02 2.13 1.54 2.09 1.29 2.32 4.63 
QM/MM 
optimised 
structure 
2.13 2.13 2.09 2.03 2.43 1.55 2.21 1.22 2.56 4.30 
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Figure 26: The 1-dimensional scans of the C1-C2 bond of 2OG reaction coordinate.  
 
 
 
  H307 H231 D233 2OG 
(C1-
O) 
2OG 
(C2-
O) 
2OG 
C1-
C2 
Fe-O 
(prox.) 
O(prox.)-
O(dist.) 
2OG 
C2-
O(dist.) 
3Me-
T(CH3)-
Fe 
Full 2OG with 
3Me-T 
optimised 
starting 
structure 
2.20 2.10 1.96 1.96 2.22 1.48 1.93 1.28 3.12 4.23 
Full 2OG with 
3Me-T global 
maxima 
structure 
2.18 2.10 1.95 2.02 2.21 1.89 1.91 1.28 2.58 4.25 
Full 2OG with 
3Me-T global 
minima 
structure 
2.20 2.08 1.98 2.36 2.07 1.99 1.98 1.40 2.07 4.32 
Full 2OG with 
3Me-T 
optimised 
without  CO2 
2.14 2.10 2.01 n/a 2.24 n/a 1.91 1.48 1.33 4.10 
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Full 2OG 
without 3Me-T 
optimised 
starting 
structure 
2.15 2.13 1.69 1.99 2.2 1.56 1.92 1.28 2.93 n/a 
Full 2OG 
without 3Me-T 
global maxima 
structure 
2.13 2.13 1.95 2.05 2.18 1.86 1.90 1.28 2.66 n/a 
Full 2OG 
without 3Me-T 
global minima 
structure 
2.15 2.10 1.99 2.51 2.08 2.06 1.99 1.41 1.37 n/a 
Full 2OG 
without 3Me-T 
optimised 
without  CO2 
2.13 2.10 2.03 n/a 2.24 n/a 1.91 1.48 1.32 n/a 
                      
Cut 2OG 
with3Me-T 
optimised 
starting 
structure 
2.04 1.99 1.95 1.93 2.32 1.54 1.88 1.29 2.43 4.2 
Cut 2OG with 
3Me-T global 
maxima 
structure 
2.15 2.06 1.92 1.99 2.36 1.64 1.91 1.28 2.79 4.17 
Cut 2OG with 
3Me-T global 
minima 
structure 
2.19 2.07 1.96 2.46 2.09 2.04 2.00 1.40 1.37 4.31 
Table 7: Measured distances from the PES scans of the C1-C2 bond of 2OG, all 
distances are displayed in Å. 
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Figure 28: The freely optimised global minimum structure of the standard QM cluster 
model without CO2. S=2 
  
A B 
Figure 27: A) the global maximum structure, B) the global minimum structure for the 
standard QM cluster model from the PES scan of the C1-C2 2OG bond. (2OG* is 
labelled as such to represent the probable breakage of the C1-C2 bond and the 
formation of CO2 and succinate) 
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A B 
Figure 29: A) the global maximum structure, B) the global minimum structure for the 
full 2OG no 3Me-T QM cluster model from the PES scan of the C1-C2 2OG bond. . 
(2OG* is labelled as such to represent the probable breakage of the C1-C2 bond and the 
formation of CO2 and succinate) 
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Figure 30: The freely optimised global minimum structure of the full 2OG no 3Me-T 
QM cluster model without CO2. S=2 
 
   
A B 
Figure 31: A) the global maximum structure, B) the global minimum structure for the 
Cut 2OG with 3Me-T QM cluster model from the PES scan of the C1-C2 2OG bond. 
(2OG* is labelled as such to represent the probable breakage of the C1-C2 bond and the 
formation of CO2 and succinate) 
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Figure 32: The whole QM/MM system, the atoms of the MM region are rendered as 
wireframes and the atoms of the QM system are rendered as balls and sticks. 
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Figure 33: The QM atoms of the QM/MM model. S=2  
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3.5 DISCUSSION  
3.5.1 Comparing the Effects of Different Cluster Size on Active Site Geometry 
The distances measured were chosen to monitor the binding of iron to the coordinating 
amino acid residues and 2OG, the binding and geometry of oxygen in relation to iron and 
the viability of the target methyl group of 3Me-T to react with the formed Fe(IV)-oxo 
species. Of the three cluster models: the standard sized QM cluster and the cluster without 
3Me-T show quite good agreement in the distance between H307, H231 and D233 to iron 
(Table 5). The cut 2OG with 3Me-T cluster shows good agreement with the other two 
clusters in the distance of D233 to iron but shows shorter distances of ~0.1Å between H307 
and H231. The distance between the binding oxygen atoms of 2OG to iron are once again 
quite consistent between the standard sized QM cluster and the full 2OG without 3Me-T 
structure, whereas the cut 2OG with 3Me-T shows slightly longer binding distances for the 
C2-O atom of 2OG to iron by ~0.1Å (Table 5). All three QM cluster sizes show good 
agreement in Fe-Oproximal and Oproximal-Odistal distances with only slight variation between 
them. The variation in distances between the three clusters is most pronounced in the 
distance between the 2OG-C2 to the distal oxygen atom. This distance in the standard sized 
QM cluster and the cluster without 3Me-T are somewhat similar, but is significantly shorter 
by ~0.5Å  in the cut 2OG cluster (Table 5). The distance between the 3Me-T methyl carbon 
atom and iron are almost identical between the standard sized cluster and the cut 2OG with 
3Me-T cluster, which is in turn similar to that of the QM/MM model and the pdb structure. 
 
The distances measured in the initial pdb structure show reasonable agreement with the 
QM/MM model, with the only major exception being the 2OG C2-O to Iron distance that is 
0.36Å longer in the QM/MM optimised structure (Table 5). However, comparisons between 
the crystal structure and the QM clusters and QM/MM model are difficult to judge as the 
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crystal structure was crystallised without 3Me-T or oxygen bound so represents a different 
stage of the full reaction mechanism. 
 
The QM/MM optimised structure shows reasonable agreement with the bond length found 
in the standard sized QM cluster for the two coordinating histidine residues, however the 
bond length between aspartate and iron is somewhat longer ~0.15Å in the QM/MM model 
as compared to the other QM cluster sizes (Table 5). This lengthening of the bond between 
D233 and iron may be caused by interaction of D233 with the positively charged residue 
R322 weakening the D233 to iron interaction. A similar effect may contribute to the 
increased distances between iron and the 2OG binding oxygen atoms 2OG-C1-O and 2OG-
C2-O in the QM/MM model, particularly the 2OG-C2-O atom is ~0.2Å further from iron in 
the QM/MM model compared to the standard sized QM model (Table 5). The sidechains of 
both R316 and R322 are found in close proximity to the negatively charged 2OG ligand, and 
their electrostatic interactions likely influence 2OG positioning and its binding to iron. The 
most striking difference between the QM/MM model and the other three QM cluster models 
is found in the geometry of the bound oxygen, in the QM/MM model the Fe-O bond distance 
is significantly longer by about ~0.2Å and the Oproximal-Odistal bond distance is shorter by 
about 0.05Å. The geometry of oxygen in the QM/MM model means the distal oxygen atom 
is found much closer to the C2 atom of 2OG by about 0.5Å, this is an important finding as 
this distance is along the proposed path of reaction that initiates the decarboxylation of 2OG 
and formation of the Fe(IV)-oxo species. This finding seems to suggest that the surrounding 
residues of the FTO active site have a facilitating effect on the formation of the Fe(IV)-oxo 
species.  
 
Overall, the cut 2OG model seems to give the most inconsistent results, both in comparison 
to the other two QM cluster models and the QM/MM model. Based on our results this may 
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indicate that the reduced 2OG group may be an unsuitable replacement for the full 2OG 
ligand when modelling the FTO active site. In comparison 3Me-T seems to have only a 
subtle effects on the QM cluster model geometry of the iron binding site in FTO. In future 
the effect of cutting 2OG and not including 3Me-T in the QM cluster models will be 
investigated to better ascertain the influence that these two important components have on 
the overall geometry of the iron binding site. 
 
3.5.2 Comparison of Extended Cluster Sizes 
To investigate the effect of the surrounding arginine residues further, the extended cluster 
models were created and their measured geometries are displayed in Table 6. The R316 
extended cluster was primarily created to investigate the influence that the positively charged 
sidechain had on the binding of the negatively charged 2OG. In the R316 extended cluster 
we see similar binding distances between the H307, H231 and D233 residues to iron as those 
found in the standard sized QM cluster (Table 6). This was the expected result as R316 is 
mainly thought to electrostatically interact with the C5 carboxylate moiety of 2OG so 
shouldn’t have much of an effect on the distance between coordinating amino acid residues 
and iron. The distance between the 2OG binding oxygen atom 2OG-C1-O was longer in 
relation the standard sized QM cluster model and a lot more similar to the distance measured 
in the QM/MM model. Although the 2OG-C2-O distance was found to be longer in the R316 
extended cluster relative to the standard QM cluster, it was still 0.16Å shorter than the same 
distance in the QM/MM cluster model. This result indicates that although R316 is an 
important interacting residue for 2OG, there must be other interacting residues in the 
proximity of 2OG which cause the 2OG-C2-O to iron distance to be ~0.2Å longer in the 
QM/MM model as compared to the standard sized QM model. Residues such as Y295 and 
S318 are also found to hydrogen bond the C5 carboxylate moiety of 2OG in the crystal 
structure and perhaps cause the observed differences in the geometry of 2OG and its binding 
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to iron. The addition of R316 to the standard QM cluster model seems to have shortened the 
important distance of 2OG-C2 to distal oxygen by about 0.25Å when compared to that of 
the standard QM cluster. This change in the position of 2OG causes the plane of the C1-C2 
bond to sit above that of the two iron binding oxygen atoms of 2OG, in the standard QM 
cluster 2OG is more planar in respect to iron, this makes the 2OG-C2 to distal oxygen 
slightly longer. This observed change in 2OG positioning may be one of the ways in which 
R316 influences active site geometry to encourage the formation of the Fe(IV)-oxo species.  
  
The R322 extended cluster model was created to assess the effect that R322 had on the active 
site geometry given its close proximity to the two negatively charged moieties of D233 and 
the C1 carboxylate of 2OG. The binding of H307 to iron in the R322 extended cluster model 
showed good agreement with the QM/MM model, being slightly shorter than the distance 
measured in the standard sized QM cluster. The binding of H231 was mostly unaffected and 
remained in good agreement with the standard sized QM cluster model and consequently 
also the QM/MM model. Although the binding distance between D233 and iron was longer 
in the R322 cluster as compared to the standard QM cluster it was still shorter than the same 
distance measured in the QM/MM model, this likely indicates that the longer D233 to iron 
distance observed in the QM/MM model is influenced by other factors than R322 alone. The 
length of the 2OG-C1-O to iron bond is found to be more consistent with that of the QM/MM 
model than the standard sized QM cluster, this is consistent with the idea that the binding 
between the C1 carboxylate moiety of 2OG and iron is influenced by the close proximity of 
R322. The Fe-O and Oproximal-Odistal bond distances are nearly unchanged in the R322 cluster 
as compared to the other QM cluster models, however the distance between the distal oxygen 
atom and the C2 atom of 2OG is much longer than in the other QM clusters and the QM/MM 
model. In the R322 extended cluster model we find the distal oxygen atom to be drawn more 
towards the sidechain of R322 (Figure 23), therefore it seems that R322 in isolation causes 
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oxygen to adopt a different, and probably non-productive, conformation as compared to the 
observed conformation of the other QM cluster models.  This seems to indicate that R322 
doesn’t have a facilitating effect on the formation of the Fe(IV)-oxo species.  
 
When both R322 and R316 are included in an extended QM cluster model we find that the 
iron to coordinating histidine bonds are shorter when compared to both the other QM clusters 
and the QM/MM model. The iron to D233 bond is slightly longer than in the other QM 
cluster models and is found to be in closer agreement to the distance in the QM/MM model. 
The binding of 2OG in this cluster more resembles that of the standard sized QM model and 
R322 extended QM cluster model. The inclusion of the two arginine residues seems to have 
only a subtle effect on the binding of oxygen to iron, the Fe-O bond distance in the R316 
and R322 cluster model (Figure 24) is positioned similarly to that of the R316 extended 
cluster model (Figure 22) and the QM/MM model (Figure 33). The distal oxygen to 2OG-
C2 distance is shorter than the standard QM model by about 0.5Å and is more similar to the 
distance found in the QM/MM model. These observations seem to indicate that the inclusion 
of the two residues R316 and R322 together cancel out the disrupting effect that R322 has 
on oxygen orientation relative to the 2OG-C2 atom that was observed in the R322 extended 
cluster model, this might indicate that the two residues have a synergistic effect on 
facilitating distal oxygen attack of 2OG. Further calculations will be required to determine 
the exact nature of the inter-play between these two important arginine residues. 
 
The triple arginine extended cluster included R96, R316 and R322 and was created to 
investigate the effect that R96 had on the geometry of the iron binding site. The distances of 
the iron coordinating amino acid residues and 2OG showed good agreement with the other 
extended clusters, this seemed to agree with our previous observations of the proposed 
effects of R316 and R322 on the iron binding site geometry. The most profound effect on 
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the active site geometry was found in the Fe-O bond distance, in the triple arginine extended 
cluster the Fe-O bond is increased by ~0.1Å compared to both the standard sized QM cluster 
model and the other extended cluster models. This makes the Fe-O bond distance in the triple 
arginine extended cluster more similar if still slightly shorter than that of the QM/MM 
optimised structure, this possibly indicates to us that R96 is an important residue for oxygen 
binding. The triple arginine extended cluster also seems to possess the shortest 2OG C2 to 
distal oxygen distance of all of the QM cluster models. To test this hypothesis, more 
calculations on new QM cluster models will be required to ascertain whether R96 has this 
influence in isolation or if it is a synergistic effect with either one or two of the other arginine 
residues R316 and R322.  
 
Overall, the extension of the QM cluster model to include arginine seemed to have profound 
effects on the 2OG C2 to distal oxygen distance, with every extended cluster apart from the 
R322 extended cluster showing significant shortening of this important measurement. 
However, comparisons between the QM/MM model and any cluster model no matter how 
large the cluster size are not direct comparisons due to the differences in solvation 
methodology. The explicit solvation of the QM/MM model as compared to the implicit 
solvation model of the QM cluster models will lead to different active site geometries and 
electronic structures.  
 
3.5.3 PES Scans for the Formation of the Fe(IV)-oxo Complex 
The profile of the PES scans of the standard sized QM cluster and the full 2OG without 3Me-
T are incredibly similar (Figure 26), despite their initial C1-C2 bond distances being 1.48Å 
and 1.56Å respectively, the two clusters share a similar energy barrier height of ~10.5 
kcal/mol. The two clusters also achieve their global maxima when the C1-C2 bond distance 
is 1.89Å for the standard sized QM model and 1.86Å for the full 2OG without 3Me-T cluster. 
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The measured distances from their global maxima structures nearly identical (Table 7). The 
structures of the global maxima of these two clusters are shown in Figure 27a and Figure 
29a, both structures show the partial dissociation of the carboxylate moiety however at this 
point the distal oxygen is still positioned around 2.6Å from the C2 of 2OG. The end point 
structures of the scan differ but this may be due to their different starting 2OG C1-C2 bond 
distances, when carbon dioxide is removed and the two clusters are optimised freely their 
geometries once again become nearly identical (Figure 28 and Figure 30). All of this 
indicates that any role that 3Me-T plays on the calculated reaction path is subtle and not 
easily quantified by our QM cluster calculations, this is a reasonable assessment given the 
uncharged nature of 3Me-T and it being positioned >4Å from iron for the duration of the 
PES scan. However to more fully understand the influence of 3Me-T on the active site 
geometry during Fe(IV)-oxo formation further calculations using QM/MM models will need 
to be performed.  
 
In contrast, the PES scan of the cut 2OG with 3Me-T cluster is very different from the other 
two clusters scans, despite sharing a similar initial 2OG C1-C2 bond distance as the full 2OG 
without 3Me-T. The barrier height of the cut 2OG with 3Me-T cluster is very low at 1.25 
kcal/mol and the 2OG C1-C2 bond distance at this point is much shorter at only 1.64Å 
compared to the other two clusters PES scans. However, the distal oxygen to C2 of 2OG 
distance at this point isn’t too dissimilar to the other two clusters at a distance of 2.79Å. 
Overall, the comparison of the three clusters that underwent 1-D PES scans of the 2OG C1-
C2 distance reinforces our hypothesis that the cut 2OG model doesn’t adequately replace the 
full 2OG ligand for the purposes of modelling the reaction mechanism of FTO. To better 
understand the electronic structural transitions that are occurring over the course of the PES 
scans more extensive calculations are required, with orbital and spin population analysis. 
The global maxima structures don’t actually represent true transition states but provide good 
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starting points for transition state search algorithms to define actual transition state  
structures.  
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3.6 CONCLUSIONS 
Despite the results presented being an incomplete set we can draw some initial conclusions 
from the work. With regards to the cutting of the 2OG molecule we have shown that this 
leads to results, in both the active site geometry and energetic results, that are inconsistent 
and probably erroneous when compared to the clusters with the full 2OG molecule and the 
QM/MM model. Including the 3Me-T molecule in the cluster calculations seems to have 
only a subtle effect on the results of the cluster calculations and for the sake of computational 
efficiency, i.e. reducing the number of atoms in the QM system, it could probably be 
excluded without drastic effect to the calculations. 
 
The inclusion of the nearby arginine residues in the cluster calculations had a large effect on 
the geometry of the active site, with binding between iron and oxygen being most affected. 
In every cluster, excluding the R322 cluster, we observed a shortened distal oxygen to 2OG 
C2 distance. This distance is thought to be a key reaction coordinate in the attack of 2OG by 
oxygen and subsequent formation of the Fe(IV)-oxo intermediate complex. Comparison 
between the QM/MM model and extended cluster sizes was confounded by the use of 
implicit solvation in the QM clusters as opposed to explicit solvation in the QM/MM model 
making the influence of the surrounding amino acid residues difficult to distinguish from 
solvent model effects. More QM/MM modelling using alanine mutations or free energy 
calculations will be necessary to assess the individual contributions of neighbouring residues 
to the reaction path. 
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3.7 FUTURE WORK 
Due to the computational complexity of the calculations and the lack of effective large scale 
parallelisation for QM calculations not all of the calculations could be finished in time for 
publication in this thesis. The first priority should be to create and optimise more QM cluster 
models that give a more direct comparison of the individual contributions of each component 
to the geometry and electronic structure of the QM model. Some examples of additional 
clusters would include: cut 2OG without 3Me-T, an extended cluster including the sidechain 
of R96, an extended cluster also including the sidechains of R96 and R316, an extended 
cluster including the sidechains of R96 and R322. The optimised QM and QM/MM models 
would then undergo extensive orbital and spin population analysis to allow the differences 
in their electronic structures to be assessed. 
 
Investigations into the effect that functional and basis set have on the geometry and 
electronic structures of the different QM clusters and QM/MM model will also be 
investigated. Optimisations and scans with different functionals and basis sets would seek to 
replicate published results of similar calculations for different non-heme iron 2OG 
dependent oxygenases. These type of calculations would allow for comparisons between the 
electronic structure of FTO and other non-heme iron 2OG dependent enzymes. 
 
Additionally, specific optimised structures will undergo different PES scans to test other 
reaction coordinates and calculate the energy barrier associated with the formation of the 
Fe(IV)-oxo complex. A reaction path for the QM/MM model would also give a better 
comparison to that calculated for the QM cluster models. Some of the structures of these 
calculated reaction paths could represent the structures of reaction intermediates and 
transition states, however these structures need to be refined with transition state search 
algorithms and more rigorous optimisations of their geometry until they possess only a single 
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negative frequency. The orbital and spin populations of theses optimised transition state 
structure would also be analysed to better understand the changes in the electronic structure 
occurring over the course of the calculated reaction path.   
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4 CONFORMATIONAL CHANGES OF THE GLUT5 
RECEPTOR IN A MEMBRANE BOUND SYSTEM: A 
MOLECULAR SIMULATION STUDY 
4.1 PREFACE 
This chapter describes ongoing research done in collaboration with Dr. Marina Tanasova 
and her research group based at Michigan Technical University, with the aim of producing 
one or more joint publications featuring both experimental and computational research. The 
docking portion of this chapter describes the use of docking software to generate reasonable 
structures for several ligands that could then be verified against experimental results relating 
to their affinity to the GLUT5 receptor. The MD portion of this chapter describes the MD 
simulations created to study the conformational dynamics and substrate interactions of the 
GLUT5 receptor embedded in a lipid bilayer. The chapter will contain an overview of the 
study so far as well as a detailed description of the contributed computational research.  
  
120 
 
4.2 INTRODUCTION 
GLUT proteins are part of a wide group of proteins classified by their role in facilitating the 
movement of glucose and other sugars through the cell membrane, forms of glucose 
transporter proteins are found throughout nature as glucose is a near universal energy source 
for most organisms [174]. Mammalian GLUT proteins can be roughly split into three 
different classes, within each class the GLUT proteins share certain sequence and structural 
similarities [175-177]. Class I GLUTs account for GLUT1-GLUT4 and are mainly involved 
in the uptake of glucose, galactose and other sugars into the cell. Class II GLUTs (GLUT5, 
7, 9 and 11) instead facilitate the transport of fructose and glucose across the cell membrane. 
Class III GLUT proteins are the class of more recently identified and more poorly understood 
glucose transporter proteins found to be distinct from Class I and II types [175, 177, 178]. 
GLUT5 is mainly found to be expressed in the cells of the small intestine where it transports 
fructose from the lumen, where fructose is in relatively higher concentration, into the 
enterocytes (the cells that make up the inner lining of the small intestine); however it is also 
found to expressed in lower levels all over the body in the kidneys, brain, testes, skeletal 
muscles and adipose tissues [179]. High levels of GLUT5 expression have been observed in 
type 2 diabetes [180, 181] and other metabolic diseases [182, 183] as well as breast [184, 
185] and other forms of cancer [186]. These diseases all have the common factor that they 
are indicative of having states of altered metabolism, cancer cells in particular rely on 
anaerobic glycolytic respiration pathways that bypass the mitochondrial stage of metabolism 
(aka as the Warburg effect) to fuel their rapid proliferation [187]. For this type of metabolism 
they need a ready source of sugars which they recruit from outside the cell by over expressing 
glucose transporter protein such as GLUT5 [186-188]. GLUT5 is a particularly interesting 
transporter protein because it is the only know one that solely transports fructose, all other 
GLUT proteins are concerned with the transport of glucose and additional sugars [178]. 
121 
 
GLUT5 is a facilitator transporter, this means it’s a membrane bound protein responsible for 
the transport of a substrate across the mostly impermeable hydrophobic cell membrane 
[174]. Although some small molecules can pass through the cell membrane by diffusion 
alone, this process is slow and unregulated, facilitated transportation is needed to reliably 
move amino acids, peptides, sugars and ions across the cell membrane [189]. Specialised 
proteins fulfil the role of transporting substrates across the cell membrane, different types of 
these proteins utilise a range of strategies to achieve this. GLUT5 as a transporter protein is 
defined as having two gates, one for the intracellular and one for the extracellular side. These 
gates can be either open or closed, if one is open the other by definition is closed in a 
mechanism known as alternating access [174-177, 189-193]. This defining characteristic 
separates them from the similar channel family of proteins, which are by definition either 
simultaneously open or simultaneously closed to both the intra and extracellular sides at any 
given time [191]. This distinction allows transporter proteins to move their substrates both 
with and against a diffusion gradient, whereas channel type transporters can only move 
substrates from high to low concentrations [175]. The mechanism of alternating access is 
achieved through large conformational motions in the protein that act in response to substrate 
binding to open and close the gates in a concerted way to move the substrate from one side 
of the membrane to the other [190]. Although the process is a cycle where each step is 
reversible, for the sake of clarity the mechanism will be described as follows. The protein 
favours and adopts the outward open conformation when no substrate is bound [194], upon 
substrate binding a conformational change occurs to close the outward facing gate restricting 
access to the binding site from the extracellular side of the protein. The substrate bound 
outward occluded structure undergoes a conformational shift that sees the two domains 
rotate ~15° to open the inward facing gate of the protein, this allows the substrate to unbind 
and enter the intracellular space. In the absence of the sugar substrate the transporter defaults 
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to the outward open conformation and is again ready to accept a substrate [175, 192]. A 
stylised diagram of the proposed alternating access mechanism is shown in Figure 34.  
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Figure 34: A stylised diagram of the proposed alternating access mechanism of GLUT5. The C-
terminal transmembrane bundle helices are represented by red boxes, the N-terminal 
transmembrane bundle helices are represented by blue boxes, and the intracellular helices are 
represented by grey boxes. Dashed lines between the intracellular helices represents the 
proposed hydrogen bonding between ICH5 and the other intraceullar helices. The fructose 
substrate is represented by a green pentagon. 
  
Outward Open Outward Occluded 
Inward Open Inward Occluded 
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GLUT5 is composed of twelve Trans-Membrane α-helices (TM) and five Intra-Cellular α-
Helices (ICH). The TM helices are arranged into two bundles, six in the C-terminal domain 
and six in the N-terminal domain [194]. Throughout the cycle of alternate access the N-
terminal domain remains rigid, whereas the C-terminal domain undergoes internal structural 
rearrangement (particularly at transmembrane helices 7 and 10) in order to facilitate the 
conformational motion necessary for opening and closing the inner and outer gates of the 
transporter, this motion is sometimes referred to be a rocker-switch-like movement [191, 
194]. The ICH are thought to be responsible for stabilising the outward open conformation 
of the protein, and are probably the reason the protein defaults to the outward open 
conformation when no ligand is bound. Salt bridges form between the IC helices which link 
the N-terminal and C-terminal domains, experimental mutational studies of the key ICH salt 
bridge forming residues E336, E400 and R407 to neutral alanine have been shown to freeze 
the transporter into an inward facing conformation [193]. The crystal structure of GLUT5 
(PDBID 4YB9) in the inward open conformation is shown in Figure 35, a stylised diagram 
of the proposed alternating access mechanism of GLUT is shown in Figure 34. GLUT5 only 
transports fructose and no other similar hexose sugars, to achieve this the protein must have 
a binding site that is specific only to fructose, and produce no conformational motion to 
transport the sugar through the membrane in the presence of any other sugar. Structural 
comparisons to understand the specificity of GLUT 5 towards fructose in contrast to the 
other GLUT1-4 transporters are hampered by the lack of experimental structures of the 
receptors in complex with different sugar substrates [175]. Further frustrations to the 
structural study of the GLUT transporters are caused by the unknown contributions of the 
lipids in the membrane, in the same way that solvated protein structures differ from their 
crystallised counterparts, so do the structure of membrane bound and crystallised transporter 
proteins. The lipids in the membrane clearly support the receptor and maintain its structure, 
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however their contribution to the structure function relationships and the conformational 
dynamics of the receptor at the atomistic level is poorly understood [195-197].  
 
 
Figure 35: The crystal structure of GLUT5 (PDBID 4YB9) is in the open inward facing 
conformation. The C-terminal transmembrane bundle helices are rendered as red ribbons, the N-
terminal transmembrane bundle helices are rendered as blue ribbons, the intracellular helices are 
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rendered as grey ribbons and the loops joining the helices are coloured beige. A) Shows a cross 
membrane view of the receptor with the important transmembrane helices labelled with grey 
boxes and black text. The intracellular helices are labelled with black boxes and white text, ICH5 
is not present in the crystal structure but its position is still labelled with a light grey box with a 
dashed line border. B) Shows the same representation of the GLUT5 structure but rotated 90 
degrees to give a view from the intracellular side of the membrane. In this panel the intracellular 
helices are labelled as above. 
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Given their link to a range of diseases and conditions [180-186], inhibitors of GLUT5 are 
extremely sought after as no potent and selective drug targeting GLUT5 is currently 
available [198]. Development of ligands to inhibit GLUT5 has been frustrated by the lack of 
a reliable experimental high throughput-assay with which to test potential compounds with, 
the binding affinity between GLUTs and their sugar ligands cannot be measured by a range 
of commonly used techniques such as isothermal calorimetry titration, surface plasmon 
resonance or microscale thermophoresis [175]. As well as being a drug target, GLUT5 is an 
interesting marker for cancer and metabolic disease. Development of selective fluorescent 
probes that bind to GLUT5 could be used to quickly diagnose unusual overexpression of 
GLUT5 that might be linked to tumour formation or metabolic disease. This strategy is 
already utilised with the use of glucose radio-labelled with the isotope 18F 
(Fludeoxyglucose), cancer cells take in the radio-labelled glucose compound at a rate that is 
significantly higher than surrounding cells; the accumulated radiotracer can then be imaged 
with a positron emission tomography scan [199]. This strategy however isn’t perfect, not all 
cancer cells have increased glucose uptake and therefore won’t show up on the PET scan 
[200, 201]. Being able to detect fructose transport into cells through GLUT5 could provide 
an alternative strategy for imaging cancer cells as well as measuring how aggressive their 
growth rate is, this could allow therapies to be tailored towards how quickly a particular 
tumour will grow and potentially metastasize [178]. Radiotracer dyes are suited towards 
detection inside the body as the emitted radiation can be detected through tissue, however 
they are considered expensive due to the on-site cyclotrons necessary to produce them, and 
their short half-lives mean they cannot be stockpiled in significant amounts [202]. 
Fluorophore conjugated sugars offer a cheaper alternative for use in laboratory settings, cells 
that take up the dye can be easily detected using spectrofluorometers to image the transport 
of the dye into cells. Although not as suited to in-vivo imaging as radiotracer dyes due to the 
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need for photon penetration, fluorescent dyes have been gaining traction as a diagnostic tool 
for early tumour detection [203-205].  
A range of Fluorescent probes were designed and synthesised by our experimental 
collaborators in Dr. Tanasova’s group, the ManCou probes were created by conjugating the 
blue fluorescent coumarin group to the aminosugar 1-amino-2,5-anhydro-d-mannitol. 
Conjugation to mannitol was chosen as it was shown to only rely on fructose transport so 
was likely to pass only through GLUT5 as opposed to fructose conjugation which produced 
conjugates that were reliant on both glucose and fructose transport and likely to pass through 
both GLUT1 and GLUT5 [206]. Variation of the C4 functional group on the coumarin 
moiety was designed to give a range of ManCou probes with different GLUT5 binding 
properties as well as different fluorescent colours. To aid in the design of new ManCou 
probes, molecular docking can provide an atomistic insight into the binding of the probes to 
the GLUT5 transporter. For the reasons described above, the crystal structure of the GLUT5 
transporter may not be representative of the protein structure in its physiological, membrane 
bound, and solvated environment. The receptor will also flex and change over time in 
response to its own internal dynamic motions as well as those of the lipid membrane and 
bound substrate molecule, these movements may influence the active site interactions. The 
study of the interactions between the substrate and receptor over the course of an MD 
simulation will give insights into how the probes bind within the transporter that may be 
helpful in the design of new fluorescent probes.   
 
4.3 COMPUTATIONAL METHODOLOGY 
The structure of the receptor in an inward open form from Bos Taurus (PDBID 4YB9 [194]) 
is missing the coordinates of a loop in the C-terminal region, these coordinates were 
modelled using MODELLER [207, 208] for Chimera [131]. The structure was superimposed 
with a structure of human GLUT3 (PDBID 4ZWB) with maltose bound in the receptor site. 
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NDBM and the 3 ManCou probes (1,3 and 4) were modelled using GaussView [167] and 
their structures were optimised using the B3LYP/6-31G functional [209, 210] and basis set 
in Gaussian09 [94]. Maltose was docked to a rigid model of the GLUT5 receptor using 
AutoDock4[42] to verify the proposed location for fructose and NDBM binding. Having 
verified their similar binding sites NDBM and fructose were then also docked to the rigid 
GLUT5 receptor. 
 
The 3 ManCou probes as well as being rigidly docked also underwent flexible receptor 
docking with GLUT5. The residues identified as key binding residues from the crystal 
structure as well as those observed to be in the rigid docking results, were selected to have 
rotatable sidechain bonds. The poses from the flexible docking results were found to agree 
well with the poses from the rigid docking results, based on this it was deemed that the 
flexible receptor docking offered no clear advantage over the rigid receptor docking method 
in this case. 
 
The lowest energy binding poses from the docking of fructose, ManCou1 and ManCou3 
were selected to undergo extended MD simulation. The protein was prepared with PROPKA 
web server [166] to define the protonation states of the titratable residues. To build the 
membrane bound system of GLUT5, the membrane builder module from the CHARMM-
GUI website [211] was used. Based on the methodology of similar previous MD simulations 
of GLUT1[212, 213], 246 POPC lipids were chosen to construct the membrane with the 
receptor bound in the centre of the membrane. The system was solvated with TIP3P [21] 
water molecules with K+ and Cl- ions added to create a neutral system with an ion 
concentration of 0.15M with tleap in Amber14 [25] to give total system dimensions of 
~100Å X ~100Å X ~110Å. The AmberFF14SB [214] forcefield was used with the lipid14 
forcefield [215] for the membrane. Fructose and ManCou1 and ManCou3 were parametrised 
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with Antechamber in Amber14 [25] using the GAFF forcefield [26]. The system was 
minimised in Amber14 using pmemd with 5000 steps of steepest descent followed by 5000 
steps of conjugate gradient minimisation. Following this, the lipids in the system were heated 
in two stages, first to 100K whilst the lipids in the system were restrained with a 10kcal/mol 
force constant. The second stage of heating warmed the system to 300K with the lipids 
restrained as in the first heating step, in addition at this stage the pressure in the system was 
equilibrated to one atmosphere. A short MD run of 5ns was first run to equilibrate the 
systems PBC box dimensions before the productive MD run. The productive MD 
simulations used the pmemd.cuda code on a GPU workstation for one microsecond. Analysis 
of the simulation trajectories was performed with CPPTRAJ for Amber14 [25] and the MD 
movie module of Chimera [131]. All images of molecular models for this chapter were 
created using Chimera [131]. 
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4.4 RESULTS 
4.4.1 Docking of NDBM, Fructose and Maltose 
 
 
Figure 36: The ribbon view structure of GLUT5 from the PDBID 4BY9 structure. The 
protein’s ribbons are shown in cyan, the atoms of fructose and its interacting residues are 
shown in stick rendering with grey carbons for fructose and beige carbons for those of the 
protein. The rest of the atoms are coloured as follows: hydrogen-white, nitrogen-blue, 
oxygen-red. 
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Figure 37: The docked structure of maltose with the interacting residues of the GLUT5 
receptor labelled. The ribbons of the protein are partially transparent to improve clarity. The 
atom colours follow the same scheme as Figure 36. 
 
Figure 38: The docked structure of fructose with the interacting residues of the GLUT5 
receptor labelled. The atom colours follow the same scheme as Figure 36. 
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Figure 39: The docked structure of NDBM with the interacting residues of the GLUT5 
receptor labelled. The atom colours follow the same scheme as Figure 36. 
 
    [1] [2] [3] [4] 
Docked 
Compound 
Estimated 
Free 
Energy of 
Binding* 
(kcal/mol)  
VDW + H-
bond 
+desolvated 
Energy 
(kcal/mol) 
Electrostatic 
Energy 
(kcal/mol)  
Final 
Total 
Internal 
Energy 
(kcal/mol)  
Torsional 
Free 
Energy 
(kcal/mol) 
Unbound 
System’s 
Energy 
(kcal/mol) 
Maltose -7.28 -8.46 -0.01 -0.92 1.19 -0.92 
Fructose -3.37 -5.33 -0.12 -3.80 2.09 -3.80 
NDBM -6.11 -8.23 -0.27 -2.13 2.39 -2.13 
 
Table 8: The different energy components of the lowest energy docking pose of each sugar 
ligand as calculated by Autodock. 
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4.4.2 Docking of the ManCou ligands 
Figure 40: The docked structure of ManCou1 with the interacting residues of the GLUT5 
receptor labelled. The atom colours follow the same scheme as Figure 36. 
 
Figure 41: The docked structure of ManCou3 with the interacting residues of the GLUT5 
receptor labelled. The atom colours follow the same scheme as Figure 36. 
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Figure 42: The docked structure of ManCou4 with the interacting residues of the 
GLUT5 receptor labelled. The atom colours follow the same scheme as Figure 36. 
 
    [1] [2] [3] [4] 
Docked 
Compound 
Estimated 
Free 
Energy of 
Binding* 
(kcal/mol)  
VDW + H-
bond 
+desolvated 
Energy 
(kcal/mol) 
Electrostatic 
Energy 
(kcal/mol)  
Final 
Total 
Internal 
Energy 
(kcal/mol)  
Torsional 
Free 
Energy 
(kcal/mol) 
Unbound 
System’s 
Energy 
(kcal/mol) 
ManCou1 -6.93 -8.79 -0.23 -1.33 2.09 -1.33 
ManCou2 -7.71 -9.60 -0.20 -1.45 2.09 -1.45 
ManCou3 -7.39 -9.61 -0.17 -1.44 2.39 -1.44 
ManCou4 -7.85 -10.08 -0.15 -1.87 2.39 -1.87 
 
Table 9: The different energy components of the lowest energy docking pose of each 
ManCou ligand as calculated by Autodock. 
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4.5 DISCUSSION 
4.5.1 Docking of NDBM, Fructose and Maltose 
The lowest energy binding poses of NDBM and maltose were found to form hydrogen bonds 
with Y14, Q149, Q270, Q271 and N276 (
Figure 37 and Figure 38). The large number of hydrogen bond donors and acceptors in the 
structure of maltose and NDBM allow the two ligands to form several hydrogen bonds with 
the interior of the GLUT5 receptor. The only major difference in the binding of NDBM as 
opposed to maltose is the VDW interaction between the aromatic ring of NDBM and H401. 
The similarities between the binding modes of NDBM and maltose are reflected in their 
similar values for the estimated free energy of binding energy from Table 8. 
Fructose makes a lot of the same hydrogen bonding interactions as NDBM and maltose, 
however it does not interact with Q149 due to its smaller size or H401 due to its lack of an 
aromatic ring moiety. The predicted binding site of fructose calculated by our docking is in 
good agreement with the binding site identified in the literature based on homology with 
similar GLUT transporter proteins [194]. The higher free energy of binding for fructose, may 
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be related to the function of GLUT5 as a fructose transporter, because of this we wouldn’t 
expect it to strongly bind fructose. This allows fructose to easily dissociate from the 
transporter and move into the intracellular space. 
 
4.5.2 Docking of the ManCou ligands 
The lowest energy docked conformation of ManCou1 to GLUT5 (
Figure 40) has the sugar moiety of forming hydrogen bonds with Q149, Q271, Q276, N405 
and H401. This pose is distinct from the conformation found in the previous docking of 
fructose, this suggest to us that the addition of the coumarin moiety has influenced the 
binding position of ManCou1. The coumarin moiety of ManCou1 forms hydrogen bonding 
interactions with Y14, S125 and N126 and makes non-polar interactions with the sidechain 
of W402 and H401. The binding pose of ManCou3 is quite distinct from the binding pose of 
ManCou1, both the sugar and substituted coumarin moiety are found in subtly different 
places than the docked conformation of ManCou1 (
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Figure 41). The sugar moiety makes hydrogen bonding interactions with Y14, Q270, Q271, 
N276, and N405. The substituted coumarin moiety likely forms hydrogen bonding 
interactions with S11, S124 and S125. The majority of the residues surrounding the 
substituted coumarin moiety of ManCou3 are hydrophobic residues such as Y14, P118, 
V128, P129 and I152, however no interaction with W402 or H101 are observed. The docked 
conformation of ManCou4 is more similar to that of ManCou3 than ManCou1, the 
substituted coumarin moiety seems to occupy a similar hydrophobic region as that of 
ManCou3 and the sugar moiety makes a lot of similar hydrogen bonding interactions (Figure 
42). The sugar moiety of ManCou4 makes hydrogen bonding interactions with Y14, N149, 
Q270, Q271, N276, H401 and N405. The substituted coumarin moiety of ManCou4 doesn’t 
appear to make any hydrogen bonding interaction and instead makes non-polar contacts with 
V128, P129, P148 and I152. The observed similarity of the interactions between ManCou3 
and ManCou4 are reflected in their very similar estimated free enegy of binding in Table 9. 
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4.5.3 Glut5 Membrane MD Simulations 
 
Figure 43: GLUT5 in a POPC lipid membrane model built using the CHARMM-GUI 
membrane builder tool. The atom colours follow the same scheme as Figure 36, with the 
addition of phosphorus which is coloured orange. 
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Figure 44: RMSD graph of the carbon-α alpha atoms of the four GLUT5 membrane 
simulations up to 400ns. 
 
Figure 45: RMSD graph of the heavy atoms of the POPC membrane of the four 
GLUT5 membrane simulations up to 400ns. 
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Figure 46: RMSF graph of the carbon-α alpha atoms of the four GLUT5 membrane 
simulations up to 400ns. 
Figure 47: RMSD graph of the heavy atoms of fructose, ManCou1 and ManCou3 
ligands up to 400ns. 
 
  
Fructose 
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4.5.4 Glut5 Membrane MD Simulations 
The RMSD of the Cα atoms of the four MD simulations: the apo-enzyme, fructose bound, 
ManCou1 bound and ManCou3 bound is shown in Figure 44. The four MD simulations seem 
to equilibrate by about 100ns and with the exception of ManCou1 to have RMSD values of 
slightly below 2Å. The ManCou1 simulation seems to adopt a new distinct conformation 
after about 100ns, this conformation seems to be stable with relatively little fluctuation from 
the 2.5Å level. The RMSD profile of fructose and the apo-enzyme are the most similar while 
the RMSD profile of ManCou3 is alike it is found to be slightly more flexible than the other 
two. In general though the RMSD of all four simulations are quite low compared to other 
protein structures, this may be due to the stabilising effect that the membrane has on the 
protein structure lowering the receptors overall flexibility. Throughout all of the MD 
simulations the protein remains embedded in the lipid bilayer, this indicates that the system 
is stable. The RMSD plot of the heavy atoms of the lipid bilayer is shown in Figure 45, the 
lipid membrane seems to fluctuate even up to 250ns into the simulation. After 250ns, the 
fluctuations in the lipid RMSD do appear to level off but more simulation time is necessary 
to know if the lipid membrane has equilibrated fully. The RMSF plot of the Cα atoms of the 
four GLUT 5 membrane simulations are shown in Figure 46, overall the profiles of the 
RMSF plots are quite similar between the four MD simulations, this is likely correspond 
with much of the structure being embedded in the lipid membrane not allowing much 
structural flexibility. Fructose, despite having overall low RMSD values has some regions 
that have higher relative flexibility than the other three MD simulations. The areas of the 
protein with low RMSF values tend to part of the transmembrane helices, these areas are 
entirely enclosed and supported by the lipid membrane and have little conformational 
flexibility. The regions of high RMSF tend to correspond to the solvent exposed loop regions 
that connect the helices of the receptor, these regions have no defined secondary structure 
and are much more conformationally flexible. The particularly flexible area of residues 
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spanning 213-226 is a flexible region that was not present in the crystal structures, possibly 
due to its many possible conformations. This region (shown in Figure 48) is located between 
two intracellular helices, these helices are usually joined by salt bridges that function to hold 
the receptor in its outward open conformation, our MD simulation is based on the inward 
open conformation so these salt bridges are not present and the lack of inter helix 
electrostatic interactions possibly making the region more flexible. The RMSD of the heavy 
atoms of the ligands for the MD simulations that contain fructose, ManCou1 and ManCou3 
are found in 
Figure 47. The positions of the ligands seem be highly variable within the receptor, fructose 
in particular seems to adopt a new conformation around 200ns, it then stay in this 
conformation for around 150ns before returning to its previous conformation again. This 
kind of fluctuation in ligand position may be indicative of a conformational change in the 
binding site causing fructose to adopt this new conformation, these kind of conformational 
changes have already been investigated and found to play a role in the function of GLUT1 
transporter proteins [212]. 
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Figure 48: A) A rendering of the GLUT5 receptor with the C-terminal transmembrane bundle 
helices  rendered as red ribbons, the N-terminal transmembrane bundle helices rendered as blue 
ribbons, the intracellular helices are rendered as grey ribbons, the flexible region of residues 213-
226 is rendered a green ribbon and the loops joining the helices are coloured beige. B) Shows an 
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enlarged close up image entered on the flexible loop region 213-226, the sidechain atoms of the 
are also displayed and the important charged residues are labelled. Atom element colours are as 
follows; carbon is dark green, nitrogen is dark blue, oxygen is red and hydrogen is white. 
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4.6 CONCLUSIONS 
Overall the docking of fructose, maltose and NDBM was found to align well with the 
experimental observations of GLUT5’s role as a fructose transporter, where the low binding 
energy of fructose allows for it to pass through the receptor as intended. Whereas maltose, 
which is not biologically transported by the receptor has a high binding affinity indicating it 
would probably not be able to pass through the receptor. NDBM acting as a probe for 
GLUT5 would also bind to the receptor with a high affinity, this is reflected in its low 
docking energy indicating a relatively strong binding to the GLUT5 receptor. Additionally 
the binding site for fructose predicted by our docking, is similar to the binding site predicted 
by the X-ray crystallographic structure paper. 
 
The docking of the ManCou ligands shows good agreement with the docking of fructose, in 
that the sugar moieties of the ManCou ligands occupy a similar spatial positioning in the 
GLUT5 receptor site as that of fructose. This positioning of the ManCou ligands is important  
to their role as GLUT5 probes, so that they will selectively bind to GLUT5 due to its 
preference for only fructose transportation. The initial results from the MD of the GLUT5 
look promising. The ligands remain bound to the GLUT5 receptor and their positional 
movements inside the receptor may give insights into the structural changes occurring in the 
receptor in response to their binding. The RMSD of the C-alpha remains relatively stable 
and appears to have equilibrated. The RMSD of the POPC membrane also appears to have 
equilibrated or be in the process of equilibrating. 
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4.7 FUTURE WORK 
Although the current docking phase of the project is completed, new ManCou probes are 
being researched for which new docked structures will be generated and possibly lead to 
additional MD simulation studies as well. 
The MD simulations of GLUT5 are still incomplete and will eventually reach the 1µs 
timescale, thorough atomistic analysis of the resultant trajectories will be performed as well 
as conformational analyses. The free energy of binding between the ligands and the GLUT5 
receptor structure will be calculated using the MMGBSA method [216]. 
Given the role of the GLUT5 receptor in sugar transport, it would be of interest to model the 
transit of different sugars and ManCou probes through the transporter. For structural changes 
occurring at long timescales non-conventional MD methods can be used such as accelerated 
MD and steered MD could be utilised, these methods have recently been utilised in 
modelling the mechanism of sugar transport in GLUT1 receptors [212, 213].  
In-silico mutagenesis studies could allow us to study the contributions of individual residues 
on the protein’s structure/function, ligand binding and conformational dynamics. Several 
experimental mutant structures have been created, some of these mutants have altered the 
selectivity of the receptor from fructose to glucose [194]. Using MD simulations to study 
these mutant structures would allow us to gain insight into why the selectivity of the receptor 
is changed at an atomistic level in specific mutant forms of the receptor. 
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5 MODELLING STUDY OF THE BINDING OF 
MONOSACCHARIDES TO ODORRANALECTIN AND 
TWO SYNTHETIC LECTINOMIMICS  
 
5.1 PREFACE 
 
This chapter describes work done in collaboration with experimental researchers that led to 
the publication of a paper entitled: “Targeting cancer‑specifc glycans by cyclic peptide 
lectinomimics”, published in August 2017, the full paper is included in the appendix of the 
thesis, and gives full credit to all of the authors. The chapter contains an overview of the 
whole study, a summary of the full methodology and results of the work, and a more detailed 
description of the computational work contributed to the research. The docking study was 
undertaken to study the interactions of odorranalectin and two artificial lectinomimics with 
a range of sugar molecules, these structural insights could then be used to explain 
experimental results relating to the affinity of the three lectins to the studied compounds. 
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5.2 INTRODUCTION 
 
Lectins are a sub-set of proteins and peptides that are dedicated to the binding of 
carbohydrates, found ubiquitously throughout nature, they are produced by nearly all forms 
of unicellular and multicellular life as well as some viruses [217, 218]. They recognise and 
bind free sugar molecules as well as the sugar moieties found in glycolipids and 
glycoproteins, usually in a highly specific manner [219]. Lectins fulfil important roles in cell 
adhesion, cell signalling and recognition [220]. In certain cases the binding of lectins to sugar 
moieties can act as a defence mechanism in the immune systems of animals and plants as 
well as their widespread utilization as toxins in both eukaryotic and prokaryotic organisms 
[218, 221]. Given the enormous variety of lectins that exist, only a fraction of the total 
amount have had their structures resolved [222, 223]. Newly characterised lectins are 
interesting lead compounds for the development of new drugs, their ability to recognise 
specific sugars, glycolipids or glycoproteins means they have the potential to be targeted 
agonists/antagonists for use in new treatment and detection strategies [223, 224]. In healthy 
cells glycosylation, the process of adding sugar moieties to lipids and proteins, serves a 
variety of functions. The process of glycosylation often occurs as a post-translational 
modification to proteins and enzymes. Glycan based modifications can help to fold proteins, 
provide them with structural support, add new functionality, or allow the protein to be 
recognised by specific lectins or antibodies [217].  
The role of glycosylation in cancer has become increasingly studied in recent years, with 
abnormal glycosylation being recognised as not only an indicator of cancer but playing a 
key role in tumour development [225, 226]. Tumour cells produce unique glycosylated 
structures not found in healthy cells, some of these structures are not only indicative of the 
aberrant metabolism of cancer cells but are directly linked with the cancer’s survival, 
proliferation and metastasis [227]. These unique tumour-associated glycans can be used as 
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markers to predict the development of cancer before other symptoms have developed, earlier 
diagnoses generally lead to better outcomes due to the increased effectiveness of treatments 
acting on early stage tumours [228]. An example of glycans as tumour markers is the 
detection of alpha fetoprotein in high levels in adults, this glycosylated protein is usually 
only found in high amounts in the developing foetus. High amounts of glycosylated alpha 
fetoprotein in adults is associated with liver malfunction [228, 229]. However, high serum 
levels of alpha fetoprotein alone are not always indicative of cancer and can be caused by 
liver cirrhosis or hepatitis C infection. Specifically though detection of the fucose 
glycolsylated form of alpha fetoprotein (AFP-L3) using the lectin Lens agglutinin is a proven 
diagnostic method specifically for the detection of hepatocellular carcinoma [230, 231]. 
Another developing therapy based on targeting cancer specific glycans is based on 
interfering with the ability of metastasising tumour cells to adhere to surrounding tissues 
[217, 232]. Anti-metastasising agents can be used along-side conventional treatments to 
reduce the likelihood that a tumour will invade other tissues to form secondary tumours. 
Some of these agents work by binding to the sugar moieties of the target cancer specific 
glycans responsible for cell adhesion and migration preventing them from attaching to the 
leucocytes and endothelial cells that are known to be responsible for facilitating the 
development of metastases [233]. Some plant based lectins have shown promise as anti-
tumour agents, by binding to certain cell surface receptors the lectins can directly trigger the 
programmed cell death pathways of the tumour cells [234]. A lectin isolated from the seeds 
of a specific variety Phaseolus coccineus (a leguminous plant) was found to selectively bind 
to sialic acid conjugates, increased amounts of sialic acid is a known hallmark of cancer 
specific glycans not abundantly found in healthy cells [235]. The lectin was shown to bind 
in response to the elevated levels of sialic acid and induce apoptosis in L929 fibrosarcoma 
cells [236]. Antibodies and lectins are ideally suited to selectively binding these adhesion 
and migration related cancer specific glycans, examples of lectins and antibodies utilizing 
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this strategy are currently under development and can be found throughout the literature 
[234, 237-241]. 
Development of other glycan targeting strategies for cancer detection and treatment is 
developing as more and more cancer specific glycans are discovered [227], approaches either 
focus on creating antibodies or lectins that are specific to tumour-associated glycans. The 
antibody biased approach is hampered by problems in activating an immune response to the 
glycan molecules needed to produce new antibodies, the glycans seem to make poor 
immunogens and antibodies derived in this way exhibit poor binding affinities [242]. Of the 
available antibodies known to bind to glycans it can be difficult to determine their exact 
specificities, as well as binding to the target glycan the antibody often binds to other off-
target glycans potentially will undesirable effects [243]. Lectins suffer from similar 
problems with a lack of known specificity producing off-target effects, in addition they are 
often inherently unstable and can denature or be broken down by enzymes in the body 
reducing their effectiveness as drugs [244]. Artificially modified lectins, lectinomimics offer 
an alternative solution, by modifying the structure of natural lectins it is hoped that the 
stability and selectivity of the lectinmimics can be improved to the point where they might 
be considered as effective agents for binding cancer specific glycans, for use as diagnostic 
probes and potential anti-cancer therapies [245, 246].  
A small 17 amino acid cyclic peptide (Odorranalectin) isolated from the skin of a frog found 
throughout South Asia (Odorrana grahami), was found to possess lectin-like properties with 
a binding preference to L-fucose [247]. The peptides structure was solved by NMR 
spectroscopy (PDBID2JQW) and found to adopt a β-turn-like conformation with a 
disulphide bridge linking residues C6 and C16. Odorranalectin is the smallest peptide found 
to have selective sugar binding affinities, this makes it of particular interest to drug 
development [246, 247]. Large peptides and proteins are undesirable as lead compounds in 
drug development due to their potential to evoke an immune response, their inability to be 
152 
 
administered orally, poor tissue penetration, and their rapid breakdown by endogenous 
enzymes [248]. Odorranalectin is a small peptide known not to provoke an immune response, 
and is being investigated for use as a component in drug delivery systems designed to cross 
the blood brain barrier to carry drug payloads to specific targets [247, 249]. Odorranalectin 
could also be used as a starting point for the development of lectinomimics for the purposes 
of binding to cancer specific glycans to create tumour sensing probes as well as new potential 
anti-cancer agents through the defined mechanisms described above. With this aim in mind 
our experimental collaborators designed and synthesised two novel Odorranalectin 
lectinomimics, replacing the disulphide bridge in Odorranalectin with a lactam bridge to 
improve stability whilst maintaining a similar geometry to that of the native lectin.  
The experimental portion of the study aimed to assess: (1) if the modifications made to the 
Odorranalectin structure affected its conformational structure and therefore its ability to bind 
to specific monosaccharides; (2) how the modifications to the Odorranalectin structure 
would affect its in vitro toxicity to healthy cells; (3) how Odorranalectin and the two 
lectinomimics would be broken down by human serum and what products would be formed; 
(4) if the ability of Odorranalectin and the two lectinomimics to bind to specific 
monosaccharides could potentially be used as a probe to distinguish different types of cancer 
cells from healthy cells based on their cell surface glycosylated structures; (5) if the binding 
to cancer specific glycans by Odorranalectin and the two lectinomimics could have an anti-
metastasising effect on certain human cancer cell lines in-vitro. Our molecular docking 
experiments would attempt to provide insight into the atomistic details of the binding 
between Odorranalectin and different monosaccharides known to be found as conjugates in 
the glycosylated cell surface structures. Additionally, docking of the modified lectins to a 
known natural substrate of the natural lectin in order to investigate how the lactam bridge 
moiety affected substrate binding.  
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5.3 SUMMARY OF EXPERIMENTAL METHODS 
 
Full description of the experimental methods can be found in the paper attached in the 
appendix, a summary of the experimental methods to give context to the aim and findings 
of the overall publication is given below.  
The two synthesised lectinomimics were distinguished from one another by the orientation 
of the lactam bridge, in Synthetic Peptide (SP2) the modified amino acid diaminopropionic 
acid (Dap) replaces cysteine on residue 6 and residue 16 is replaced by aspartate. The 
sidechains of residue 6 and 16 can then be cross-linked to produce the lactam bridge. In 
Synthetic Peptide (SP3) Dap replaces cysteine on residue 16 and aspartate on residue 6, the 
two substituted residues are then linked to produce a lactam bridge between residues 6 and 
16. A linear control peptide with the same sequence as Odorranalectin but no disulphide 
linking was also produced. Fluorescently labelled analogues of Odorranalectin, SP2 and SP3 
were also synthesised for use in fluorescence based binding assays, these were created by 
linking the peptides to fluorescein. A polyethylene glycol linker molecule was added to link 
the amino end of the peptides to the fluorescein moiety, this was done to increase the 
solubility of the compounds and minimise any potential steric effects caused by the bulky 
fluorescein moiety on the binding of the fluorescently labelled analogues to other molecules. 
The conformations of the synthesised peptides were studied using Circular Dichroism (CD) 
spectroscopy. Additional assessment of the conformations adopted by the synthesised 
peptides was performed using Macromodel 9.9 [250] for Maestro [251].  
The fluorescently labelled analogues of Odorranalectin, SP2 and SP3 were assayed with the 
Bovine Serum Albumin (BSA) conjugated monosaccharides: l-fucose, d-galactose, d-
glucose, N-acetyl-d-neuranimic acid, N-acetyl-d-galactosamine and N-acetyl-d-
glucosamine. The binding affinities of each of the lectins to each of the BSA-conjugated 
sugars could then be measured with the fluorescence intensity. A similar fluorescently 
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tagged control lectin (Aleuria aurantia lectin) with a known fucose specificity was assayed 
in a similar fashion to act as a comparison against Odorranalectin, SP2 and SP3.  
The binding of Odorranalectin, SP2 and SP3 against the model glycoproteins fetuin and 
asialofetuin was assessed with Isothermal titration calorimetry. The structures of these two 
glycoproteins are highly similar, fetuin is distinguished from asialofetuin by the terminal 
sialic acid moieties found on its glycan chains. This assay allowed for measurement of the 
binding affinities of the three peptides with glycoproteins which have well-defined glycan 
structures. 
The stability of Odorranalectin, SP2 and SP3 in human serum was tested by incubating the 
three peptides at 37°C in a human serum solution, samples were taken at different times (0, 
45min, 2h, 4h, 8h and 24h) these samples were analysed with high performance liquid 
chromatography and mass spectrometry.  
The binding specificity of the fluorescently labelled analogues of Odorranalectin, SP2 and 
SP3 to bind cell surface glycosylated structures was measured using a fluorescence staining 
assay with a several varieties of human cancer cell cultures as well as a control of healthy 
human skin fibroblasts. Comparison fluorescence assays of other fluorescently labelled 
lectins, Aleuria aurantia lectin, Sambucus nigra lectin and Ulex europaeus I with a variety 
of human cancer cell lines were also performed. A competitive binding assay to compare the 
binding affinity of fluorescently labelled Odorranalectin vs unlabelled Odorranalectin to the 
MCF-7 (human breast epithelial Adenocarcinoma) was also performed to assess if the 
fluorescent labelling of the lectin structure affected its ability to bind to the cell surface 
glycosylated structures. The in vitrotoxicity of Odorranalectin, SP2 and SP3 towards healthy 
human skin fibroblasts at a range of concentrations was tested with a luminescence based 
cell viability assay. 
A model to test the ability of Odorranalectin, SP2 and SP3 to bind to cell surface cancer 
specific glycans and act as cell migration inhibitors was performed with a transwell 
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migration assay of three metastatic human breast cancer cell lines and an additional mouse 
breast tumour model cell line.  
 
5.4 COMPUTATIONAL METHODS 
 
Twenty odorranalectin NMR structures were downloaded from the PDB (PDBID 2JQW) 
and ensemble clustered using UCSF Chimera [131]. Eight of these structures were grouped 
in the first cluster, and model number 10 was selected as the most representative for the 
average odorranalectin structure. Structures of the four sugar ligands were created using 
Gaussview [167] and optimized using Gaussain09 [94] with the Hartree–Fock method and 
3-21G basis set. The optimized sugar structures were rigidly docked to the lectin peptide 
using Autodock 4 [42]. The defined site for the docking search was based on the binding site 
from the NMR structure. The initial positions and orientations of the ligands were 
randomized. Of the ten docked structures, only the lowest binding energy values for each 
ligand are given (Table 10 and Table 11) and the corresponding structures were visualized 
in Maestro [251] (Figure 50 and Figure 51). The lactam bridge of the modified lectin 
structures SP2 and SP3 was created by modifying the disulfide bridge between C6 and C16 
to become a lactam bridge using Gaussview [167], the structures were then minimised. The 
two lactam bridged peptides and the original lectin also underwent docking with L-fucose 
using Autodock 4 [42] to produce 50 structures of lectin-ligand complexes. All images of 
molecular models in this chapter were created using Maestro [251]. 
 
5.5 SUMMARY OF EXPERIMENTAL RESULTS AND CONCLUSIONS 
 
The CD spectra showed that SP3 mainly adopts a similar conformation to that of 
Odorranalectin in solution, the signal of SP3 however did indicate the presence of other 
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conformations not similar to that of Odorranalectin. SP2 gave CD spectra results that were 
indicative of a disordered structure and was found to be similar to that of the linear control 
peptide. The computational conformational prediction of Odorranalectin agreed with the 
findings of the CD spectra, only one conformational cluster was found, with no alternative 
conformations being predicted. The computational structure prediction indicated that SP3 
was more likely to adopt a conformation that was similar to Odorranalectin than SP2.   
The assay to test the binding affinity of the BSA conjugated monosaccharides to the 
fluorescently labelled Odorranalectin showed a strong preference to l-fucose with lesser 
affinity to both galactose and N-acetyl-d-galactosamine. As expected the fluorescently 
tagged control lectin AAL only showed a binding interaction to l-fucose. The ITC measured 
assay of Odorranalectin, SP2 and SP3 with the model glycoproteins fetuin and asialofetuin 
showed similar binding affinities of both Odorranalectin and SP3 with a much greater 
affinity for asialofetuin over fetuin. The lower affinity of fetuin to Odorralectin and SP3 may 
be caused by the terminal sialic acid moiety of the glycan chains blocking the binding of the 
lectins. SP2 was found to have no detectable binding to the two model glycoproteins.  
The results of in vitro the cell toxicity tests showed that Odorranalectin was considered 
somewhat toxic to health human skin fibroblasts at relatively high concentrations (2mg/L). 
Surprisingly the two lectinomimics SP2 and SP3 showed no appreciable in-vitro toxicity at 
even the highest tested concentrations. 
The human serum stability tests showed that all three peptides experienced some level of 
proteolytic degradation, Odorranalectin and SP3 were however more to this resistant than 
SP2. It was also found that SP2 was more likely to suffer from rapid cleavage of linear 
residues 1-5 whereas Odorranalectin and SP3 only suffered cleavage of residues A1 and Y2. 
The resulting metabolites of A1 and Y2 cleavage in Odorranalectin and SP3 were also found 
to degrade much more slowly than any of cyclic metabolites of SP2. 
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The staining assays of the fluorescently labelled analogues of Odorranalectin SP2 and SP3 
with human cancer cell lines showed that Odorranalectin, SP3 exhibited similar binding 
profiles to one another. However, the fluorescence intensity of the SP3 results were less 
intense than those of Odorranalectin. SP2 was found not to bind to any of the tested cancer 
cell lines. Odorranalectin was shown to produce a positive binding fluorescent reaction to 
T-47D, MCF-7, HEP-G2 and MDA-MB-231 cell lines but no binding reaction to the control 
healthy human skin fibroblasts. This is an encouraging result for the use of Odorranalectin 
to detect cancer associated cell surface glycan in vitro with a similar profile to AAL with the 
only notable exception being the MDA-MB-231 cell line for which AAL produced only a 
weakly fluorescent result. The competitive binding assay of the MCF-7 cancer cell line with 
fluorescently labelled Odorranlectin and native Odorranalectin showed that, the native form 
displaces the fluorescently labelled form, this means the native Odorranalectin has a greater 
binding affinity for cancer specific cell surface glycans than the fluorescent labelled form.  
The results of the transwell cell migration assay showed both Odorranalectin and SP3 do 
possess similar antimetastatic abilities against MDA-MB-231 and 231mfp human cancer cell 
lines, they achieve max inhibition at concentration levels of 50μg/L, increase of 
concentration to 100μg/L showed no appreciable improvement. The two lectins showed a 
greater inhibitory effect on the human 231mfp cell line, but only a minor effect on the 
migration of the mouse 4T1 cell line. These results indicate that the three metastatic cancer 
cell lines are having their cell mobility inhibited by the binding of Odorranalectin and SP3 
to their cell surface glycan, however all three cell lines to lesser degrees have alternative 
non-inhibited mechanisms for cell migration not affected by the lectins.  
 
5.6 DOCKING RESULTS AND DISCUSSION 
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Figure 49: The 20 NMR structures of Odorranalectin taken from the pdb structure of 2JQW. The 
peptides are displayed in ribbon view with each structure being randomly assigned a different 
colour to show the structural variance between them. 
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Figure 50: The backbone ribbon of the peptide is shown as a rainbow tube, the binding residues 
of the peptide are shown in a sticks rendering with C, O, N, H, S coloured grey, red, blue, white 
and yellow. The sugar molecules are shown in CPK rendering with the C atoms coloured in 
orange, the rest of the atoms are coloured the same as the peptide binding residues. Potential 
hydrogen bonds and the distance between donor and acceptor are shown in a light green. A) 
Highlights the difference in the binding sites for L-Fucose and D-Glucose. B) The binding site 
for L-Fucose. C) The binding site for D-Galactose. D) The binding site for D-Galactosamine. E) 
The binding site for D-Glucose. F) An Alternative view of the binding site for D-Glucose. 
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  [1] [2] [3] [4] 
Sugar 
Compound 
Estimated 
Free Energy 
of Binding* 
(kcal/mol)  
VDW + H-
bond 
+desolvate
d Energy 
(kcal/mol) 
Electrosta
tic Energy 
(kcal/mol)  
Final 
Total 
Internal 
Energy 
(kcal/mol)  
Torsional 
Free 
Energy 
(kcal/mol) 
Unbound 
System’s 
Energy 
(kcal/mol) 
D-
Galactosamine 
-2.32 -4.10 -0.35 -2.93 +1.79 -2.93 
D-Galactose -2.52 -3.89 -0.41 -3.62 +1.79 -3.62 
D-Glucose -1.50 -3.26 -0.02 0.00 +1.79 0.00 
L-Fucose -2.60 -3.43 -0.36 -2.53 +1.19 -2.53 
 
Table 10: Table of the energy components for the docking of the different sugar compounds 
to Odorranalectin where the *The estimated free energy of binding is defined as: [1 ]+ [2] + 
[3] - [4]. 
 
 
Figure 51: The backbone ribbon of the peptides is shown as a rainbow tube, the binding residues 
of the peptide are shown in a sticks rendering with C, O, N, H, S coloured grey, red, blue, white 
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and yellow. l-fucose is shown in CPK rendering with the C atoms coloured in orange, the rest of 
the atoms are coloured the same as the peptide binding residues. A) Odorranalectin, SP2 and 
SP3 with the docked conformations of l-fucose all overlaid to show the similarity between their 
structures. B) Odorannalectin with docked l-fucose. C) SP2 with docked l-fucose. D) SP3 with 
docked l-fucose. 
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    [1] [2] [3] [4] 
Lectin 
Compound 
Estimated 
Free 
Energy of 
Binding* 
(kcal/mol)  
VDW + H-
bond 
+desolvated 
Energy 
(kcal/mol) 
Electrostatic 
Energy 
(kcal/mol)  
Final 
Total 
Internal 
Energy 
(kcal/mol)  
Torsional 
Free 
Energy 
(kcal/mol) 
Unbound 
System’s 
Energy 
(kcal/mol) 
Odorranalectin -2.60 -3.43 -0.36 -2.53 +1.19 -2.53 
SP2 -2.84 -3.87 -0.16 -2.53 1.19 -2.53 
SP3 -2.83 -3.86 -0.17 -2.52 1.19 -2.52 
Table 11: Table of the energy components for the docking of the l-fucose to Odorranalectin, 
SP2 and SP3 where the *The estimated free energy of binding is defined as: [1 ]+ [2] + [3] 
- [4]. 
 
Molecular docking of the four monosaccharides (l-fucose, d-galactose, N-acetyl-d-
galactosamine, and d-glucose) was conducted to insight into their binding modes with 
Odorranalectin. Energetically favorable interactions were observed for l-fucose, d-galactose 
and N-acetyl-d-galactosamine. The binding pose of d-glucose is distinct in position and 
higher in energy to that of the other docked sugars causing its binding energy on average to 
be higher than the other three sugars by ~1 kcal/mol (Table 10). These results are in good 
agreement with the observed preferential binding of Odorranalectin to l-fucose in 
comparison to the undetectable binding to d-glucose in the fluorescence based binding assay. 
The hydrophobic side chains of the peptide enclose the binding sites of all four of the sugars. 
In the case of d-glucose, these are the side chain of F7 and the aliphatic moiety of K5; and 
for the other three sugars, in addition to F7 and K5, we have also the side chain of Y9. The 
similar binding orientations of l-fucose, d-galactose and d-galactosamine make it hard to 
assess the individual van der Waals’ contributions of the neighbouring non-polar residues, 
to the binding energy. l-fucose, d-galactose and d-galactosamine were found to have the 
same four hydrogen bonds with K5, F7, R8 and Y9; whereas d-glucose, was found to form 
only two hydrogen bonds with the backbone of C6 (Figure 50). This may contribute to its 
relatively higher binding affinity. In addition to the four hydrogen bonds observed in the 
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complexes of d-galactose and d-galactosamine, l-fucose can also form an additional weaker 
hydrogen bond with the backbone carbonyl of R8. The charge of the ring oxygen of l-fucose 
is −0.68. Thus l-fucose can form an electrostatic dipole interaction with the positively 
charged side chain of K5, this may contribute to its relatively strong binding affinity [252]. 
The docking of l-fucose to SP2 and SP3 showed similar interacting residues to that of the 
native peptide Odorranalectin, however the poses differed in their orientations (Figure 51), 
as well as similar estimated free energy of binding (Table 11). The main difference observed 
in the position of l-fucose in SP2 and SP3 as opposed to Odorranalectin is the loss of the 
hydrogen bond with the side chain on K5. Instead the sugar is found to hydrogen bond the 
side chain of N11, this interaction is not found in the docking of l-fucose to Odorranalectin. 
The difference in binding is probably due to conformational changes induced by replacing 
the disulphide bridge with a lactam bridge. Importantly, the structures of SP2 and SP3 were 
minimized structures only, while the structure of Odorranalectin is a representative structure 
from NMR spectroscopy. To more accurately compare the binding affinities of 
Odorranalectin to SP2 and SP3, it would be necessary to account for the conformational 
flexibility of SP2 and SP3 with a conformational sampling method such as MD. The 
proposed alternative binding site for l-fucose interacting with C6, C16 and T17, suggested 
by the NMR titration experiment [253] was not observed in any of the binding poses of any 
of the dockings, even after significant enlargement of the docking area. However, future 
studies involving the consideration of lectin and glycan flexibility, as well as explicit 
solvation, are necessary to confirm this observation.  
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5.7 CONCLUSIONS 
Our molecular docking results for the docking of Odorranalectin to the monosaccharides l-
fucose, d-galactose, N-acetyl-d-galactosamine, and d-glucose showed good agreement with 
the experimental fluorescence based binding assay. The docking of SP3 showed that the 
modified lectin bound l-fucose in a similar yet distinct way than Odorranlectin, this 
confirmed that the lactam bridge modification probably does affect the sugar binding site of 
the lectin. Docking of SP3 to l-fucose showed that the experimentally observed lower 
binding affinity of SP3 to l-fucose was probably not based on the position of the lactam 
bridge in the sugar binding site; instead the lower binding affinity of SP3 was probably 
caused by a larger change in the conformation that was suggested by the CD spectra. The 
observed breakdown of SP2 and Odorranalectin in human serum to their respective cyclic 
metabolites, likely doesn’t affect their ability to bind the sugar molecules as the cleaved 
residues (A1 and Y2) aren’t directly involved in sugar binding according to our predicted 
docking poses. Overall the study showed promising findings for modifying lectin disulphide 
linkages to lactam bridges for the purposed of creating lectinomimics. 
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6 ELECTRONIC STRUCTURE AND ABSORPTION 
SPECTRA OF NEW SYNTHETIC FLUORESCENT 
COMPOUNDS 
6.1 PREFACE 
This chapter describes work done in collaboration with experimental researchers that has so 
far lead to the publication of a paper entitled “Luminescent Probes for Sensitive Detection 
of pH Changes in Live Cells through Two Near-Infrared Luminescence Channels” being 
published in June 2017, the full paper included in the appendix of this thesis gives full credit 
to all of the authors. There is also another paper that has recently been accepted “Fluorescent 
Probes for Sensitive and Selective Detection of pH Changes in Live Cells in Visible and 
Near-infrared Channels” which is also attached in the appendix. A third manuscript is in the 
final stages of preparation and will also soon be submitted. In each of these studies, QM 
calculations were used to determine the 3D structures, absorption spectra, excited states and 
HOMO/LUMO gap energies. This information was used to design and improve new pH 
sensitive luminescent probes. 
The chapter contains an overview of each study and a summary of the full methodology and 
results of the works, as well as a more detailed description of the computational work 
contributed to the research. 
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6.2 INTRODUCTION 
 
Fluorescence is a property defined as the ability to absorb a photon, and almost 
instantaneously re-emit another photon at a different usually shorter wavelength. A 
fluorophore is a chemical compound or group that possesses fluorescent properties, 
fluorophores can be incorporated into other molecules to act as fluorescent labels [254]. 
These fluorescent probes have become an integral tool for biologists, as they can be used to 
tag molecules of interest in order to track their movements in biological systems, and their 
incorporation into fluorescence microscopy has provided scientists with an important 
technique for the non-invasive real-time imaging of live cells [255]. Of particular interest 
are fluorescent probes that can respond to a change in conditions in the extracellular and 
intracellular environments, these allow chemical information to be gathered from the interior 
of small biological structures in a non-invasive manner [256, 257]. Fluorescent probes can 
be designed for a range of uses: to sense macromolecules (specific enzymes, proteins, DNA 
and RNA), specific moieties of larger molecules, and concentrations of specific small 
molecules or ions [258-261]. A fluorescent probe that is sensitive to the concentration of H+ 
ions can be used to detect the pH of the solute in which it is dissolved, and allow for the 
measurement of pH based on the resultant fluorescence spectra [261]. The majority of pH 
sensitive probes work by interconverting between a protonated and deprotonated forms, 
where the two forms have distinct fluorescent properties. In response to the concentration of 
H+ ions the equilibrium between the two forms changes leading to a shift in the fluorescence 
spectra, this allows for the measurement of pH [261, 262]. Studying pH at a cellular level is 
an important technique for understanding the internal architecture of the subcellular 
environment, as well as for understanding the pH differences that arise as a result of altered 
metabolism and disease [263]. Changes in cellular pH are associated with altered metabolic 
pathways than can develop as a result of inflammatory responses, cancer, neurodegenerative 
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diseases, and certain metabolic diseases [264, 265]. In particular, tumour formation is 
associated with increased acidity of the extracellular fluid, and increased basicity of the 
tumour cell internal environment [266, 267]. The acidification of the surrounding 
extracellular environment around tumour cells is thought to be caused by their altered and 
unusually anaerobic metabolic pathways [268]. In normal cells low pH regions can be found 
inside lysosomes these organelles harness their acidic internal conditions to provide the 
optimal conditions for hydrolysing enzymes responsible for the breakdown of proteins, 
peptides, lipids and carbohydrates. Lysosomes fulfil important roles such as the autophagy 
of unnecessary cellular structures, metabolism of waste products and the destruction of 
pathogens [269]. Visualising pH in the intracellular environment with pH sensitive 
fluorescent probes in live cells can give insights into important cellular functions relating to 
lysosome activity, distribution and formation [270].  
However developing fluorescent probes for biological imaging has many challenges (in no 
particular order): (1) probes should not have cytotoxic properties that can harm cells and 
disrupt the very processes they are trying to study; (2) many natural substances in cells such 
as proteins can fluoresce at similar wavelengths to those of the probe causing a phenomena 
called autofluorescence, this can obscure images with background fluorescence and give 
false positive results; (3) probes used for intracellular imaging must be able to cross the cell 
membrane, this usually means they should be water soluble and rely on cellular active 
transport mechanisms; (4) high energy shorter wavelength light can damage cells, so ideally 
probes must have absorption and emission wavelengths higher than 600nm; (5) for in vivo 
imaging, the absorbed and emitted wavelengths of light must be able to penetrate tissue for 
the detection of fluorescence; (6) the stability of the probe, the probe must be chemically 
stable both to intracellular conditions as well as being reasonably stable with regards to 
photobleaching effects (the breakdown of the fluorophore by light); (7) probes should have 
reasonable quantum yields, this is the efficiency of photons that are emitted by the probe vs 
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the number of photons they absorb, poor quantum yields result in probes that don’t give 
strong fluorescent signals and can’t be detected; (8) the probe should be sensitive only to the 
desired analyte and not show false positive results in the presence of other chemicals [256-
259, 262].  
Most of the aforementioned problems concerning autofluorescence, the photodamaging 
effect on cells and the tissue penetrating power of the light can be avoided by ensuring that 
the absorbed and emitted light wavelengths of the probe are in the Near-Infrared (NIR) 
region (650-900nm) [258, 259, 271] . The development of NIR probes is an emerging field 
and new NIR probes are being designed for a range of biologically important uses such as 
detecting reactive oxygen species, inorganic ions, thiol containing species, hydrogen 
sulphide, specific enzymes and pH [258, 259]. It is hoped that these strategies could be used 
to selectively image cancer cells, leading to simpler and non-invasive fluorescence based 
screening of cancerous cells in patients [259, 272]. 
Most fluorophores exhibit a Stokes shift, this is the increase in wavelength between the 
absorbed and emitted photon. Fluorophores with this property require excitation with higher 
energy shorter wavelengths of light, and this is problematic due to the tendency of higher 
frequency photons to damage cells and cause autofluorescence effects [271, 273]. Certain 
fluorophores exhibit anti-Stokes shift properties, this means they absorb lower energy 
photons, longer wavelengths of light, and upconvert them to emit shorter wavelength 
photons [274]. These anti-Stokes shifting fluorophores are particularly useful for the 
imaging of biological systems because the light needed to activate the fluorescent properties 
can be very low energy, this means there is no cell damaging effect and less photobleaching 
of the dye while still providing high levels of detection sensitivity [273, 275]. Most Anti-
stokes shift dyes are lanthanide based nano-particles, however these compounds generally 
have problems with cytotoxicity making them unsuitable for use with living cells [276, 277].  
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In the two papers described in this chapter our experimental collaborators have successfully 
developed and synthesised a pair of novel pH sensitive probes that display anti-stokes shift 
fluorescent properties, and another three novel probes that have fluorescent properties in 
both acidic and neutral basic conditions and for use in imaging intracellular pH in living 
cells [273]. 
 
6.3 “LUMINESCENT PROBES FOR SENSITIVE DETECTION OF PH 
CHANGES IN LIVE CELLS THROUGH TWO NEAR-INFRARED 
LUMINESCENCE CHANNELS” – SUMMARY 
 
These two novel probes were designed around anti-Stokes shifting fluorophores known to 
fluoresce in the NIR range in response to pH changes that were developed previously, 
however the spirolactam based fluorophores alone were found to be quite cytotoxic and had 
poor water solubility making them unsuitable for intracellular imaging [261, 278, 279]. The 
fluorophore uses a reversible spirolactam ring opening/closing reaction to “sense” pH 
changes, in acidic conditions (pH <7.4) the protonated form of the fluorophore’s spirolactam 
ring is opened and possesses both conventional and anti-stokes shifting fluorescent 
properties. In neutral and basic pH conditions (pH >7.4) the spirolactam ring is deprotonated 
and closed, in this state the fluorophore is colourless and shows no fluorescent properties. 
The opening of the spirolactam ring in response to pH causes increased π-conjugation in the 
fluorophore and the emergence of their fluorescent properties. This range of pH sensitivity 
means that the fluorophore is very weakly fluorescent at extracellular pH levels and become 
very fluorescent in the acidic conditions of lysosomes. 
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Figure 52: The generic structure of the pH sensitive rhodamine fluorophore in both its 
protonated and deprotonated forms. 
 
In “Luminescent Probes for Sensitive Detection of pH Changes in Live Cells through Two 
Near-Infrared Luminescence Channels” the aforementioned fluorophore was conjugated to 
mannose sugar molecules by a linker composed of a 2,2`-(ethylenedioxy)diethylamine to 
produce two distinct probes. Probe A containing a single mannose residue and Probe B 
containing two mannose residues. In the study different properties of the probes were 
investigated: (1) the response of the absorption and fluorescence spectra of the two probes 
to varying pH levels; (2) the selectivity of the probes towards H+ ions as opposed to other 
positively charged metal ions; (3) the photostability of the two probes in response to constant 
excitation; (4) The cytotoxicity of the two probes to live human cells; (5) the permeability 
and resultant fluorescence of the probes in live human cells.  
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Figure 53: The structure of probe A from “Luminescent Probes for Sensitive Detection 
of pH Changes in Live Cells through Two Near-Infrared Luminescence Channels” in its 
protonated and deprotonated forms. 
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Figure 54: The structure of probe B from “Luminescent Probes for Sensitive Detection 
of pH Changes in Live Cells through Two Near-Infrared Luminescence Channels” in its 
protonated and deprotonated forms. 
 
6.3.1 Computational Methods 
The structures of the two probes A and B in both acidic and neutral-basic pH conditions 
were built using GaussView [167]. The four structures were then optimised with Gaussian09 
[94] in a Polarizable Continuum Model (PCM) of solvent water with a 6-31G(d) basis set 
using the DFT B3LYP functional. The HOMO/LUMO orbitals of the two probes in acidic 
and basic conditions were generated from their optimised structures and visualised in 
GaussView [167].  
 The protonated structures of probe A and B underwent excited state Time Dependent - DFT 
(TD-DFT) optimisations of the first six singlet (S=0) excited states in PCM solvent water 
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with the B3LYP functional and a 6-31G* basis set in Gaussian09 [94]. From the excited 
state optimisations, the absorption spectra data was extracted using GaussView [167]. All 
images of molecular models for this chapter were created using GaussView [167]. 
6.3.2 Summary of Experimental Results  
The two probes had their absorption and fluorescence spectra measured in a range of pH 
conditions between pH 2.2-8.0. As pH decreases the absorbance peak observed at ~375nm 
decreases. Whereas the absorbance peak at ~715nm and its accompanying shoulder peak at 
~650nm is found to reach maximum absorbance at pH 4.4, decreasing the pH below 4.4 
results in less observed absorbance in this region. It is thought the tertiary amine may become 
protonated at particularly low pH levels affecting the π-conjugation of the fluorophore 
system and therefore its optical absorbance. The fluorescence spectra of the two probes 
showed them to be not fluorescent when pH >7.4, as the pH is decreased peaks are observed 
to form and increase in intensity at ~740nm in both the conventional and anti-stokes shift 
fluorescence spectra. Peak levels of fluorescence are observed at pH 4.4, in more acidic 
conditions the intensity of the fluorescence is decreased, this is again thought to be due to 
the protonation of the tertiary amine group. In acidic conditions where the spirolactam ring 
opened form of the probes is most prevalent the strongest conventional fluorescence is 
observed with an excitation wavelength of 690nm, the strongest anti-stokes shift 
fluorescence is observed with an excitation wavelength of 808nm. In both probes this pH 
response is reversible in the measured pH range of 2.2-8.0. The fluorescence quantum yields 
of probes A and B at pH 4.4 were calculated to be 8.4% and 8.1% respectively. 
Both probes showed very little change in their fluorescent intensity at both neutral-basic and 
acidic conditions in solutions of a range of metal ions (Cu2+, Na+, Fe2+, Zn2+, Al3+, Ca2+, 
Mg2+, Mn2+, Ag+, K+, Ni2+ and Co2+), indicating that they make good selective probes of H+ 
and therefore pH even in the presence of metal ions. 
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The probes were excited continuously by 690nm light and in intervals of time the 
conventional fluorescence intensity was observed to assess the photostability of the probes, 
the conventional fluorescence intensity of both probe A and B showed a reduction in 
intensity of about ~11% after 3 hours of interval excitation. The anti-stokes shift 
fluorescence intensity of the two probes was measured in a similar manner with an excitation 
wavelength of 808nm, after 3 hours the anti-stokes shift fluorescence intensity of both probes 
had barely decreased. This demonstrated the excellent photostability of the two probes anti-
stokes shifting fluorescent properties.  
The cytotoxic properties of the two probes were assessed with an XTT assay with live human 
fibroblasts, cell viability was reduced somewhat by both probes, however even at a 
concentration of 50µM the viability greater than 70%. At the concentration levels used for 
cell for the cell staining portion of the experiment (5-20 µM) cell viability would not be too 
negatively affected by the probes.  
To test the ability of the probes to stain live cells, they were incubated at varying 
concentrations (5-20 µM), with HeLa and KB cell lines. The distribution and intensity of 
fluorescent regions in cells treated with the two probes was compared against lysotracker, 
an established dye for staining acidic compartments in live cells. Probe A and B show 
fluorescent spots that are shown to match well to the same cellular areas of low pH as those 
areas stained by lysotracker. Both conventional and anti-stokes shift fluorescence intensity 
was found to increase with probe concentration. The ability of the probes to respond to extra 
and intracellular pH levels was tested by incubating the cells in buffer solutions at a range 
of pH values (4.5, 5.5, 6.5 and 7.5) with nigericin, a compound used to equilibrate 
intracellular pH levels to those of the extracellular environment. At the normal physiological 
pH 7.5 both probes showed only weakly fluorescent results, a decrease in pH level saw both 
the conventional and anti-stokes fluorescence intensity of the stained cells increase. The 
observed pH sensitive change in fluorescence was in good agreement with the optical 
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responses of the probes in different pH solutions. The two probes also both showed a greater 
sensitivity to pH in the range tested than the commercial lysotracker.  
 
6.3.3 Computational Results and Discussion 
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Figure 55: i) and ii) show probe A in the deprotonated form, ii) is a rotated view of i) 
emphasising the angle between the spacer region and the plane of the fluorophore. iii) 
and iv) show probe B in the blue form, iv) is a rotated form of iii). 
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Figure 56: i) and ii) show probe A in the protonated fluorescent form, ii) is a rotated 
view of i) emphasising the angle between the spacer region and the plane of the 
fluorophore. iii) and iv) show probe B in the pink form, iv) is a rotated form of iii). 
 
Figure 57: i) and ii) show the excited state geometry of probe A in its protonated form, 
ii) is a rotated view of i) emphasising the angle between the spacer region and the plane 
of the fluorophore. iii) and iv) show the excited state geometry of probe B in its 
protonated form, iv) is a rotated form of iii). 
 
Structure 
HOMO/LUMO gap 
(eV) 
Probe A 
deprotonated 0.128 
Probe B 
deprotonated 0.12813 
Probe A 
protonated 0.08492 
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Probe B 
protonated 0.08483 
Excited state 
Probe A 
protonated 0.08042 
Excited state 
probe B 
protonated 0.08039 
 
 
Table 12: The calculated HOMO-LUMO gap energies for the two fluorescent probes A 
and B in their optimised deprotonated and protonated forms as well as the excited state 
optimisations of the protonated form. 
 
 
Figure 58: The absorption spectra of the excited state optimisations of the protonated forms 
of probes A and B. 
 
Probe 
Singlet first excited 
state energy (eV) 
Wavelength 
(nm) 
Oscillatory 
strength 
A 1.797 689.94 1.3534 
B 1.7982 689.48 1.3661 
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Table 13: Results from the excited state calculations of Probe A and B. 
 
Figure 59: i) HOMO orbital of Probe A in its deprotonated form, ii) LUMO orbital of 
Probe A in its deprotonated form, iii) HOMO orbital of Probe A in its protonated form, 
iv) LUMO orbital of Probe A in its protonated form. 
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Figure 60: i) HOMO orbital of Probe A in its deprotonated form, ii) LUMO orbital of 
Probe A in its deprotonated form, iii) HOMO orbital of Probe A in its protonated form, 
iv) LUMO orbital of Probe A in its protonated form. 
 
Despite the only difference between probes A and B being the addition of another mannose 
group to the spacer moiety, the two probes show observable differences in fluorescence at 
acidic pH. The optimised spirolactam ring closed structures of probes A and B at basic pH 
are structurally quite similar, their optimised geometries can be seen in Figure 55. The 
optimised structures of the ring opened forms of probes A and B in acidic conditions are also 
alike, a minor difference is that the mannose in probe B is roughly parallel to the plane of 
the fluorophore region (Figure S2). The main noticeable structural difference between the 
opened and closed spirocyclic ring forms of the two probes is the angle between the mannose 
tail moiety and the plane of the fluorophoric ring moiety. The spirocyclic ring closed form 
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of the probes in neutral-basic conditions shows a more acute angle between the spacer moiety 
and the fluorophore plain whereas in the acidic form the angle is closer to being 
perpendicular, this means in the closed spirocyclic form the tail moiety lies closer to the 
fluorophoric ring moiety (Figure 56). The energy differences between the LUMO and 
HOMO orbitals is very similar in both probes A and B. In the acidic forms the HOMO-
LUMO energy gap is smaller than in the basic forms (Table 12). The greatest structural 
difference between probes A and B is seen in the structure of the excited state optimised 
structures of the spirocyclic ring opened forms in acidic conditions (Figure 57). In this probe 
B is found to adopt a more compact and distorted in geometry compared to the other 
structures of probe A, the angle between the spacer and the fluorophore is very acute and the 
mannose residues lie directly over the fluorophore, this could possibly cause fluorescence 
quenching by consuming energy via molecular rotation of the mannose residue of probe B. 
These differences in the optimised geometry may explain the difference in the 
experimentally observed fluorescence. The absorption spectra for the two excited state 
optimisations was shown in Figure 58 and Table 13, although similar, some variation is seen 
in the region 300-550 nm. The HOMO and LUMO orbitals are presented in Figure 59 and 
Figure 60 for probes A and B, respectively. The opening of the spirocylic ring under acidic 
conditions causes the HOMO orbital of both probe A and B to shift from the substituted 
indole ring and its conjugated alkene chain region to become more spread out over the 
rhodamine-like fluorophore moiety. The LUMO orbitals of probe B seem to show a similar 
if less pronounced effect where the orbital becomes more spread out over the rhoadmine-
like fluorophore moiety upon ring opening. 
 
6.4  “FLUORESCENT PROBES FOR SENSITIVE AND SELECTIVE 
DETECTION OF PH CHANGES IN LIVE CELLS IN VISIBLE AND 
NEAR-INFRARED CHANNELS” - SUMMARY  
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The three probes A, B and C described in this paper improved upon the fluorescent 
functionality of the probes developed in the previous paper. Most pH sensitive probes like 
those from “Luminescent Probes for Sensitive Detection of pH Changes in Live Cells 
through Two Near-Infrared Luminescence Channels” don’t have fluorescent properties in 
neutral-basic conditions, this can lead to “blind spots” at these pH levels. Probe A, B and C 
were created by conjugating the spirolactam rhodamine based fluorophore to different 
coumarin moieties, the coumarin fluorophore moiety is known to have fluorescent properties 
in the visible light spectral range, and the spirolactam rhodaminefluorophore known to have 
pH sensitive NIR fluorescent properties. By combining these two fluorophores it was hoped 
that the probes would have the desired distinctive fluorescent properties in both acidic and 
neutral-basic conditions allowing for the probes detection in non-acidic conditions to remove 
imaging “blind spots”. To increase the water solubility of the probes an azide moiety joined 
to the fluorophore by an oligo(ethylene glycol) spacer was attached to the fluorophore 
moiety. The terminal azide group is a commonly used moiety in click chemistry and allows 
for functionalisation through the addition of diverse moieties such as sugars and peptides for 
the future development of derivative compounds. As well as testing the spectral responses 
of the probes to pH levels both in solution and in vivo, the probes would be tested for their 
sensitivity to H+ over commonly found metal ions, photostability over time, cell membrane 
permeability, and cytotoxicity.  
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Figure 61: The structure of probe A from “Fluorescent Probes for Sensitive and 
Selective Detection of pH Changes in Live Cells in Visible and Near-infrared Channels” 
in both its protonated and deprotonated form. 
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Figure 62: The structure of probe B from “Fluorescent Probes for Sensitive and 
Selective Detection of pH Changes in Live Cells in Visible and Near-infrared Channels” 
in both its protonated and deprotonated form. 
 
Figure 63: The structure of probe C from “Fluorescent Probes for Sensitive and 
Selective Detection of pH Changes in Live Cells in Visible and Near-infrared Channels” 
in both its protonated and deprotonated form. 
 
6.4.1 Summary of Experimental Results  
The fluorescence spectra of the 3 probes dissolved in buffer solutions were recorded as the 
pH of the solutions was decreased from pH 7.6 to 1.6. At neutral-basic pH the three probes 
A, B and C showed absorption peaks at 420nm, 445nm and 415nm respectively with some 
additional very weak absorbance at ~650nm also being recorded. As pH is decreased new 
absorption peaks at 655nm 670nm and 653nm are observed for probes A, B and C 
respectively, this absorption was found to increase in intensity as the pH is lowered from 7.4 
to 4.0, below 4.0 the absorption remains high but doesn’t increase further. The measured 
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fluorescence spectra of the probes A, B and C show two sets of new NIR peaks emerging at 
711nm, 696nm and 707nm respectively, in response to the pH being lowered from 7.4 to 
1.6. Additional new non-NIR fluorescent peaks were observed at 497nm, 482nm and 498nm 
for probes A, B and C respectively were also observed with a similar pH sensitive response 
as the NIR peaks. All three probes were shown to possess these optical response properties 
in a completely reversible manner in the range of pH 2.0-10.0. The quantum yields of probes 
A, B and C were calculated to be 2.77%, 1.85% and 0.65% at pH 2.0 with an excitation 
wavelength of 625nm, with a shorter excitation wavelength of 425nm the quantum yields of 
the three probes were 2.73%, 2.64% and 4.86% respectively.  
All three probes showed little response in their fluorescence spectra intensity in both neutral-
basic (pH 7.6) and acidic (pH 2.0) conditions in solutions with different metal ions (Fe2+, Cr 
2+, Mn2+, Fe 3+, Zn2+, Mg2+, Ag+, Ca2+, Al3+, Cu2+, Ni2+, Co2+, Hg2+ and Cd2+) indicating their 
selectivity for H+ and therefore their ability to be pH sensitive probes even in the presence 
of metal ions. 
To test the photostability of the three probes they were repeatedly excited by 690nm 
wavelength light in 5min time intervals while their fluorescence spectra was recorded in 
10min intervals for a total of 3 hours. After 3 hours all three probes had lost <10% of their 
fluorescence intensity indicating their excellent photostability.  
The cytotoxic properties of the three probes were assessed by incubating them at a range of 
concentrations (5-50µM) with live cells from the MDA-MB231 cell line. Probe A had a 
moderate effect on cell viability with concentrations 5-20µM having >70% cell viability. 
Probes B and C were less tolerated and had a more severe effect on cell viability, and only 
retained >70% cell viability at 5µM and 10µM levels of concentration. All three probes had 
profoundly negative effects on cell viability at the 50µM level of concentration. 
Live cell staining was performed with the MDA-MB231 and HUVEC-C cell lines for all 
three probes at 10µM concentrations, the commercially available lysosensor blue probe was 
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used to compare the ability of the probes to detect areas of low pH at the intracellular level. 
Based on the initial observations it was found that probes A and C showed no NIR 
fluorescent signals in the live cell staining tests, probe B however performed well and 
underwent further live cell staining. Probe B is less hydrophobic than the other two probes, 
this may be the reason it was more able to permeate into the live cells and produce 
fluorescence results in the NIR range; as opposed to probe A and C which performed equally 
well in solution but weren’t able to fluorescently stain live cells. Probe B underwent 
additional live cell testing and was incubated with MDA-MB231 and HUVEC-C cells in 
buffer solutions at a range of pH levels 4.5, 5.5, 6.5, 7.5 and 8.5, nigericin was used to 
equilibrate the intracellular pH levels to those of the buffer solution. Increasing NIR 
fluorescence in response to decreasing pH was observed at the pH levels tested, with 
maximum fluorescence being observed in the pH 4.5 buffer solution. Comparing probe B 
stain locations to those of the lysosensor blue probe showed that the two probes were found 
in the same intracellular regions of low pH.  
 
6.4.2 Computational Methods 
GaussView [167] was used for building the structures of probes A, B and C both in 
protonated and deprotonated state. Geometry optimisation of the six structures was 
performed using DFT with the B3LYP functional [209, 210] and 6-31G* basis set in 
Gaussian09 [94]. The Polarizable Continuum Model (PCM) [280, 281] with a dielectric 
constant of 78.39 was used to represent the water solvent. Computationally predicted 
absorption spectra were calculated using Time Dependent - DFT (TD-DFT) with B3LYP 
functional [209, 210] and 6-31G* basis set in PCM [280, 281] in Gaussian09 [94]. From the 
optimisations of the first six singlet (S=0) excited states in PCM solvent water with the 
B3LYP functional and a 6-31G* basis set in Gaussian09 [94] the absorption spectra data 
was extracted using GaussView [167]. From these calculations, the HOMO and the LUMO 
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orbitals and absorption spectra were visualised using GaussView [167]. All images of 
molecular models for this chapter were created using GaussView [167].  
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6.4.3 Computational Results and Discussion 
 
Figure 64: The calculated absorption spectra of the three fluorescent probes A, B and C in 
both their protonated (pink) and deprotonated (blue) forms. 
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Figure 65: The combined calculated absorption spectra of the three fluorescent probes in 
their deprotonated forms. 
 
Figure 66: The combined calculated absorption spectra of the three fluorescent probes in 
their protonated forms. 
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Compound HOMO 
Energy 
(eV) 
LUMO 
Energy 
(eV) 
HOMO-LUMO 
Gap Energy 
(eV) 
A Deprotonated -0.1882 -0.0608 0.1274 
A Protonated -0.2021 -0.1141 0.0880 
B Deprotonated -0.1941 -0.0645 0.1296 
B Protonated -0.2081 -0.1160 0.0922 
C Deprotonated -0.1810 -0.0634 0.1176 
C Protonated -0.2036 -0.1119 0.0917 
Table 14: The calculated HOMO and LUMO energy as well as HOMO-LUMO gap 
energies of the three fluorescent probes in both their protonated and deprotonated forms. 
 
Compound Excitation Energy 
Wavelength (nm) 
Oscillator 
Strength 
A Deprotonated 392.19 0.6798 
A Protonated 578.34 1.1863 
B Deprotonated 397.81 0.0415 
B Protonated 558.32 1.1952 
C Deprotonated 444.82 0.0102 
C Protonated 566.28 1.0661 
Table 15: The calculated excitation energy wavelengths and oscillator strengths three 
fluorescent probes in both their protonated and deprotonated forms. 
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Figure 67: The optimised structures of the protonated and deprotonated forms of fluorescent 
probe A , with atoms coloured as follows carbon is grey, hydrogen is white, nitrogen is blue 
and oxygen is red. Visualisations of their HOMO and LUMO orbitals are coloured by 
wavefunction in either red or green. 
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Figure 68: The optimised structures of the protonated and deprotonated forms of fluorescent 
probe B, with atoms coloured as follows carbon is grey, hydrogen is white, nitrogen is blue 
and oxygen is red. Visualisations of their HOMO and LUMO orbitals are coloured by 
wavefunction in either red or green. 
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Figure 69: The optimised structures of the protonated and deprotonated forms of fluorescent 
probe C, with atoms coloured as follows carbon is grey, hydrogen is white, nitrogen is blue 
and oxygen is red. Visualisations of their HOMO and LUMO orbitals are coloured by 
wavefunction in either red or green. 
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In general, the structures of the deprotonated forms of the probes showed a conformation in 
which the tail moiety is found to become parallel to the fluorophore region (Figure 67, Figure 
68 and Figure 69). Upon protonation and breakage of the spirolactam bridge the structures 
did not show much structural change, the tail moiety remained roughly parallel to the 
fluorophore moiety. The calculated absorption spectra of probes A, B and C in their 
deprotonated forms show maxima between 360nm and 400nm (Figure 65). The absorption 
spectra of the protonated forms of the probes show a broad peak around 570nm with a 
shoulder found at ~380nm (Figure 66). The calculations show similar differences in the 
positions of the maxima between the deprotonated and protonated forms as in the 
experimental spectra. Probe B in its protonated form also shows the highest oscillator 
strength as the experimental absorption spectra. The maximum in the spectra of protonated 
form of B is position at lowest wavelength in respect to protonated forms of A and C. The 
inspection of the energy difference between HOMO and LUMO shows a similar trend with 
Probe B having the largest energy gap in both protonated and deprotonated forms (Table 
14). The HOMO orbital of the deprotonated probes B and C mainly shows contributions 
from the aromatic nitrogen atom of fluorophore moiety and some contribution from the 
phenyl ring adjacent to the spirolactam bond (Figure 67, Figure 68 and Figure 69). In the 
HOMO orbital of the deprotonated form of probe A, there is a major contribution from the 
coumarin moiety. The LUMO orbitals of all 3 probes in their deprotonated forms are found 
to be centred on the coumarin moiety. In the protonated form the HOMO orbitals of all 3 
probes are very similar and exhibit contributions from the coumarin and fluorophore moiety. 
The LUMO orbitals of the protonated forms of the 3 probes are also very similar between 
the 3 probes, as well as showing distribution across the coumarin and fluorophore moeity 
we see some of the orbital also on the phenyl ring adjacent to the amide bond. 
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7 CONCLUSIONS 
The molecular dynamics simulations of tryptophan halogenase gave us insight into the 
structural similarities of the two halogenase enzymes, PrnA and PyrH. From our MD 
simulations we found that the selectivity of the two enzymes probably arises from their 
distinct tryptophan binding sites which orient the tryptophan in the binding site so only one 
halogenated product is produced. Our comparisons of the MD simulations to crystal 
structures revealed the differences brought about when the proteins are crystallised. An FAD 
strap region that had previously been identified in PyrH was also shown to probably exist in 
PrnA and may hold the key to the two observed differences in the kinetics of the two 
enzymes. Analysis of the mutant structures of PrnA revealed that the likely reason for their 
inactivity is their inability to bind hypochlorous acid in the active site. 
 
Our QM cluster models and QM/MM model of the FTO active site showed geometric 
parameters that were consistent with experimental results. Some of these QM clusters were 
used to calculate the formation of the Fe(IV)-oxo species successfully. Our differently sized 
QM clusters models seem to indicate that the cut form of 2OG is not an adequate replacement 
for the realistically sized 2OG ligand for the purposes of studying the FTO active site.  
 
Our docking studies successfully predicted the structure of the bound complex of fructose to 
GLUT5 with results that were consistent with those predicted by experimental methodology. 
We successfully created a solvated membrane bound simulated model of GLUT5 and have 
performed some preliminary analysis of its conformational dynamics and shown the model 
structure to be stable at the timescale of our MD simulations. 
 
The docked structures of the different sugar ligands to Odorranalectin were successfully 
created and their relative free energy of binding results reflected their actual relative binding 
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affinities measured by experimental methods. From the docked structures we were able to 
suggest why some sugars had a greater affinity to the lectin structure than others. 
 
Our computational structures of the various fluorescent probes revealed possible structural 
reasons for their different fluorescent results. Our calculated absorption spectra of the probes 
showed some agreement with those derived by experimental means. The computed orbital 
structures were used to suggest electronic structural differences that may have led to the 
observed differences in fluorescent results between the various probes. 
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